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Abstract 
Acute coronary artery occlusion is the most common cause of sudden cardiac 
death. In some cases an acute myocardial infarction (MI) can immediately lead 
to lethal arrhythmias, but the factors that determine whether an MI precipitates 
arrhythmias are uncertain. In this thesis, I compare and contrast the detailed 
electrophysiology of hearts that develop arrhythmias post MI compared to those 
that do not using voltage sensitive fluorescent dyes in isolated rabbit hearts. 
In an attempt to improve the information from voltage mapping studies, initial 
work involved attempts to use ratiometric imaging of the fluorescence from the 
dye RH237. These identified optimal filter settings to collect voltage data at two 
distinct wavebands that would eliminate movement artefact and permit absolute 
voltage measurements. But routine implementation of this technique was 
prevented by additional technical issues related to uneven illumination levels 
and alignment of the two cameras. 
In initial studies the drug E-4031, a selective blocker of the delayed rectifier 
potassium current (IKr), was used to assess the contribution of this channel to 
repolarisation in rabbit ventricle, both in the steady state at a range of 
physiological and sub-physiological frequencies and in the transition between 
step frequency changes. The data suggests that IKr has a small but significant 
contribution to repolarisation at normal heart rates, 300ms pacing cycle length; 
a close to maximal concentration of E-4031 (0.03M) increased action potential 
duration (APD90) by 8.5 ± 1.7ms (P<0.01). This contribution is considerably larger 
at lower stimulation frequencies; at 1Hz E-4031 increased APD by 73.7 ± 13.7ms 
(P<0.05). The EC50 for E-4031 in this study was 0.01M which is similar to that 
reported in the literature. The recovery of the channel from inactivation 
appeared an important determinant of the rate of adaptation of the action 
potential duration. 
In the main experimental section, a novel snare technique was used to produce 
the acute coronary artery occlusion in the apical region of the left ventricle (LV) 
free wall. From control experiments (n=21), 47.6% of the hearts develop 
ventricular fibrillation (VF) within 30 minutes of coronary artery occlusion. On 
average, hearts with intrinsically longer epicardial action potential duration 
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prior to ischaemia (mean APD50 168.8 ± 5.5ms) did not develop VF, and those 
with shorter APD (mean APD50 141.5 ± 3.5ms) during pre-occlusion period were 
more prone to VF (P<0.001). However, artificially prolonging the APD with the 
drug E-4031 (0.03 concentration) prior to coronary artery occlusion did not 
significantly change the incidence of arrhythmia. Brief and transient exposure to 
isoprenaline (0.3Mconcentration) before the occlusion shortened the average 
APD prior to occlusion but still did not increase the likelihood of VF. Therefore, I 
concluded that shorter epicardial APD values prior to ischaemia are associated 
with a higher incidence of arrhythmia but are not the cause.  
To investigate this further, a panoramic optical mapping technique was used to 
look at the electrophysiological properties across the entire ventricular surface 
of the hearts. The panoramic optical mapping study confirmed the correlation 
between shorter APD pre-occlusion and the incidence of VF during occlusion and 
indicated that the region of the LV exhibiting a shorter APD is confined to the 
apical half of the LV, and does not include basal LV or RV electrophysiology. 
Panoramic imaging also revealed a delayed activation time predominantly in the 
basal aspects of the LV. Both of these events – shorter APD in the apex and 
longer activation time in the base – were a feature of hearts that developed VF 
on ligation of the coronary artery. Future work will investigate the 
cellular/molecular basis for these differences in ventricular electrophysiology. 
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IK1  Inward rectifier potassium current 
INa  Sodium current 
INCX  Sodium-calcium exchanger current 
Ito  Transient outward current 
IU  International unit 
KCl  Potassium chloride 
LED  Light-emitting diode 
LP  Long-pass 
LQTS  Long QT syndrome 
MI  Myocardial infarction 
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mV  Millivolts 
NA  Numerical aperture 
Na+  Sodium 
NCX  Sodium/calcium exchanger 
OAPs  Optical action potentials 
PDA  Photodiode array 
pO2  Partial pressure of oxygen in the blood 
PVCs  Premature ventricular contractions 
pVT  Polymorphic ventricular tachycardia 
RRP  Relative refractory period 
SA  Sinoatrial 
SCD  Sudden cardiac death 
SEM  Standard error of the mean 
SR  Sarcoplasmic reticulum 
SQTS  Short QT syndrome 
TActM Activation time (from pacing stimulus to the midpoint of the  
upstroke of the action potential) 
TdP Torsade de Pointes 
TWA T-wave alternans 
VF Ventricular fibrillation 
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Vm  Transmembrane potential 
VPACE  Ventricular pacing 
VPBs  Ventricular premature beats 
VSDs  Voltage-sensitive dyes 
VT  Ventricular tachycardia 
[Ca2+]o Extracellular calcium concentration 
[K+]o  Extracellular potassium concentration 
[Mg2+]o Extracellular magnesium concentration 
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Aim 
The aim of this introduction is to describe basic cardiac electrophysiology and 
the changes that occur during acute myocardial ischaemia, to provide a general 
overview of the phenomena of sudden cardiac death related to ventricular 
fibrillation associated with acute myocardial ischaemia, and to summarize the 
mechanisms of ventricular arrhythmias which lead to sudden cardiac death.  
Cardiac electrophysiology 
Cardiac action potential 
The cardiac action potential (AP) is a dynamic and phasic change in membrane 
potential generated by ionic gradients and tightly orchestrated sequence of 
opening and closing of ion channels. The two general types of cardiac action 
potential are non-pacemaker and pacemaker action potentials. The non-
pacemaker action potential is generated in atrial, ventricular and Purkinje 
myocytes and the event is triggered by depolarisation of the adjacent connected 
cells. These action potentials have a stable resting potential, a fast 
depolarisation phase, and a repolarisation phase as shown in Figure 1.1. In 
contrast, the electrical activity of pacemaker cells, namely cardiomyocytes in 
the sinoatrial (SA) and atrioventricular (AV) nodes, display automaticity. In these 
cells, the diastolic membrane potential is not stable, continuously depolarising 
to a threshold for the activation of rapid depolarisation. The action potential 
from non-pacemaker cells is divided into five numbered phases (0 - 4, see Figure 
1.1) and the underlying ionic currents responsible for these phases are 
summarized in Figure 1.1.   
Chapter 1  22 
 
Figure 1.1 Rabbit ventricular action potential.  
The number indicates different phases of AP. The arrows indicate the movement of ionic 
currents into the cell (blue arrows) or leaving the cell (red arrows) which contribute to the 
generation of AP. 
Phase 0 is the rapid depolarisation phase caused by the activation of a fast Na+ 
current (INa) exhibiting very rapid activation and inactivation kinetics. A 
threshold membrane voltage needs to be reached (~-70mV) before the fast Na+ 
channel start to activate, during this phase the Na+ conductance is the dominant 
membrane conductance and therefore the membrane potential is determined by 
the equilibrium potential for Na+ (~+30mV). At these positive potentials, INa 
inactivation is accelerated and the Na+ conductance quickly falls. As the 
membrane potential depolarises past ~-40mV, inward Ca2+ currents are activated 
namely L-type (ICa,L) and T-type (ICa,T). These currents also inactivate at positive 
potentials. 
Phase 1 is the initial repolarisation phase. This phase is largely due to the 
activation of a transient outward current (Ito) that is rapidly activated during 
depolarisation alongside the decrease in Na+ and Ca2+ conductance associated 
with inactivation of INa and ICa. 
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Phase 2 is the plateau phase of the cardiac action potential and contributes to 
the lability of the action potential duration (APD). During this phase, there is an 
approximate balance between positive inward and outward currents. The 
primary inward current is the L-type Ca2+ current (ICa,L), whereas the primary 
outward current is the delayed rectifier potassium current (IK). The ICa,L is the 
primary link in excitation-contraction coupling in the heart. The influx of 
calcium ions stimulates calcium release from internal stores and activates the 
contractile proteins. The electrogenic Na+/Ca2+ exchanger (NCX) transiently 
works in reverse mode to bring the influx of Ca2+ into the cell and extract the 
Na+ (3 Na+ : 1 Ca2+) thereby contributing to the net outward current during this 
plateau phase. 
Phase 3 is the repolarisation phase. It is mainly caused by an imbalance of the 
currents involved in phase 2. ICa,L decreases as the channels being inactivated, 
and IK increases with time due to its slow activation and later becomes the 
dominant repolarising current. There are several components of IK: a very slow 
component (IKs), a rapid component (IKr), and ultrarapid delayed rectifier K
+ 
current (IKur). However, IKur has only been identified in atrial cells in human 
(Feng et al., 1998; Wang et al., 1993). Studies show that these different 
components of IK are carried by different channels (Nerbonne, 2000). 
Phase 4 is resting membrane potential which is stable (approximately at -90 mV) 
that occurs in between AP in non-pacemaker cardiomyocytes. The stable 
potential during phase 4  is largely due to non-time-dependent background K+ 
current termed the inward rectifier current (IK1) which passes the current more 
readily in the inward direction as compared to the outward direction. This 
property ensures that when the membrane potential is approximately 0mV 
during the plateau phase, the outward current carried by IK1 is small and does 
not require large inward currents to maintain a semi-stable phase. 
Spatial dispersion of APD 
Studies have shown that there is marked heterogeneity in ventricular AP 
morphology both within and between species. APD is longer at the apex than at 
the base (Cheng et al., 1999) and shorter in the epicardium as compared to the 
endocardium (Fedida and Giles, 1991). In larger mammals, the epicardial AP also 
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shows a distinctive “spike and dome” morphology thought to be due to Ito which 
is more abundant in the epicardium. Study by McIntosh et al. (2000) 
demonstrates that the APD from three different ventricular layers are not 
uniform (Figure 1.2). 
 
 
Figure 1.2 Spatial dispersion of APD from single cardiac myocytes. 
Spatial dispersion of APD from single cardiac myocyte isolated from three different layers 
of left ventricle during stimulation at 0.3Hz. The morphology of the AP varies depending on 
its location. The effect of transmural infarct (•) also displayed in the figure. (Adapted from 
McIntosh et al. (2000) 
As shown in Figure 1.2, a third AP type is sometimes seen in midwall of the 
mammalian ventricle, namely the “M-cell” which has a longer APD than either 
epicardial or endocardial cells. M-cells have been identified in a range of 
mammalian species including human, rabbit, guinea pig, canine and pig 
ventricles (Drouin et al., 1995; McIntosh et al., 2000; Sicouri et al., 1996; Sicouri 
and Antzelevitch, 1991; Stankovicova et al., 2000). The effect of these cells on 
the electrophysiology of the ventricle is uncertain (and controversial) since the 
marked APD prolongation observed in isolated cells is attenuated by the 
electrical network of cells within the ventricle wall (Yan and Antzelevitch, 
1998). 
Refractory period 
The refractory period in cardiac myocytes can be divided into: 1) absolute 
refractory period (ARP), 2) relative refractory period (RRP), and 3) effective 
refractory period (ERP). The refractory period is an important feature of cardiac 
muscle because it ensures enough time elapses for the heart to fill between 
contractions before reactivation is possible. During the ARP, no action potential 
can be triggered regardless of how much inward current is supplied. In this 
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period, the myocardium is non-excitable because the Na+ currents are 
inactivated. In the RRP, the Na+ channels slowly recover during the final 
repolarisation of the cell. During this period, myocardial excitability is reduced, 
conduction is slower, AP amplitude is lower, and the threshold potential is 
shifted to less positive potentials requiring a greater stimulus. APs can be 
generated but not propagated during ERP.  
Refractory period is a key concept in the understanding of arrhythmogenic 
mechanisms (Burton and Cobbe, 2001).  Ventricular tachycardia is frequently 
caused by a re-entrant circuit in an area of myocardium leading to continuous 
self-excitation of an area of myocardium effectively independent of sinus node 
activity. Normally, self-excitation does not occur because the refractory period 
is longer than the time taken for this area to be reactivated. But if this time 
becomes longer than the refractory period, either by an increase in circuit path 
length or a slower conduction velocity, re-excitation and hence sustained re-
entrant ventricular tachycardia is possible. This mechanism is encapsulated in 
the idea of electrical “wavelength” which is the distance travelled by the AP 
over the period of a refractory period (Smeets et al., 1986), i.e.: 
Electrical wavelength = Refractory period x Conduction velocity. 
Conversely anything that causes the refractory period to shorten decreases the 
wavelength and therefore increases the risk of establishing re-entrant circuits by 
making space for a re-entrant wave or allowing more waves to be present at one 
time (Han and Moe, 1964). 
Heterogeneity in refractoriness can cause the unidirectional conduction block 
necessary for the initiation of a re-entrant wave. Under normal circumstances, 
the heterogeneity in refractoriness is too small to provide a substrate in which 
re-entry can be induced, but in the presence of pathological abnormality such as 
acute ischaemia, post-repolarisation refractoriness becomes evident (Opthof et 
al., 1993; Sutton et al., 2000). 
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Electrical restitution 
Restitution is defined as the relationship between APD and the preceding 
diastolic interval (Elharrar and Surawicz, 1983). Under normal circumstances, 
the APD does not vary at a constant cycle length. However, as the cycle length 
decreases, for example during the higher heart rates associated with exercise, 
the diastolic interval (DI) reduces and the APD shortens to maintain a minimum 
diastolic period required for recovery from the refractory state before the next 
cycle. A restitution curve is derived from a plot of the APD against the diastolic 
interval. The relationship between the diastolic interval and the APD in human 
and rabbit is illustrated in Figure 1.3. The slope of the restitution curve is 
initially steep at the minimum diastolic interval representing a dramatic 
shortening of APD as the interval between stimuli is decreased. As the diastolic 
interval is increased (heart rate decreased) the APD increases and the 
dependence on diastolic interval flattens out as the diastolic interval increases 
(Franz, 2003). The cellular basis for this relationship is complex and is thought to 
arise from the time course of the recovery of the main ionic currents that 
underlie the AP, in particular INa, ICa,L IKr and IKs (Franz, 2003).   
 
 
Figure 1.3 Restitution curve.  
Comparison between restitution curve in a) human (Morgan et al., 1992), and in b) rabbit 
(Hayashi et al., 2003). 
The shape of the restitution curve has consequences for the stability of the 
action potential duration at as heart rate changes and for the propensity for 
arrhythmias.  Nolasco and Dahlen (1968) showed that a steep relationship 
between APD and DI (slope >1) resulted in alternating APD values and 
increasingly unstable APD. At slopes <1, changes in APD tended to stabilise at 
one value. Later work on whole hearts showed that arrhythmias and VF were 
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more frequent when the heart was operating in that part of the restitution curve 
where slope >1 (Qu et al., 2000; Watanabe et al., 2002).  
Electrophysiological changes in regional myocardial ischaemia 
After coronary artery ligation, the ischaemic myocardial cells depolarize 
(Kardesch et al., 1958; Prinzmetal et al., 1961; Samson and Scher, 1960) in 
parallel with the accumulation of extracellular K+ released by myocardial cells 
during acute ischaemia (Hill and Gettes, 1980; Hirche et al., 1980). Kardesch et 
al. (1958) have reported that there was a decrease in amplitude and a marked 
shortening of the action potential duration a few minutes after occlusion in 
intact rabbit and canine hearts. Similar observations also seen in ischaemic cells 
from porcine and canine hearts (Czarnecka et al., 1973; Downar et al., 1977; 
Kleber et al., 1978) during acute regional ischaemia.  
In normal cardiac cells, the time course of recovery of excitability normally 
follows the repolarisation time course. However, during ischaemia the cell 
membrane may remain inexcitable even though the membrane has been 
completely repolarized. This phenomenon is known as “post-repolarisation 
refractoriness” (Downar et al., 1977; Lazzara et al., 1975). The time course of 
the change in refractoriness during ischaemia is distinct from that of the changes 
in APD, as shown by Downar et al. (1977); APD shortens after 2 minutes of 
coronary artery occlusion while post-repolarisation refractoriness develops after 
approximately 10 minutes.  
Electrocardiogram (ECG) 
The ECG is a clinically useful tool to assist in diagnosing rhythm abnormality, 
alteration in electrical conduction, and myocardial ischaemia and infarction.  
ECG in the normal heart 
Recording of the ECG from the body surface of man was performed for the first 
time by Waller (1887) by using a Lippmann’s capillary electrometer which was 
composed of a narrow glass capillary half filled with mercury above which was a 
weak solution of sulphuric acid. This arrangement allowed the recording of small 
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rapidly changing voltages that could be recorded from the body surface during 
cardiac depolarisation and repolarisation (Figure 1.4).  
 
Figure 1.4 Cardiac ventricular AP and ECG in the normal heart.  
a) 5 phases of ventricular AP with b) corresponding ECG parameters. 
By convention, the first deflection of the ECG is the P wave.  It indicates the 
spread of depolarisation from the SA node throughout the atria thereby causing 
atrial depolarisation. The brief isoelectric period after the P wave corresponds 
to the time when the impulse is travelling through the AV node and during atrial 
repolarisation. 
The QRS complex indicates ventricular depolarisation. Conduction abnormalities 
such as bundle branch block, or presence of ectopic foci will generally manifest 
as prolongation of the QRS complex or other changes in its morphology from the 
normal pattern.  
The ST segment, an isoelectric period following QRS complex roughly 
corresponds to the plateau phase of the ventricular action potential in which the 
entire ventricle is depolarized. This ST segment is particularly important in the 
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diagnosis of myocardial ischaemia and infarction, where it can become either 
elevated or depressed, indicative of regional shortening of myocardial action 
potentials. 
The T wave indicates ventricular repolarisation and lasts longer than 
depolarisation. 
Q-T interval represents the time for the entire ventricular depolarisation and 
repolarisation sequence to occur. This interval roughly estimates the duration of 
ventricular action potentials. Prolonged QT interval is an important diagnostic 
parameter for the susceptibility of the heart to certain types of arrhythmias.  
The duration of each ECG component in human (Klabunde, 2005) and in rabbit 
(Lord et al., 2010) under normal condition is summarised in Table 1.1. 
Table 1.1 Summary of ECG components. 
Comparison between the duration in human (at a resting heart rate of 70 bpm) and rabbit (at 
a resting heart rate of 180bpm). 
 
ECG in myocardial ischaemia and infarction 
The ECG continues to be an important foundation for the early diagnosis of 
acute myocardial ischaemia and myocardial infarction (MI). In acute coronary 
heart disease, the ECG provides useful information about the presence, severity 
and extent of myocardial ischaemia. During ischaemia, oxygen depletion to the 
myocardial cell will lead to electrophysiological changes that can alter both 
rhythm and conduction. Evaluation of the electrical changes by the 12-lead ECG 
recording can determine the extent, location, and progress of damage to the 
heart following the ischaemic insult (Klabunde, 2005).  
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Local myocardial ischaemia normally manifests as a change in the ST segment, 
either as ST elevation (displacement of the ST segment above the isoelectric 
baseline) or as ST depression (displacement of ST segment below the isoelectric 
baseline) on the ECG. This change in ST segment is due to a fall in resting 
membrane potential and action potential magnitude in ischaemic myocardium. 
The potential difference between the ischaemic myocytes and surrounding 
healthy myocardial cells will lead to the flow of an “injury current” during 
normally isoelectric periods resulting in a shift of the ST segment level and/or 
ECG baseline. ST segment changes caused by a partial occlusion of the coronary 
artery may be reversible once the blood supply to the myocardium is restored. 
However, a full thickness or transmural myocardial infarct will result in 
permanent changes in ECG parameters. A few hours after infarction, the ECG 
shows ST segment elevation. Several days later, as ischaemic cells become 
necrosed and electrically silent, the ST elevation is replaced by pathological Q 
waves and T wave inversion (Levick R.J, 2010). 
Apart from ST segment changes, acute myocardial ischaemia has been shown to 
modify the duration of QT interval, increase repolarisation heterogeneity 
(manifested as increase in QT dispersion) and prolong the duration of the 
maximum electrocardiographic QT interval (Bijl and Verheugt, 1992). The QT 
interval prolongation secondary to acute myocardial ischaemia has been 
attributed to several mechanisms: local hypothermia, local conduction delay, 
neurogenic effect and local hypocalcaemia (Doroghazi and Childers, 1978).  
Animal models of myocardial ischaemia 
Many ventricular arrhythmias, particularly those associated with acute 
myocardial ischaemia, are almost impossible to study closely in human patients 
because of the unpredictable nature of the event and the electrophysiological 
changes during the event can occur within minutes. Furthermore, in human 
patients there may be other contributory factors that promote arrhythmia apart 
from acute ischaemia such as the electrolyte imbalance, presence of a healed 
infarct, hypertrophy, dilatation or heart failure. Therefore, detailed information 
on arrhythmogenic mechanisms associated with ischaemia and infarction has to 
be obtained from experimental animal models. A good model of myocardial 
ischaemia in experimental animals must accurately reproduce the spectrum of 
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ischaemic heart disease as seen in human. Animal models of myocardial 
ischaemia can be achieved either by fully blocking or partially narrowing the 
coronary artery. A variety of procedures including surgical procedures or drug 
intervention have been used to occlude coronary arteries, for varying periods, in 
different species. The simplest method to produce myocardial ischaemia is by 
ligating a single coronary artery. Another method to produce ischaemia was 
achieved by introducing air embolism into the coronary arteries (Gunn, 1913, 
cited in Curtis, 1998). Other method to produce ischaemia is by atherosclerosis 
induction that closely mimics the human condition (Russell and Proctor, 2006) 
but this method is rarely used in ischaemia research since the process is slow to 
develop and variable in outcome. 
The severity of the ischaemia induced by coronary artery occlusion depends on 
the presence or absence of collateral vessels because collateral flow provides an 
alternative source of blood to the ischaemic field. The animal species that are 
commonly used to study ventricular arrhythmias include large animals (dogs, 
pigs, cats) and small animals such as rabbits, rats, and guinea pigs. Warltier et 
al. (1982) demonstrated that the same ligation site on the LAD in dogs can 
produce varying infarct sizes, due to the variable extent of their collateral 
development (Estes, Jr. et al., 1966; Jugdutt et al., 1979; Schaper et al., 1967). 
Studies using pigs (Fedor et al., 1978; Verdouw et al., 1983) produce a 
consistent infarct size following coronary artery ligation because they possess 
relatively few collateral vessels. In contrast, ligation of coronary artery in guinea 
pig produces a minimal infarct because the collaterals are so abundant (Schaper, 
1986). 
Rabbit model of myocardial ischaemia and infarction 
Rabbits are commonly used to produce experimental models that mimic heart 
failure and myocardial infarction in human. Studies have demonstrated that 
rabbit myocardium shows important similarities in function to the human heart, 
in that the force-frequency relation is positive, and calcium removal from the 
cytosol is 70% by the sarcoplasmic reticulum and 30% by NCX activities 
(Hasenfuss, 1998; Holubarsch et al., 1991; Pogwizd et al., 2001). According to 
Miura et al. (1989), there are minimal collateral vessels in rabbit hearts. Rabbits 
can serve as a reliable experimental model in the study of MI related to coronary 
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artery occlusion (Lee et al., 2002). Rabbits are less costly than dogs and have 
less variability in terms of distribution, size and length of coronary arteries.  
Despite a comparatively greater anatomical consistency, variation is nonetheless 
observed: there is not one constant pattern but two anatomical branching 
patterns of left coronary artery (LCA) in rabbit hearts, namely bifurcation and 
trifurcation. In the bifurcation branching pattern, the coronary artery branches 
into two main divisions: anterior division (AD) and postero-lateral division (PLD). 
On the other hand, in the trifurcation pattern, the coronary artery branches into 
three divisions: AD, lateral division (LD), and posterior division (PD) (Lee et al., 
2002; Podesser et al., 1997). The difference between the two branching pattern 
is illustrated in Figure 1.5. 
 
Figure 1.5 Branching pattern in rabbit coronary artery.  
Illustration of a) bifurcation type of the left coronary artery (LCA) into anterior division (AD) 
and postero-lateral division (PLD), and b) trifurcation type of the LCA into AD, lateral 
division (LD) and posterior division (PD). Depending on the type of the branching pattern, 
the red rings around the PLD and PD in bifurcation and trifurcation patterns, respectively, 
indicate the ligation site on the respective artery; RCA = right coronary artery (Adapted from 
Petchdee, 2009).    
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Sudden cardiac death 
Sudden cardiac death (SCD) refers to an unpredictable death in patients with or 
without pre-existing heart disease. However, in the majority of cases, SCD 
appears as the first manifestation of a pre-existing, sometimes unrecognized, 
coronary artery disease. In the majority of cases, SCD is frequently caused by 
abnormality in the heart rhythm (arrhythmia) including ventricular tachycardia 
(VT) and ventricular fibrillation (VF) that compromise cardiac pumping which 
further leads to deprivation of oxygenated blood in vital organs. Most clinical 
studies define SCD as death that occurred within 1 hour of an acute change in 
clinical condition, or an unpredictable death occurring within the previous 24 
hours (Fishman et al., 2010; Zipes and Rubart, 2006). Clinical case studies by 
Bayes de Luna et al. (1989) reported that ambulatory electrograms from patients 
who died from sudden cardiac death during the recordings reveal that the most 
common cause of sudden cardiac death was ventricular tachyarrhythmias (84%) 
most frequently ventricular fibrillation (VF) secondary to ventricular tachycardia 
(VT) whereas only 16% was due to bradyarrhythmias. Autopsies performed on the 
patients suggest that the main cause of sudden cardiac death is acute 
myocardial ischaemia (Priori et al., 2001). 
Acute myocardial ischaemia and infarction 
Myocardial ischaemia has been one of the most extensively studied topics in 
cardiovascular research. According to Mosby’s Medical Dictionary, 8th edition 
(2009), myocardial ischaemia is a condition of insufficient blood flow to the 
heart muscle via the coronary arteries, often resulting in chest pain (angina 
pectoris). Saunders Comprehensive Veterinary Dictionary, 3rd edition (2007) 
defined myocardial ischaemia as deficiency of blood supply to the heart muscle, 
due to obstruction or constriction of the coronary arteries. However, the most 
accepted definition of myocardial ischaemia among researchers is an imbalance 
between the amount of oxygen and substrates supplied to the heart and the 
amount needed to perform normal function of the heart (Hearse, 1994). Thus, 
myocardial ischaemia is a condition in which there is an imbalance between 
supply and demand of the oxygen that lead to anaerobic metabolism and 
reduced contractile function (Verdouw et al., 1998). Myocardial ischaemia may 
result from the presence of atherosclerotic disease of the coronary artery 
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(Brown et al., 1989), or it may occur without a predisposing coronary artery 
disease, due to perivascular fibrosis (Weber et al., 1993) and a reduction in 
coronary flow reserve (Scheler et al., 1994; Wallbridge and Cobbe, 1996). Janse 
and Wit (1989) have stated that dispersion of repolarisation and refractoriness 
between ischaemic and non-ischaemic myocardial cells as an important pro-
arrhythmic mechanism during acute myocardial ischaemia.  
Myocardial infarction (MI) which is a major cause of death and disability 
worldwide may be the first manifestation of coronary artery disease (CAD) or it 
may occur in patients with established disease. According to the World Health 
Organisation (WHO), MI can be recognised by clinical symptoms, ECG 
abnormalities, elevated values of biochemical enzymes (biomarkers) of 
myocardial necrosis, and by imaging, or it may be defined in pathology as cell 
death of myocardium due to prolonged ischaemia (Thygesen et al., 2012). 
Thygesen et al. (2012) stated that after the onset of myocardial ischaemia, 
histological cell death is not immediate but takes at least 20 minutes (or less in 
some animal models) to develop. Complete myocardial cell necrosis takes 
several hours (at least 2-4 hours, or longer) before it can be identified by post-
mortem examination. The duration depends on several factors such as the 
presence of collateral circulation to the ischaemic zone, persistent or 
intermittent coronary arterial occlusion, the sensitivity of the myocytes to 
ischaemia, pre-conditioning and individual demand of myocardium for oxygen 
and nutrients.  
Classification 
Clinically, MI can be classified into 5 types based on universal definition by 
Thygesen et al. (2012): 
Type 1: Spontaneous MI related to a coronary plaque rupture, fissuring, or 
dissection with resulting intraluminal thrombosis 
Type 2: MI secondary to myocardial ischaemia resulting from increased oxygen 
demand or decreased supply 
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Type 3: MI related to sudden cardiac death usually with symptoms suggestive of 
myocardial ischaemia associated with new ECG changes in the absence of 
cardiac biomarkers in the blood 
Type 4: MI related to cardiac procedure such as percutaneous coronary 
intervention (PCI) and stent thrombosis 
Type 5: MI related to coronary artery bypass grafting (CABG)  
Myocardial ischaemia and myocardial infarction can also be classified into 
transmural and non-transmural based on morphology and anatomical features. A 
transmural MI involves the ischaemic cell death across the full thickness of the 
affected heart muscle, from endocardium to epicardium. Whereas, for the non-
transmural MI, the region of the ischaemic cell death only affected part of the 
myocardial wall (Engblom et al., 2005; Engels et al., 1995; Widimsky et al., 
1984). Ryan et al. (1996) have documented that the regions which are most 
vulnerable to ischaemia are in the endocardial and subendocardial zones of the 
myocardial wall. 
Metabolic consequences of myocardial ischaemia and 
mechanisms of ischaemia-related arrhythmias 
The consequences of ischaemia are due to the inadequate myocardial oxygen 
supply and local accumulation of metabolic waste products. Several studies 
(Carmeliet, 1999; Ferrero, Jr. et al., 1996; Kagiyama et al., 1982; Weiss and 
Shine, 1982; Weiss et al., 1992) have reported that the most prominent changes 
in electrophysiological properties in the heart during acute ischaemia include 
rises of extracellular potassium concentration ([K+]o), activation of the ATP-
sensitive potassium current (IKATP) due to metabolic inhibition, and fall in 
intracellular pH.  
During myocardial ischaemia, aerobic metabolism, i.e. oxidative phosphorylation 
in the mitochondria is inhibited as the pO2 within the myocardium falls to below 
~1mmHg. Immediately anaerobic glycolysis sustains adenosine triphosphate 
(ATP) production by breaking down glucose to lactic acid (Elliott et al., 1992). 
This continues to maintain intracellular ATP for many minutes, but the fall in 
intracellular pH as a result of lactic acid accumulation inhibits glycolysis (Neely 
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et al., 1975) and ATP synthesis stops. This results in depletion of intracellular 
ATP in cardiac myocytes because it cannot be regenerated. Consequently 
adenosine diphosphate (ADP) and adenosine monophosphate (AMP) accumulate 
and they are subsequently metabolized into adenosine. Adenosine is a potent 
vasodilator because it binds to receptors on vascular smooth muscle where it 
causes a decrease in calcium influx leading to vasodilatation (Naik et al., 2007). 
ATP depletion within cardiomyocytes inhibits the sodium/potassium (Na+/K+) 
ATPase. In the absence of Na+/K+ ATPase, the cells are no longer capable of 
counterbalancing the Na+ influx through Na+ channels, leading to an increase in 
concentration of intracellular Na+.    
At the same time, there is also a significant increase in K+ conductance due to 
the opening of ATP sensitive K+ channels (IKATP) as a consequence of the decrease 
intracellular ATP (Lederer et al., 1989). There is also an increase in extracellular 
K+ concentration due to increased intracellular K+ efflux during ischaemic insult. 
Regional ischaemia produces a spatial heterogeneity in [K+]o, IKATP, and pH 
resulting in increased dispersion of conduction velocity (Kaplinsky et al., 1979b; 
Pogwizd and Corr, 1987b), APD (Behrens et al., 1997; Kuo et al., 1983), and 
effective refractory period (Avitall, 1979; Downar et al., 1977), factors which 
aggravate the substrate for the initiation and maintenance of re-entry. Gilmour, 
Jr. and Zipes (1985) have suggested that extracellular K+ accumulation is 
responsible for the depolarisation of tissue surrounding the ischaemia area 
creating an injury current between ischaemic and normal myocardial cells that 
could initiate ventricular premature beats. In addition, activation of KATP 
channels shortens the APD (Kantor et al., 1990; Vanheel and de, 1992; 
Venkatesh et al., 1991) and increases heterogeneity of APD and dispersion of 
refractoriness in the ischaemic region, favouring the initiation of re-entrant 
circuits, and thus ventricular arrhythmias (Billman, 1994; Furukawa et al., 
1991). Moreover, increase in extracellular potassium concentration can cause 
unidirectional block by depolarising the myocardium sufficiently to inactivate 
the inward Na+ current. Commonly the central zone of region of ischaemic 
myocardium becomes inexcitable, while the myocardial cells in the border zone 
retain a low level of perfusion and therefore remain excitable. The conduction 
delay associated with the region of block facilitates re-entrant circuit formation 
(Ettinger et al., 1973) and the development of ventricular tachycardia. 
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Cardiac arrhythmias 
Sudden cardiac death is a disastrous complication of acute myocardial infarction 
(Huikuri et al., 2001). The reason why certain patients develop lethal ventricular 
arrhythmia soon after acute myocardial infarction and some patients survive is 
still poorly understood.  A clinical study on the incidence and timing of sudden 
death or resuscitated cardiac arrest after MI conducted by Solomon et al. (2005) 
showed that the risk of sudden death was highest in the first 30 days after MI in 
patient with prior left ventricular dysfunction, heart failure, or both.  
Mechanisms of ventricular arrhythmias 
Normal electrical conduction in the heart involves an AP originating from the 
sino-atrial (SA) node, conducted through the atria via the atrio-ventricular (AV) 
node down to the Purkinje fibres and then to the ventricles. Abnormality in the 
properties of ionic currents can lead to abnormal impulse generation and/or 
propagation which further leads to electrical disorder in the ventricles.  
Three main mechanisms of ventricular tachyarrhythmias are: 
1) Automaticity 
2) Triggered activity 
3) Re-entry 
In the case of re-entrant arrhythmias, the first and second mechanisms are 
potential triggers for the arrhythmia, while re-entry itself maintains the 
arrhythmia. 
Automaticity 
Automaticity is a normal feature in the cells in the sino-atrial node. In this case, 
the electrical behaviour is determined by the expression of channel proteins, 
including the pacemaker current (If), the T-type Ca
2+ current (ICa,T), and 
deactivation of delayed rectifier potassium current (IKr or IKs). Under normal 
conditions in the ventricle and atria, If is absent or its activation voltage is too 
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negative. However, Carmeliet and Vereecke (2002) demonstrated that β-
adrenergic stimulation in Purkinje fibres shifts the activation kinetics of If in that 
tissue to a less negative activation potential thus enhancing the diastolic 
repolarisation. Under these circumstances, Purkinje fibres may be the source of 
arrhythmic triggers. 
Triggered activity 
There are two types of triggered activity; early afterdepolarisations (EADs) and 
delayed afterdepolarisations (DADs). The membrane potential at the onset 
differentiates between these two types of triggered activity; EADs occur during 
phase 2 and phase 3 of AP, whereas DADs occur immediately after the 
membrane potential has returned to the baseline (phase 4). These triggering 
events (EADs and DADs) are most commonly observed during plasma electrolyte 
imbalances (low [K+]o, [Ca
2+]o, [Mg
2+]o and pH) and they are more common in 
heart failure (Pogwizd et al., 2001). Delayed after-depolarisations are caused by 
spontaneous release of Ca2+ from the sarcoplasmic reticulum (SR) of cardiac 
muscle during diastole (Pogwizd et al., 2001), the raised intracellular Ca2+ is 
extruded mainly by the electrogenic Na+/Ca2+ exchanger and the subsequent 
inward current can depolarise the cardiac cell sufficiently to activate INa and a 
subsequent arrhythmic action potential. These events occur when the SR Ca2+ 
content is higher than normal or when the SR Ca2+ release channel is sensitised 
to cytoplasmic Ca2+. 
The mechanism of EADs is less well defined. A common cause of EADs is 
prolongation of the APD and the extension of the plateau phase sufficiently to 
allow reactivation of inward currents ICa,L (Pogwizd et al., 2001). Prolongation of 
APD can be due to bradycardia or inhibition of repolarising currents, e.g. IKr.  
Re-entry 
Botting et al. (1985) stated that of the three main mechanisms, only re-entry 
has been demonstrated as the arrhythmogenic mechanism during acute 
ischaemia. However, in most of the cases, re-entry is triggered by an ectopic 
impulse in the context of an abnormal dispersion of refractoriness between the 
normal and ischaemic myocardium. Experimental studies with animal models 
have demonstrated that lethal arrhythmias occur most frequently 4-7 minutes 
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post occlusion (Fleet et al., 1994; Kaplinsky et al., 1979a; Scherlag et al., 1974) 
due to re-entrant mechanisms (Kaplinsky et al., 1979b; Kuo et al., 1983; 
Pogwizd & Corr, 1987b). Acute regional myocardial ischaemia in canine right 
ventricular wedge preparations results in heterogeneous loss of the transient 
outward potassium current (Ito)-mediated AP dome across the ischaemic border 
leading to phase 2 re-entry which is capable of initiating VF by producing R-on-T 
extrasystoles (Yan et al., 2004). 
During acute myocardial ischaemia, shortening of repolarisation by ATP-
regulated potassium channel openers (IKATP) has been reported to increase the 
susceptibility of the heart towards re-entry and fibrillation (Coromilas et al., 
2002; Padrini et al., 1992; Uchida et al., 1999). The substrate for initiation and 
maintenance of ventricular arrhythmia during acute ischaemia has been 
extensively studied in porcine and canine hearts. Janse et al. (1980) showed that 
during coronary artery occlusion in isolated perfused hearts, the “focal” 
mechanism occurs at the normal side of the ischaemic border and the macro- 
and micro-reentry in ischaemic myocardium are responsible for the very early 
ischaemic arrhythmias. A study by Pogwizd and Corr (1987a) reported that 
during early ischaemia in canine hearts, the initiation and maintenance of 
ventricular arrhythmia is due to both intramural re-entry and non-reentrant 
mechanisms. In both these studies, the arrhythmic event is preceded by 
ventricular premature beats (VPBs). 
Chou et al. (2007) have demonstrated that during the subacute phase of 
myocardial infarction, the dynamic properties of the action potential and Ca2+i 
cycling are heterogeneously altered in the peri-infarct zone which may promote 
ventricular premature beats and increase the incidence of wavebreaks during 
VF. Several early studies (Harris, 1950; Harris et al., 1954) in canine model of 
acute ischaemia concluded that ectopic beats were generated near the infarct 
borders by automatic foci. The authors suggested that these events were 
triggered by the release of K+ from ischaemic cells, but given present knowledge 
of cardiac electrophysiology, this is unlikely to be the cellular mechanism, 
currently it is uncertain  what circumstances in the peri-infarct zone may make 
premature electrical events more common. 
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Premature ventricular contractions (PVCs) 
Premature ventricular contractions (PVCs) are a form of abnormality of heart 
rate rhythm in which the heart beat is initiated at ventricular Purkinje fibres 
rather than by the SA node. Frequently, they occur spontaneously with no known 
cause. PVCs have been recognized to precede lethal arrhythmia and to identify 
patients susceptible to sudden death following myocardial infarction. In patients 
with acute myocardial infarction, tissue injury and cell death has been 
recognised as a common cause of spontaneous ventricular ectopy associated with 
the infarct border zone of ischaemic myocardium (Bigger, Jr. et al., 1977; Eldar 
et al., 1992). Accelerated idioventricular rhythms and ectopic beats may occur 
during coronary reperfusion. Episodes of spontaneous ventricular ectopy increase 
the tendency of the heart to develop re-entrant ventricular arrhythmias, 
particularly along the infarct border zone as a result of non-homogeneous 
conduction and repolarisation (Cantillon, 2013). Ghuran and Camm (2001) have 
stated that PVCs are usually asymptomatic and their presence in the peri-infarct 
zone regardless of frequency and complexity had no relation to mortality or the 
development of sustained ventricular arrhythmias. In contrast, however, a meta-
analysis study conducted by Ataklte et al. (2013) to assess the association 
between PVCs and risk of sudden cardiac death reported that frequent PVCs are 
associated with increased risk of sudden cardiac death. 
T-wave alternans (TWA) 
Another phenomenon which is clinically significant in reflecting susceptibility to 
ventricular arrhythmias in patients is T-wave alternans (TWA). TWA is recognised 
by regular fluctuations on a beat-to-beat basis in the amplitude, morphology or 
polarity of the ECG T-wave and is associated with dispersion of repolarisation. It 
has also been termed repolarisation alternans (Narayan et al., 1999; Narayan 
and Smith, 2000). Macroscopic TWA was first reported in the early 20th century 
(Hering, cited by Narayan, 2006). Further observations of macroscopic TWA have 
noted in association with ischaemia (Kleinfeld and Rozanski, 1977), long QT 
syndrome (LQTS) (Roden et al., 1996) and with ventricular arrhythmias (Raeder 
et al., 1992; Verrier et al., 2003). Macroscopic TWA has been observed to occur 
immediately prior to the onset of ventricular arrhythmia (Armoundas et al., 
2000). Previous studies have revealed that TWA indicates spatial or temporal 
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dispersion of repolarisation that may precede VF (Weiss et al., 1999; Smith and 
Cohen, 1984). Clinically, TWA can be a good ECG index of sudden cardiac death 
associated with dispersion of repolarisation and ventricular arrhythmias 
(Narayan, 2006). 
Ischaemia-induced ventricular fibrillation 
The ability of ischaemia to induce ventricular fibrillation (VF) in an isolated 
hearts was first studied by Gunn using rat model (Gunn, 1913, cited in Curtis, 
1998). More recently, ischaemia-induced arrhythmias were studied using the left 
coronary artery ligation technique (Kannengiesser et al., 1975) in which the 
total coronary flow to the heart was reduced by approximately 27%, but in this 
report no-VF was observed. In another study using global ischaemia (Bricknell 
and Opie, 1978) VF incidence was very low despite an 85% reduction in global 
coronary flow in rats.  It was later found out that the global coronary flow would 
have to be reduced by more than 85% for the heart to routinely develop VF 
(Wolleben et al., 1989). The relationship between the extent of flow reduction, 
region involved and tendency to VF was studied in detail by Curtis and Hearse 
(1989) and Ridley et al. (1992). These studies showed that there are several 
factors that can influence the susceptibility of the hearts to ischaemia-induced 
VF; (i) variation of K+ content in the perfusion solution, (ii) the size of the 
ischaemic region, (iii) the severity of ischaemia and (iv) heart rate. Studies have 
shown that the K+ concentration in the perfusion solution can change the 
incidence of VF from 100% to 0% (Curtis & Hearse, 1989; D'Alonzo et al., 1994) 
which is similar to the relation between K+ concentration in blood and incidence 
of sudden cardiac death seen in human patient (Nordrehaug, 1985; Nordrehaug 
et al., 1985). Variation in the collateral blood supply to the ischaemic site can 
determine the tendency of the heart to develop ischaemia-induced VF in which 
heart with low level of residual flow was found to be more susceptible to VF 
(Maxwell et al., 1987). Meanwhile, Bernier et al. (1989) demonstrated that VF 
incidence was lower at slow heart rates in rat hearts, an effect suggested to be 
due to the slower rate of development of ischaemic injury.  
In studies involving a variety of experimental animals, the time-course of 
ischaemia-induced VF is divided into two phases: phase 1 VF which occurs during 
the first 30 minutes of ischaemia and phase 2 VF which develops after 30 
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minutes of ischaemia (Curtis, 1998). Kaplinsky et al. (1979a) further divided 
phase 1 VF into immediate (occurring 2-10 minutes after ischaemic onset) and 
delayed (between 12-30 minutes of the beginning of ischaemia). Another 
classification of phase 1 VF was made (Meesman et al., 1978, cited in Curtis, 
1998); phase 1a developing before 12 minutes of ischaemia and phase 1b 
occurring after 12 minutes of onset of ischaemia. However, it is difficult to 
determine the exact time-course of appearance of ischaemia-induced VF in 
human, particularly phase 1 VF because the exact time of onset of ischaemia is 
unknown. 
Study aims 
Approximately 50% of deaths from cardiac causes are arrhythmic in nature and 
occur within 1 hour of the onset of symptoms. Pathological examination reveals 
that in the majority of cases show evidence of acute myocardial infarction but 
the mechanistic link between ischaemia and lethal arrhythmia is still poorly 
understood. 
The main aims of this thesis were: 
1) To use the isolated Langendorff-perfused rabbit to reveal the 
electrophysiological consequences following occlusion of the coronary 
artery. 
2) To examine the electrophysiological gradients that develop within 10–30 
minutes after an acute myocardial ischaemia and their relationship to the 
subsequent arrhythmias 
3) To provide a better understanding of the mechanistic link between 
ischaemia and arrhythmias, information that will aid the design of 
therapies that will reduce the incidence of lethal ventricular arrhythmias. 
Hypothesis 
I hypothesize that an electrophysiological property of the heart, specifically the 
intrinsic APD prior to coronary artery occlusion, predisposes the heart to VF 
during acute ischaemic event. 
43 
Chapter 2: Methods 
  
Chapter 2  44 
Introduction 
For over than 100 years, the concept of mapping electrical activity of the hearts 
has continued to evolve from the first observation of rhythmic muscular 
contraction around the ring of a jelly fish (Mayer, 1906, cited in Rosenbaum and 
Jalife, 2001), to the description and mapping of re-entry in the turtle heart by 
Mines (1913), to the first systematic mapping of sinus rhythm and identification 
of atrial flutter by Lewis et al. in 1920 (cited in Rosenbaum & Jalife, 2001). The 
technique of activation mapping based on the simultaneous recording from many 
sites is crucial in order to understand the mechanisms and locations of atrial and 
ventricular arrhythmias and was originally developed using solid state electrodes 
placed either on the surface of an exposed heart (Durrer et al., 1970; Ideker et 
al., 1989) or on the surface of the body. The rapid depolarisation event could be 
detected as transient electrical event, the timing of which could be used to map 
the spread of electrical activity throughout the heart (De and Corlan, 2007; Dixit 
and Callans, 2002; Friedman, 2002; Oster et al., 1998). However, the slower 
repolarisation event was frequently poorly resolved and details on the plateau 
phase of the cardiac action potential were not evident. 
An alternative approach to map electrical activity in experimental situations is 
the use of membrane-bound fluorescent voltage-sensitive dyes. This technique 
has been applied to a variety of tissue preparations from intact heart, to 
isolated myocardial tissues or cells, to cardiac cells grown in tissue culture (Akar 
et al., 2001; Lee et al., 2012; Lichtman and Conchello, 2005). It serves as a 
powerful tool to study cardiac arrhythmias since the optical signal describes the 
complete time course of the action potential and hence allows mapping of both 
activation and repolarisation phases. Imaging of the electrical activity with 
advanced cameras has facilitated the study of the mechanisms of initiation, 
maintenance, and termination of re-entrant arrhythmias. 
Rosenbaum (2001) has described an optical mapping system as consisting of 
three main components: 
1) the heart preparation, stained with a voltage-sensitive fluorescence dye; 
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2) a system of optics, which filters the emitted light and focuses the image onto 
a photodetector; and 
3) a photodetector, which measures the emitted light.  
These components will be discussed in detail below. 
Voltage-sensitive dyes 
Voltage-sensitive dyes are fluorescent molecules which have a high affinity for 
the membrane of cells and with fluorescent properties that are sensitive to the 
transmembrane potential. Voltage sensitive dyes are broadly classified into slow 
and fast types. In cardiac optical mapping, fast electrochromic dyes have been 
the dye of choice because of their very rapid response time. In the case of di-4- 
or di-8-ANEPPS, the fluorescence properties change within a few microseconds 
of the change in voltage (Loew, 2010). With this property, changes in membrane 
potential can be represented accurately by changes in dye fluorescence (Morad 
and Salama, 1979). 
The principle by which voltage-sensitive dyes translate cardiac membrane 
potential into light intensity has been described by Rosenbaum (2001) and is 
shown in Figure 2.1. During rapid upstroke of the action potential, a 
depolarisation of the cell from its resting transmembrane potential of Vm = 
-80mV toward less negative voltage, e.g. Vm = -40mV and 0mV, causes the 
fluorescence emission spectrum of the dye to shift to the left (shorter 
wavelengths), producing an inverted action potential signal. The shaded region 
under each spectrum corresponds to the amount of light that passes through the 
emission filter (represented by the vertical line) and is measured by the light 
detector.  
Ideally, voltage-sensitive dyes should be non-toxic with minimal photo bleaching 
and minimal pharmacologic (e.g. vasoconstrictive) effect and have a large 
spectral shift with membrane potential. The choice of dye in a particular 
experiment is often decided based on the excitation and emission spectra of the 
dye. The main voltage-sensitive dyes used in this study were RH237 and Di-4-
ANEPPS. RH237 was used in single view optical mapping experiments (Chapter 4, 
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5, and 6) whereas Di-4-ANEPPS was used in the panoramic view optical mapping 
experiments (Chapter 8). Both are styryl dyes developed by Loew et al. (1985). 
Comparison of the excitation and emission spectra between these dyes is shown 
in Figure 2.2. 
 
Figure 2.1 Voltage-sensitive dyes.  
(a) Schematic diagram of the principle of voltage-sensitive fluorescence, and chemical 
structure of (b) RH237 and (c) Di-4-ANEPPPS. Adapted from Rosenbaum (2001). 
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Figure 2.2 Spectra of voltage-sensitive dyes used in optical mapping study. 
 
  
Chapter 2  48 
Optical mapping set-up 
In this study, two sets of optical mapping set-ups were used; 1) single view 
optical mapping that allows us to map electrical activity on a specific site on the 
hearts surface and 2) panoramic view optical mapping from the whole epicardial 
surface of the hearts. 
Single view optical mapping 
Epicardial membrane potentials from the anterior surface of the hearts were 
recorded using an optical mapping array (Figure 2.3). The isolated Langendorff-
perfused heart was placed into custom-made perspex chamber (Figure 2.4a) to 
physically reduce motion artefact and maintain the temperature of the heart at 
37oC by filling the chamber with thermostat-controlled heated solution. Motion 
artefact was reduced further during optical recordings by sliding forward the 
back piston against the heart to gently compress the heart against the front-wall 
of the chamber (Figure 2.4b). Further reduction of motion artefact was achieved 
by using 10M Blebbistatin (Enzo® Life Sciences) in Tyrode’s solution (Fedorov et 
al., 2007). Blebbistatin specifically inhibits myosin II ATPase in the actin 
detached state (Allingham et al., 2005; Straight et al., 2003). 
The heart was loaded with 100L bolus of the voltage-sensitive styryl dye RH237 
(Molecular Probes) dissolved in dimethyl sulfoxide (DMSO) (1mg/ml). The dye 
was made up into stock solution by adding 1ml of DMSO into 5mg RH237 and 
aliquoted into small Eppendorf tubes. The aliquots were stored at -20oC, 
wrapped in aluminium foil to protect from the light. Aliquots were thawed on 
the day of the experiment just prior to use. The bolus of dye was administered 
by slow injection into the coronary circulation over 1 minute through an 
injection port in a bubble trap in line with the aortic cannula. Bolus injection of 
RH237 was repeated throughout the experiment when necessary.  
The dye was excited by blue-green LED light at 505nm wavelength. Fluorescent 
light emitted from the anterior epicardial surface was collected by a camera 
lens (Nikon 85mm, f/1.4) passed through a 695nm long-pass (LP) filter, and the 
image was focused onto a 256 (16 x 16) photodiode array (PDA) (Hamamatsu 
Photonics). During optical recordings, two corner channels of the PDA were 
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reserved for recording the ECG and pacing stimuli traces. In the single view 
optical mapping experiments, the CCD camera (Dalsa) was used to acquire high 
resolution plain images of the heart surface but it was not directly involved 
during the optical action potential recordings. 
 
 
Figure 2.3 Diagram of single view optical mapping set-up. 
 
 
Figure 2.4 Photographs of the heart inside the perspex chamber.  
(a) Front view of the chamber. (b) Side view of the chamber showing the back piston which 
can produce a gentle compression of the heart when pressed against the front plate. 
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Panoramic view optical mapping 
The methodology relating to panoramic mapping will be described in detail in 
Chapter 8. 
Work involving animals 
Altogether in this study, a total of 91 rabbits were used of which 79 rabbits were 
used for in vitro experiments (Chapter 3, 4, 5, 6 and 8) and 12 rabbits were used 
for in vivo experiments (Chapter 9). All procedures involving animals were 
performed in accordance with the UK Animals (Scientific Procedures) Act 1986 
and complying with the Guide for the Care and Use of Laboratory Animals 
published by the US National Institutes of Health (NIH Publication No. 85-23, 
revised 1996). 
The rabbit coronary artery occlusion during Langendorff 
perfusion 
This study used a model of acute coronary artery occlusion during the 
experiment to study the relation between acute myocardial ischaemia and its 
link to ventricular arrhythmia. 
Coronary artery occlusion by using ligation technique 
The ligation technique to occlude the coronary artery during experiment has 
been developed in our lab by a previous PhD student, (Petchdee, 2009). Adult 
male New Zealand White rabbits (2.5 – 3.5 kg) were sacrificed by terminal 
anaesthesia using intravenous injection of 0.5ml/kg Euthatal (sodium 
pentobarbitone 200mg/kg, Merial) mixed with 1000 IU of heparin injected 
through the left marginal ear vein. The heart was rapidly excised, immersed in 
chilled Tyrode’s solution to temporarily stop the heart contraction. The heart 
was then retrogradely perfused (Langendorff mode) at a rate of 20 ml/min 
(Gilson Minipuls peristaltic pump) with chilled Tyrode’s solution of the following 
composition (in mmol/L: Na+ 134.5, K+ 5.0, Ca2+ 1.9, Mg2+ 1.0, Cl- 101.8, SO4
2- 
1.0, H2PO4
- 0.7, HCO3
- 20, acetate 20 and glucose 25) for vessel visualization. 
With the help from an external light source, the coronary artery was identified 
and differentiated from the superficial coronary vein. Once the coronary artery 
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was identified, a 4-0 polyester suture (EthibondTM) was used to ligate the 
proximal part of the left postero-lateral division (PLD) of the rabbit coronary 
artery (Podesser et al., 1997). The suture was then threaded through a short 
piece of 2mm diameter polyethylene tubing forming a snare (Figure 2.5). This 
procedure took approximately 3 – 5 minutes.  
The snared heart was subsequently transferred to the optical mapping set-up. 
The heart then mounted onto an aortic cannula of the Langendorff system and 
perfused with Tyrode’s solution, filtered through a 5m filter (Millipore) before 
the experiment started. The pH of the solution was maintained at 7.4 by 
continuous bubbling with 95% oxygen (O2) / 5% carbon dioxide (CO2) medical gas 
mixture (BOC Gas, UK). The perfusing solution as well as the solution 
surrounding the heart inside the chamber was maintained at 37oC by a glass-
column heat exchanger connected to a thermostat-controlled water bath. 
Langendorff perfusion was by a constant flow rather than constant pressure 
method. A constant flow of 30 ml/min was used throughout the experiment. 
Perfusion pressure was continuously monitored with a transducer connected to 
the aortic cannula. The initial perfusion pressures from all the experiments 
normally ranged from 20-30 mmHg. Pressures would typically increase by 20-30 
mmHg throughout the experiments (2-3 hours). Perfusion pressures were closely 
monitored and recorded at a regular interval over the course of the 
experiments.    
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Figure 2.5 Method to produce acute local ischaemia in isolated rabbit hearts.  
(a) Before ligation. (b) During ligation, the left postero-lateral division (PLD) of the coronary 
artery was occluded with a suture using a short piece of polyethylene tubing to form a 
snare. The ligature was connected to a calibrated spring device. To produce a local 
ischaemia, the snare was tightened for 30 minutes. In this example, the heart had a 
bifurcation branching pattern (see Figure 1.5 – page 32 on rabbit coronary artery 
distribution). 
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To produce a local ischaemia during the experiments, two different set-ups for 
the acute ligation system were used:  
Horizontal ligation set-up  
In the single view optical mapping experiments (described in Chapter 3) the 
ligature from the snare was passed through a small hole at the left side of the 
perspex chamber and connected to a calibrated spring device. This device was 
calibrated in a way to apply a minimum force on the snare required to produce a 
reversible coronary artery occlusion (Petchdee, 2009). During the experiments, 
the spring was tightened for 30 minutes to occlude the vessel and produce a 
local ischaemia. After 30 minutes of occlusion, the snare was released to allow 
reperfusion of the previously ischaemic region.  
 Vertical ligation set-up 
The vertical ligation set up was used to produce acute regional ischaemia in the 
panoramic optical mapping experiments (see Chapter 8). This method is 
described in detail in Chapter 8.  
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Pacing protocols 
To investigate the epicardial electrical conduction, two types of pacing method 
were used in this study.  
Ventricular pacing (VPACE) 
Ventricular stimulation was the main pacing method used in single view optical 
mapping experiments involving the drug E-4031 (Chapter 4) and isoprenaline 
experiments (Chapter 6) with the aim to pace the hearts at the required cycle 
length. In these experiments, the hearts were subjected to AV node ablation in 
order to be able to pace the hearts slower than the intrinsic rate; hence VPACE 
was used instead of APACE. Custom made bipolar platinum stimulating 
electrodes were used to produce point stimulation on the ventricular epicardial 
surface. Most of the time, the stimulating electrodes were placed over the base 
of the right ventricular area. The electrodes were inserted via a 1mm hole in 
front of the perspex chamber.  
Atrial pacing (APACE) 
The atrial pacing method was mainly used in the panoramic view optical 
mapping experiments (refer Chapter 8). In this set of experiment, the heart was 
paced at a fixed rate 350ms cycle length. Atrial pacing was used to get an 
activation pattern as close as possible to the pattern in vivo. Pairs of platinum 
hook electrodes were placed in the right atrium.  
For each pacing method, a constant voltage source (Digitimer DS2A-MKII 
stimulator) which provided a square pulses with width 2ms was used throughout. 
The stimulus threshold was measured and the voltage set at twice that required 
to capture the myocardium. Timing of the pulse was computer-controlled using a 
locally developed program written by Dr Francis Burton, University of Glasgow. 
Details of the pacing protocol will be given in respective chapters. 
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Optical data  
Optical action potentials (OAPs) 
Optical imaging with voltage-sensitive dyes allows simultaneous recording of 
action potentials from hundreds of sites over a range of scales from single cell to 
whole heart. These optical action potential signals are produced from a group of 
membrane-bound dye molecules within a volume of tissue. This volume depends 
on: (i) the optical magnification of the imaging system (ii) the depth of focus of 
the optics (ii) the pixel density of the camera sensor. 
Optical signals were obtained from a 16x16 array yielding 252 useable pixels (4 
pixels in each corner being reserved for ECG and pacing signals). Each pixel had 
a sensing area of 0.95mm x 0.95mm and the distance between the centres of 
neighbouring recording pixels was 1.1mm. With an optical magnification of x1.2, 
each pixel detected light from an epicardial area of 0.8mm x 0.8mm. The depth 
of field can be calculated from the equation obtained from the optics used in 
this thesis: 
Depth of field  = 1000m / [(7 x NA x magnification) + λex / 2(NA)
2] 
   = 1000 / [(7 x 1.4 x 1.2) + 0.535 / 2 x 1.42] 
   = 90m     
(NA = Numerical Aperture, λex = emission wavelength) 
 From this calculation, the optical signal in this study originates from the tissue 
within 90m of the epicardial surface, corresponding to approximately 6 cell 
diameters.  
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Optical data analysis 
The optical signals obtained from this study were analysed using custom analysis 
programme, OPTIQ (locally developed by Dr FL Burton, University of Glasgow). 
The optical action potentials (OAPs) were averaged and spatially filtered with a 
Gaussian filter. Further temporal filtering was done by using Medians + Boxcar 
filter. Several parameters such as action potential duration at 50%, 75% and 90% 
of repolarisation (APD50, APD75, and APD90, respectively), the activation time 
(TActM), the repolarisation time (TRepol) and colour maps for these parameters 
were generated using this software. OPTIQ could also generate a movie-like 
display of the activation spread across the mapped region on the ventricular 
epicardial surface. 
In this study, activation time was defined as the midpoint of the upstroke 
(TActM). Another way to define activation time was based on the time at the 
first derivative (i.e. the fastest rate of rise during the AP upstroke). 
Repolarisation time (TRepol) was defined as the time at return to baseline from 
the peak. In this study, the time at 50% repolarisation was used to calculate the 
APD at 50% repolarisation (APD50) and the time at 90% repolarisation was used to 
determine the APD at 90% repolarisation (APD90). APD was defined as TRepol50 
minus TActM (for APD50) or TRepol90 minus TActM (for APD90). In this study, APD50 
and APD90 were chosen for analysis in different sets of experiments. The 
definition of TActM, TRepol and APD were illustrated in Figure 2.6. 
For analysis purposes, APD90 was chosen in experiment involving E-4031 in 
Chapter 4 because the maximal effect of E-4031 is during the later part of the 
repolarisation (Phase 3 of AP). Therefore, APD90 would give a better indication of 
the effect of E-4031 on APD. APD50 was chosen for analysis in experimental work 
involving acute coronary artery occlusion (Chapter 5, 6, and 8) because during 
ischaemia, there was triangulation of the ventricular AP. Therefore, the effect 
was much clearer at APD50 as compared to APD90. 
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Figure 2.6 Definition of TActM, TRepol and APD 
Illustration on the definition of activation time (TActM) and time at 50% and 90% 
repolarisation (TRepol50 and TRepol90, respectively) based on analysis of the optical action 
potentials and first derivative in OPTIQ software. APD50 was calculated based on the 
difference between TRepol50 and TActM and APD90 was determined by the difference 
between TRepol90 and TActM. 
ECG data 
ECG signals recording 
In single view optical mapping experiments, simultaneous pseudo-ECG recording 
was obtained by using pairs of silver chloride disc electrodes inserted into both 
sides of the chamber. For panoramic view optical mapping experiments, the ECG 
electrodes were the vertical structural bars in the rotating chamber. Signals 
from these electrodes were amplified with an isolated amplifier (custom built by 
Medical Electronics, University of Glasgow) and displayed on oscilloscope 
(Nicolet Instrument Corporation, Wisconsin, USA) to allow real time viewing. 
During optical recordings, the 2 corner channels of the PDA were used to store 
the ECG and pacing stimuli traces. Continuous pseudo-ECG signals were also 
recorded onto a laptop computer using a USB compatible digitizer (DI-158U, 
Dataq Instruments Inc). 
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ECG data analysis 
ECG provides a non-invasive assessment of the electrical activity of the heart 
and can be measured with equal facility in in vivo and in vitro preparations. In in 
vitro, changes in ECG parameters may be correlated with changes in action 
potential produced by experimental interventions. ECG recordings from the 
experiments were analysed using ChartTM 5 Pro (ADInstruments) software (Figure 
2.7). The main ECG parameters extracted using this software were RR, PR, QRS 
and QT intervals (P, R and T amplitude information was available but not used). 
The software works in a semi-automated way; the computer assigns a cursor at 
certain points on each of the ECG beat, but may be manually overridden. The 
landmarks for the cursors are P start, P peak, QRS start, QRS end, T peak and T 
end (Figure 2.7b); the results can be displayed in a table form (Figure 2.7c). 
Reliability of the data depends on the quality of the ECG recordings, a limitation 
explained further in Chapter 9.  
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Figure 2.7 ECG analysis.  
Example of display from software Chart
TM
5 Pro showing a) typical ECG traces from acute 
coronary artery ligation experiments, b) the averaged view indicating the placement of 
cursors to analyze the ECG, and c) the table view showing the results of ECG analysis. 
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In this study, some instances of PVCs and TWA were observed. For the analysis 
purposes, PVCs were defined based on the findings of the simultaneous ECG 
recording in which the PVCs was characterized by premature and broad QRS 
complexes not preceded by a P wave, and its direction is opposite the major 
deflection of the normal QRS (Figure 2.8a). As for the T wave alternans, it was 
defined by a periodic beat-to-beat variation in the amplitude and/or shape of 
the T wave on the ECG (Figure 2.8b).   
 
Figure 2.8 PVCs and TWA 
Example of ECG demonstrating the instances of (a) PVCs and (b) TWA observed during the 
optical signal recording.   
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Statistical analysis 
All data obtained in this study are expressed as mean ± standard error of the 
mean (SEM). To perform significance testing, data were imported into GraphPad 
Prism software. Time courses of the APD changes from pre-occlusion period and 
occlusion period within the same heart were compared by repeated measures 
ANOVA. The parameters at specific time points in VF hearts were compared with 
the same parameters at corresponding time points in no-VF hearts using 
unpaired Student’s t-test. A two-tailed p-value of less than 0.05 was considered 
significant. The data obtained in this study have been tested for normality using 
one-sample Kolmogorov-Smirnov test (one-sample K-S test) performed in SPSS 
software and based on this test, all data were normally distributed.  
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Chapter 3: Use of ratiometric approach to examine 
membrane potential signals with voltage-sensitive 
dye 
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Aim 
This chapter will discuss the application of the voltage-sensitive fluorescence 
dye emission ratiometric technique as a means of studying the spatial 
distribution of voltage signals across the epicardial surface. This is desirable 
because successful application of this technique would allow absolute voltage 
signals to be compared, also in addition to reducing the effects of motion 
artefacts and baseline drift on the optical signal.  
Introduction 
Transmembrane potentiometric dyes have been widely used in electrophysiology 
study to monitor the electrical activity such as action potentials and membrane 
polarization in intact heart as well as in various cardiac cells or tissue 
preparations. However, voltage-sensitive fluorescence measurements are limited 
by baseline drift and motion artifacts which could obscure the changes in resting 
membrane potential and repolarisation, respectively. A study done by Knisley et 
al. (2000) found that the ratio calculated as the short wavelength divided by the 
long wavelength of the fluorescence emission reduces the effect of motion 
artifacts. 
Work by Beach et al. (1996), Bullen et al. (1997), Knisley et al. (2000) and 
Montana et al. (1989) has employed the concept of dual wavelength ratiometric 
approach to measure membrane potential with voltage-sensitive dyes (VSDs). 
Dual wavelength ratiometric measurements with VSDs are based on the concept 
of spectral shift in which there are opposite changes in voltage-dependent 
optical signals at the low and high wavelength wings of the spectra as shown in 
Figure 3.1. Loew (2001) described that membrane depolarisation results in a 
shift of the emission spectrum of the dye to shorter wavelength upon excitation 
of the dye molecules from the ground state to the excited state. Thus, there will 
be an increase in the fluorescence intensity at short wavelengths and a decrease 
of the fluorescence intensity at long wavelengths.  
This mechanism serves as a basis for the ratiometric approach, in which the 
fluorescence from bands either side of the peak of the emission spectrum are 
measured and their ratio calculated. This is based on the assumption that the 
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spectrum will only shift but not change shape or amplitude (Loew, 2001). The 
main advantage of this approach is that the ratio sensitivity is roughly equivalent 
to the absolute sensitivities at each wavelength. Another advantage is that the 
ratio value calculated from the dual wavelengths should relate to absolute 
voltage of the transmembrane potential independent of the absolute magnitude 
of the individual signals (Loew, 2001). 
 
Figure 3.1 Voltage-dependent spectral shift.  
Top: Voltage-dependent shift in spectrum for a voltage-sensitive dye. During depolarisation, 
there is a decrease in fluorescence at the red wing of the spectrum and an increase in 
fluorescence on the blue wing of the spectrum. Bottom: The spectral shift with band pass 
filter to monitor shorter wavelength and long pass filter to pick up the longer wavelength. 
Modified from Loew (2001).  
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Methods 
Heart preparation 
A total of 4 rabbits were used in this set of experiments. Hearts from male New 
Zealand White rabbits (2.5 - 3.5kg) were obtained as previously described, and 
Langendorff-perfused with the standard Tyrode’s solution at 37°C.  
Ratiometric fluorescence emission recording 
Optical mapping set-up 
 
Figure 3.2 Schematic diagram of optical mapping set-up. 
Optical mapping set-up for voltage-sensitive dye emission ratiometric experiments. 
Figure 3.2 demonstrates the optical mapping arrangement for dye emission 
ratiometric experiments. Excitation light from an array of blue-green LEDs with 
a centre wavelength of 505nm (Cairn Research Ltd, Kent, UK) was used to excite 
dye molecules from the epicardial surface of the heart. The fluorescence 
emitted from the stained heart surface was collected with a camera lens (Nikon 
85mm, f/1.4) and passed through a 45 degrees dichroic mirror (Comar 
Instruments). Fluorescence signals were then focused on two 16 × 16 element 
(256) photodiode arrays (PDA) (Hamamatsu Photonics). Depending on the filter 
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set being used, the image with longer wavelength than the cut-on wavelength of 
the dichroic mirror was focused on PDA1 after being passed through a long-pass 
filter whereas the image with shorter wavelength than the cut-on wavelength of 
the dichroic mirror was reflected and focused on PDA2 after passing through a 
band-pass filter. 
In these experiments, different filter sets were used in two sets of experiment. 
The filter sets were as follows: 
Filter set 1: 
Dichroic mirror = 645nm  
Band-pass filter = 605/55nm  
Long-pass filter = 695nm 
Filter set 2: 
Dichroic mirror = 680nm  
Band-pass filter = 645/75nm 
Long-pass filter = 695nm 
Three experimental protocols were done with filter set 1 and one experiment 
was done with filter set 2. 
Experimental protocols 
Background signals recording 
After the heart was mounted in the chamber and retrogradely perfused in 
Langendorff mode with Tyrode’s solution, background optical signals produced 
by the heart in the absence of voltage-sensitive dye were recorded. 
Signals recording after dye loading 
Then, a bolus of 100L voltage-sensitive fluorescence dye RH237 (stock solution 
dissolved in DMSO, concentration 1mM) was injected into the heart, through an 
injection port proximal to the aortic cannula (Chapter 2). The optical signals 
were recorded after 5 minutes to give enough time for the dye to diffuse into 
the myocardium and stain it. Serial recordings were done at the intrinsic rate of 
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the heart and during ventricular pacing at 250ms cycle length. Action potentials 
(APs) were acquired for 6 seconds during each recording. Simultaneous ECG 
signals were obtained using two electrodes inserted into both sides of the 
chamber and amplified and displayed on an oscilloscope (Nicolet Instrument 
Corporation, Wisconsin, USA) to allow real-time viewing of the ECG.    
Hyperkalaemic induction 
Previous study done by Kishida et al. (1979) has shown that the resting 
membrane potential in cardiac tissue is depolarized by extracellular 
hyperkalaemic induction. Therefore, a bolus of potassium chloride (400mM) was 
injected into the heart to alter the resting membrane potential in order to study 
the efficacy of emission ratiometry. The KCl bolus was given through the same 
injection port used to inject the dye. Signals were recorded immediately after 
the KCl injection and acquired continuously over the following 2 minutes.     
Coronary artery ligation 
Coronary artery ligation to produce acute local ischaemia in isolated rabbit 
hearts was achieved by using snare technique as being described in Chapter 2. 
The left posterior division of the coronary artery was occluded with a suture 
using a short piece of polyethylene tubing to form a snare. The ligature was 
connected to a calibrated spring device. To produce a local ischaemia, the snare 
was tightened for 30 minutes. The electrical activity from this region was 
optically recorded at 1 minute intervals. At the end of this period, the snare was 
released to reperfuse the heart. 
Spectrophotometry 
Spectrophotometry was performed to characterize the excitation light produced 
by the different LEDs (green and blue-green) as well as the excitation and 
emission light produced by the voltage-sensitive dye, RH237. Based on this 
spectrophotometric analysis, the long-pass and band-pass filters that need to be 
used for the optical mapping set-up were revised. 
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Data analysis  
Fluorescence emission signals obtained from the experiments were viewed and 
analysed using OPTIQ programme. Further ratiometric calculation of both long 
and short wavelength was done in MATLAB programme, Ratio Explorer written by 
Dr Francis Burton (University of Glasgow) (Figure 3.3). 
Before calculating the ratiometric values, files containing long and short 
wavelength from the background (before the dye loading) need to be loaded into 
the programme. Subsequently, files of long and short wavelength from the 
recording after the dye loading were loaded into the programme. In any given 
pixel, changes in fluorescence and ratios were calculated by using this formula: 
 
For a given pixel, S is the value of short wavelength, Sb is the value of short 
wavelength from the background, L is the long wavelength value, and Lb is the 
background value for the long wavelength. The Mean function takes the average 
signal value over the duration of the recording.  
Ratio = (S – Mean (Sb)) / (L – Mean (Lb)) 
 
Chapter 3  69 
 
 
Figure 3.3 Example of display from Ratio Explorer programme.  
Top: Signal recording from long and short wavelength acquired before the dye loading 
(background) displayed as mean fluorescence colour map and action potential traces. 
Bottom: The left side shows colour map for minimum (min) fluorescence from long and 
short wavelengths (above and lower panels, respectively). The right side are the ratiometric 
values displayed as min fluorescence colour map and the action potential traces. 
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Experimental results 
Spectrophotometric measurement 
The measurement of the excitation spectra for two different LEDs (blue-green 
and green) together with the excitation and emission spectra of voltage-
sensitive fluorescence dye RH237 were done using the spectrophotometer. This 
initial spectrophotometric measurement is important to serve as a basis for 
determining the LEDs and filter set to be used for the dual wavelength 
ratiometric experiments. From these results, the blue-green LEDs were chosen 
as the excitation light source and two different filter sets were used. The band 
marking for the filter relative to the emission spectra of RH237 are shown in 
Figure 3.4 (filter set 1) and Figure 3.5 (filter set 2).   
 
Figure 3.4 Excitation and emission spectra (filter set 1).  
Graph of excitation and emission spectra of RH237 and excitation spectra from 2 different 
LEDs with band marking for filter set 1 relative to the emission spectra of RH237. 
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Figure 3.5 Excitation and emission spectra (filter set 2). 
Graph of excitation and emission spectra from RH237 and excitation spectra from 2 
different LEDs with specific band marking for filter set 2 relative to the RH237 emission 
spectra. 
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Filter set 1 and Filter set 2 
Initially, (n=3) experiments were done with filter set 1; these included acute 
coronary artery ligation. As Figure 3.6 shows, reasonably good AP traces were 
recorded at the long wavelength in terms of signal-to-noise, but the AP traces at 
the short wavelength had very small amplitude (<10 units on a 12-bit A/D). 
Hence the ratio also had poor signal-to-noise.  
 
Figure 3.6 Example of signals recording with filter set 1. 
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After three experiments yielding similar results with filter set 1, the filter set 
was changed in an attempt to improve the amplitude of the short wavelength 
signal. Filter set 2 yielded much better signals (Figure 3.7): the amplitude of the 
signal obtained at the long wavelength was similar to that observed with filter 
set 1, but the short wavelength signals were significantly larger. Consequently, 
the ratio was less noisy. 
 
Figure 3.7 Example of signal recording with filter set 2.  
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Dual-emission wavelength ratiometric measurement 
Acute regional ischaemia (filter set 1) 
Dual-emission wavelength measurements were performed for the acute coronary 
artery ligation experiments using filter set 1. Figure 3.8 shows an example of the 
colour map of the mean, min and amplitude fluorescence signals from one of 
these experiments before occlusion. The lower panels display the AP traces of 
the long and short wavelength as well as the ratio from three different sites 
marked on the colour map. These three different sites represent areas with 
different levels of illumination intensity as demonstrated by the colour map. 
Figure 3.9 shows the mean, min and amplitude colour map of the fluorescence 
signals obtained from the same experiment, this time recorded 10 minutes after 
coronary artery occlusion. The amplitude colour map for the long wavelength 
indicates that the level of fluorescence was uneven; in the middle of the field of 
view signals had high amplitude compared to the periphery. This was caused by 
the centre-bright distribution of illumination provided by the array of LEDs. 
As shown in Figure 3.8 and Figure 3.9, the combination of filters used in this 
experiment (filter set 1) produced very small signals in the short wavelength 
compared to the long wavelength. Although the small amplitude of the short 
wavelength will reduce the ratio amplitude correspondingly, the resting 
potential from a whole heart should nevertheless be relatively constant. 
Therefore, we would expect to see a uniform ratio baseline throughout the 
whole field. However, in these experiments we found that the range of the 
ratios varied markedly between three sample sites of the mapping field in the 
same heart. The minimum ratio value was 0.054 for site 1 and 0.060 for site 2 
and 3. 
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Figure 3.8 Fluorescence signal pre-occlusion. 
Example of colour map showing min and amplitude fluorescence signals with the mean 
colour map from the background. The AP traces in the lower panel correspond to the 3 
different sites marked on the colour map. 
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Figure 3.9 Fluorescence signal at 10 minutes occlusion. 
Top panel: Example of colour map showing min and amplitude fluorescence signals with 
the mean colour map from the background. Lower panels show corresponding AP traces 
from 3 different sites marked on the colour map 10 minutes after ligation. 
Chapter 3  77 
Hyperkalaemic challenge 
This hyperkalaemic challenge study was done using filter set 2. A rapidly 
injected bolus of 1ml KCl (400mM) was used to cause transient changes in resting 
potential that were reversible and predictable and over a short time scale. The 
alternative way of producing hyperkalaemic induction by adding KCl to the 
perfusion solution would lead to much slower changes membrane potential, due 
to mixing in the perfusion system. 
Figure 3.10 shows an example of changes that occur when bolus of KCl was 
injected into the heart. AP signal amplitude declined rapidly following KCl 
injection and more gradually returned to the original amplitude on washout (not 
shown). In this experiment, the amplitude of signals produced from the short 
wavelength were more similar to that of signals at the long wavelength (Figure 
3.11). Even so, there were large variations in ratio values between the three 
sample sites within the same experiment (Table 3.1).  
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Figure 3.10 Hyperkalaemic induction.  
Top panel: Example of display from Ratio Explorer during hyperkalaemic induction. Bottom 
panel: Expanded AP traces from long and short wavelength, and their corresponding ratio 
showing the AP before and during KCl bolus. The red arrows indicate the timing of KCl 
bolus. 
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Figure 3.11 Fluorescence signal during hyperkalaemic induction.  
Top panel: colour maps showing min fluorescence of long and short wavelength and ratio. 
Lower panels: APs from 3 different sites with varying level of fluorescence intensity marked 
on the colour map. The range of ratios produced from the ratiometric calculation for those 
three sites vary with varying intensity. 
  
Table 3.1 Dual-wavelength ratiometric values with filter set 2.  
Comparison between the range of ratio values (min and max) from three different sites as in 
Figure 3.11. 
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Simulation of optical action potential 
It is clear from these results that the ratiometric data obtained from these dual-
emission wavelength experiments could not be used to calibrate the ratio into 
absolute voltage because the ratios were not uniform and the results showed a 
high variability in absolute value across the surface of the ventricle, even with 
the improved filter set 2. 
Because ratiometric fluorescence techniques have been used extensively for 
intracellular Ca2+ measurements successfully in the past (Brack et al., 2010), we 
proceeded to investigate possible sources of error by using a computational 
model to study the variables that might affect the reliability of the ratiometric 
measurement. The simulation programme, SimulateOAP (Figure 3.12) was 
written in MATLAB by Dr Francis Burton (University of Glasgow). It uses, as its 
starting point, an action potential template based on the optical action 
potentials recorded experimentally. The program simulates fluorescence signals 
for both short and long wavelength sections of the emission spectrum for a 16x16 
array of values. The program then adds the effects of 3 major non-uniformities 
that could be present in the mapping system: (i) non-uniform illumination 
intensity across the surface of the myocardium, (ii) movement artefact, i.e. 
translations in X and Y of the individual fluorescence signals over time, and (iii) 
differences in the alignment of the two cameras used to record short and long 
wavelengths. Figure 3.12 shows a list of the adjustable parameters and theirs 
value displayed as a table on the left hand side.  
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Figure 3.12 SimulateOAP.  
Typical display from SimulateOAP. The left panel shows the parameters names and values. 
The main classes of variable involved in optical mapping experiments are shown in blue. 
The right panel (top) displays an example of colour map of surface fluorescence multiplied 
by illumination. The right panel (bottom) is an example of a simulated AP ratio trace from 
one site at coordinate (7,7). 
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1) Ratio value is sensitive to illumination levels 
As is evident from the fluorescence colour maps from the experimental data 
(Figure 3.8, 3.9 and 3.10), there was variation in the illumination level at the 
long and short wavelength across the mapping field. The effect of unequal 
illumination level on ratiometric calculation was therefore simulated. Figure 
3.13 shows an example of simulated AP ratio obtained by varying the 
illumination level at pixel coordinate (7, 7), near the middle of the mapped 
field, in the presence of constant background fluorescence at both long and 
short wavelengths. Relative magnitudes of background levels were similar to 
those seen experimentally. The baseline illumination level for the long 
wavelength was 2500 and the short wavelength was 400, again chosen to match 
approximately the relative magnitudes of the experimental signals. The 
simulated ratio for the baseline illumination level is shown in Figure 3.13a. 
Figure 3.13b shows the resulting AP ratio when the illumination level was 
reduced to half of the baseline value and increased to double the value (Figure 
3.13c). In all three simulations, the ratio AP had a similar shape which was 
faithful to the underlying simulated voltage profile (template). However, there 
was variation in the minimum value for the ratio with varying light levels as 
depicted in Table 3.2. Clearly, the ratiometric measurement is sensitive to 
illumination level in the presence of uncorrected background fluorescence. 
When the simulation was repeated in the absence of background fluorescence, 
or subtracting background fluorescence, ratio values were within a constant 
range, as expected (results not shown).   
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Figure 3.13 Effect of varying illumination level on ratio AP.  
Simulated AP ratio produced with long and short wavelength at baseline illumination level 
(a), half illumination level from the baseline (b), and double illumination level from the 
baseline. 
Table 3.2 Effect of varying illumination level on ratio AP. 
Minimum and maximum values from the ratio AP simulated by varying the light level in 
Figure 3.12. 
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2) Ratio AP produces reliable shape even at large movement 
It is clear from experiments that motion artifacts due to heart contraction can 
affect the shape of the AP. For this reason Blebbistatin was added to the 
solutions to eliminate motion artifacts and yield APs that could be analyzed. 
Given the presence of motion artifacts, we used simulation to investigate the 
effect of heart movement on ratio AP. To do this, the position of the heart in X 
and Y axes was changed over time following sinusoidal trajectories (Figure 3.14). 
Simulated ratios together with corresponding simulated long and short 
wavelength are shown in Figure 3.15. For reference, Figure 3.15a shows traces in 
the absence of movement in either X and Y axis. Figure 3.15b shows simulated 
AP ratio produced when there was a slight movement of 1 pixel in the direction 
of X and Y axis and the ratio looked almost the same as in Figure 3.15a. In Figure 
3.15c and 3.15d, there was movement of 2 and 5 pixels respectively in X and Y 
axis direction. The simulated AP shapes mimic the distortions seen 
experimentally very well. At each level of simulated movement artefact, the AP 
ratio was remarkably true to the underlying voltage profile, although a small 
amount of distortion can be seen with larger movements, especially in the 
diastolic period of the traces. The range of ratio values was the same, namely 
0.180 - 0.205, regardless of how much the heart moved in X and Y axis. In 
summary, ratiometric measurement produces reliable AP shape with consistent 
minimum value over a wide range of heart movement.  
 
Figure 3.14 Sinusoidal movement trajectories on heart surface.  
Example of a) variation in surface fluorescence, b) movement trajectory in X and Y direction 
on the surface, and c) a close-up view of the movement trajectory illustrating the relation of 
heart movement with spatial variations in surface fluorescence.  
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Figure 3.15 Effect of heart movement on ratio AP. 
Effect of heart movement in X and Y axis direction on AP ratio with corresponding long and 
short wavelength. a) No movement X=0 Y=0, b) Slight movement X=1 pixel Y=1 pixel, c) X=2 
pixels Y=2 pixels, d) Large movement X=5 pixels Y=5 pixels. 
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3) Camera alignment is important for accurate AP shape 
Another potential artefact in the optical mapping method is due to camera 
misalignment. As described earlier, large heart movement with perfectly aligned 
cameras yielded ratio traces in which motion artefact was reliably eliminated. 
Therefore, the magnitude of the effect of camera misalignment in the presence 
of varying degrees of heart movement was studied. Camera misalignment of any 
number of pixels in X and Y directions could be incorporated into the simulation. 
For our purpose, to simulate severe but plausible misalignment between our 
cameras, displacements of 1 pixel in both X and Y direction was chosen. At the 
same time, the illumination profile was made to be uniform across the whole 
mapped field. Figure 3.16a demonstrates normal AP shape at both long and short 
wavelengths and the ratio when the simulated heart was completely still. 
However, when moderate heart movement of 3 pixels in X and Y directions was 
imposed (Figure 3.16b) AP ratio was no longer able to recover the underlying 
voltage profile accurately. As movement became even greater (Figure 3.16c) 
distortion of the ratio signal increase correspondingly. Even though the shape of 
the ratio AP changed with varying degrees of heart movement, all ratios had 
approximately the same minimum value (0.186-0.187).  
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Figure 3.16 Effect of camera misalignment and heart movement on ratio AP. 
Effect of camera misalignment (X error = 1 pixel; Y error = 1 pixel) on ratio AP with two 
degrees of heart movement. a) Perfect AP ratio produced when there was no movement. b) 
AP shape in the presence of movement by 3 pixels in X and Y directions. C) AP shape in the 
presence of movement by 5 pixels in X and Y directions. 
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Discussion 
In the first part of this chapter, results from the dual-emission wavelength 
optical mapping experiments were described. The initial aim for this study was 
to use the ratiometric approach to examine the membrane potential and try to 
correlate the ratio with the absolute voltage. Even though I successfully 
obtained the ratiometric measurement and was able to demonstrate the change 
in membrane potential during hyperkalaemic induction, the ratio could not be 
calibrated to yield an absolute voltage across the image field. The explanation 
for the poor compensation of varying illumination and movement was not clear. 
Therefore, a model was constructed to investigate all the variables that could 
affect the ratiometric measurement. In this model, the effects of three 
important variables, 1) illumination level, 2) heart movement, and 3) camera 
alignment on the ratiometric measurement, were simulated. From the model, it 
was shown that the fluorescence ratio was sensitive to illumination intensity if 
no (or incorrect) background fluorescence values were used. Even though the AP 
shapes produced in the ratio were similar at different levels of illumination, 
varying the light level changed the minimum values of the ratio. Despite 
measuring background fluorescence in these experiments prior to addition of 
dye, these values proved insufficiently accurate for the purpose of providing a 
uniform range of fluorescence ratio values across the image field. The reason for 
this is not clear. Two possibilities are: 1) minor movement of the heart between 
measurement of background and post-dye recording, and 2) time dependent 
changes in intrinsic fluorescence of the myocardium, e.g. due to oedema, means 
the initial measurement was not correct for the post-dye phase. 
The simulations showed that with correct baseline illumination levels and 
aligned cameras, the ratiometric measurement successfully eliminated the 
motion artefacts caused by heart movement and produced a ratio signal that 
faithfully reproduced the AP. However, camera misalignment by just 1 pixel in X 
and Y direction produced distorted AP shapes in the ratio signal in the presence 
of heart movement, but the minimum values were unaffected.  
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In conclusion, dual-wavelength ratiometric measurement can be used to 
attenuate the problems of motion artefact, uneven staining and uneven 
illumination in optical mapping experiments when suitable filters are chosen to 
ensure comparable fluorescence signals on short and long wavelength signals. In 
this study, however, the technique could not be routinely used, signals still 
contained a persistent movement artefact and the ratio value varied 
dramatically over the field of view. Calculations suggest that in order for this 
technique to be routinely used experimentally both correct background 
fluorescence values and accurate camera alignment need to be obtained.  The 
results of simulation suggest that the cameras need to be aligned within a 
tolerance of <1 pixel, and background measurements of both wavelength have to 
be correct within 10%. These two issues present particular technical problems 
that could not be resolved during the period of this PhD and are currently under 
consideration by others in the research group.
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Chapter 4: Single view optical mapping – Effect of 
E-4031 on action potential duration 
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Aim 
The aim of the study was to examine the effect of hERG channel block in the 
whole rabbit heart to assess the use of the drug as a means of manipulating 
rabbit ventricular action potential duration. This property of the drug E-4031 
was investigated in this study because it was going to be used later in 
subsequent experiments as a way to manipulate the APD (see Chapter 6).  
Introduction 
Class III antiarrhythmic agents (Vaughan Williams classification) predominantly 
block potassium channels, thereby producing action potential duration 
lengthening by prolonging repolarisation (Lenz and Hilleman, 2000). Several 
studies have shown that most class III agents also produce other antiarrhythmic 
effects in addition to potassium channel-blocking action (Carmeliet, 1985; Singh 
and Vaughan Williams, 1970). Class III antiarrhythmic agents increase APD 
without affecting conduction by selectively blocking K+ (and not Na+) channels in 
non-pacemaker tissue (Follmer and Colatsky, 1990; Sanguinetti et al., 1991; 
Wallace et al., 1991). Moderate prolongation of the action potential duration 
and refractory period, together with the maintenance of normal conduction 
velocity, tend to prevent re-entrant arrhythmias via increase in AP wavelength. 
E-4031 (1-[2-(6-methyl-2-pyridyl)ethyl]-4-(4-methylsulfonyl- aminobenzoyl) 
piperidine) is a potent methanesulfonanilide class III drug which selectively 
blocks the voltage-gated potassium channels encoded by human ether-a-go-go 
related gene (hERG) that mediate the repolarising delayed rectifier potassium 
(IKr) current. hERG is the main subunit of the potassium channel Kv11.1 coded by 
a gene KCNH2 (Gerlach et al., 2010; Perrin et al., 2008). Excessive prolongation 
of action potentials through inhibition of this channel by E-4031 can cause 
acquired long QT syndrome (LQTS). LQTS is associated with Torsade de Pointes 
(TdP) arrhythmia, a form of ventricular tachycardia that can rapidly degenerate 
into ventricular fibrillation (Ponte et al., 2010).  The effects of E-4031 on action 
potential duration have been investigated extensively in isolated tissue 
preparations in swine, guinea pigs, chicks (Agarwal et al., 2012; Nouchi et al., 
2011; Oinuma et al., 1990) and human stem cell-derived cardiomyocytes 
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(Jonsson et al., 2010). However, only limited data exist about the effect of E-
4031 on the APD of rabbits whole heart experiments. 
Methods 
Preparation of the rabbit hearts 
A total of 16 animals were used in this set of experiments. Hearts from male 
New Zealand White rabbits (2.5 - 3.5kg) were Langendorff-perfused as described 
in Chapter 2. A constant perfusion rate of 30ml/min was used throughout the 
experiments. Perfusion pressure was continuously monitored with a transducer 
connected to the aortic cannula. In normal hearts, perfusion pressure ranged 
from 20-35mmHg. 
Atrioventricular (AV) node ablation 
To study the effect of E-4031 on rabbit ventricular APD, the hearts were paced 
over a range of pacing cycle lengths from 1000 to 200ms.  After the heart was 
mounted onto the aortic cannula, the right atrium was cut to remove the SA 
node and to expose the AV node area. Anatomically, the AV node is located 
within the triangle of Koch, a region located at the base of the right atrium 
defined by the following landmarks: the coronary sinus ostium, tendon of 
Todaro, and the septal leaflet of the tricuspid valve. To assist in locating the AV 
node, the triangle of Koch region was delicately probed with the tips of a pair of 
forceps. The point at which there was a vigorous contraction of the heart when 
the forceps touched was taken as the AV node. To allow pacing slower than the 
heart’s intrinsic cycle length, complete AV block was produced by injecting a 
small volume (<0.2ml) of 10% formalin solution into the AV node with a 23-gauge 
needle to uncouple atrial and ventricular activity (Guzman et al., 1959). 
Uncoupling was further confirmed by inspection of the pseudo ECG which 
demonstrated the presence of QRS complex in the absence of P wave. Maciver et 
al. (2010) states that the accomplishment of this AV block method depends on 
several factors: 1) the ability to obtain direct and accurate access to the AV 
node, 2) the reliability in delivering small volumes of the necrosis agent, and 3) 
the confirmation of the AV node tissue ablation. In our experiments, we were 
able to achieve all Maciver’s three criteria for AV block in which 1) the direct 
and accurate access to the AV node was successfully achieved, 2) only small 
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volume of formalin solution (0.2 ml) was used to block the AV node, and 3) the 
AV node ablation was confirmed by absence of P wave on the ECG.  
Electrophysiological recording and analysis 
Epicardial membrane potentials from the anterior surface of the hearts were 
recorded using an optical mapping array (see Chapter 2). The isolated 
Langendorff-perfused heart was placed into the perspex chamber to reduce 
motion artefact and maintain the temperature of the hearts at 37oC by filling 
the chamber with thermostat-controlled heated solution. Further reduction of 
motion artefact was achieved by using Blebbistatin (10). The heart was 
loaded with 100L (concentration 2mmol/L) bolus of the voltage-sensitive dye 
RH237 (Molecular Probes) by slow injection into the coronary circulation over 
duration of 30 seconds through an injection port in a bubble trap in line with the 
aortic cannula. Details of the optical mapping setup and recording may be found 
in Chapter 2.     
E-4031 drug 
E-4031 (Enzo Life Sciences, MWT:510.5) used in these experiments was made as 
stock solution dissolved  in dimethylsulfoxide (DMSO) and stored at -20oC. There 
were 5 concentrations used for these experiments: 3nM, 10nM, 30nM, 0.3 and 
3. The chemical structure of E-4031 is demonstrated in Figure 4.1. 
 
Figure 4.1 E-4031 structure. 
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Pacing protocol 
After the AV node ablation procedure, the heart was put into the chamber and 
paced directly via electrodes placed over the base of the right ventricle. For 
each experiment, the heart was paced with the following protocols: 
Continuous pacing at 500ms cycle length 
At the beginning of the experiment, the heart was paced at 500ms cycle length 
for approximately 20-30 minutes to allow APD to reach a steady-state.  
Abrupt rate changes 500ms300ms500ms cycle length 
To study the time course of the change in APD after an abrupt step in cycle 
length, hearts were paced at basic cycle length of 500ms for 30 seconds 
duration. Then, the cycle length was shortened to 300ms (1 minute) and then 
returned to 500ms (1 minute). Optical recordings were obtained every 10s 
throughout this period. The 1 minute period was chosen on the basis of earlier 
studies showing that APD reached a steady-state in this time following abrupt 
rate changes.    
Range of cycle lengths: 1000ms, 800ms, 700ms, 600ms, 500ms, 400ms, 
300ms and 200ms 
To examine the cycle length related changes in ventricular APD, the hearts were 
paced at a range of cycle lengths from long to short cycle length (1000-200ms). 
At each pacing cycle length, optical recordings were made after 16 beats to 
allow adaptation to the new rate.  
Continuous pacing at 500ms cycle length  
In the final part of the protocol, hearts were paced at 500ms cycle length and 
the optical signals recorded every 1 minute intervals for 10 minutes duration to 
track recovery. 
All these protocols (4 sets) were performed before the drug was perfused into 
the heart. In the presence of E-4031, the same sets of protocol were repeated. 
The results obtained from these protocols before and after drug were compared.   
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Electrocardiogram (ECG) 
During the experiments, ECG signals were obtained using two electrodes inserted 
into both sides of the chamber. Signals from these electrodes were amplified 
and displayed on an oscilloscope (Nicolet Instrument Corporation, Wisconsin, 
USA) to allow real-time viewing of the ECG. 
Optical data analysis 
The optical signals obtained from this study were analysed using an analysis 
programme OPTIQ (see Chapter 2). The key electrophysiological parameter 
examined in this study was APD90 because E-4031 selectively blocks the IKr 
channel, one of the primary channels involved during rapid repolarisation phase 
(phase 3) of action potential. Figure 4.2a illustrates a typical response to regular 
pacing at 1000ms. The action potential duration (APD90) was calculated from the 
difference between activation time and the time at 90% repolarisation (Figure 
4.2b). Figure 4.3a shows a typical activation map produced in the OPTIQ 
software from the experimental recording. Figure 4.3b shows average AP traces 
from 3x3 pixels (9 pixels) that were used for the analysis. 
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Figure 4.2 Optical data analysis.  
a) Diagram showing AP train at 1000ms cycle length ventricular pacing i) Stimulus probe ii) 
ECG trace iii) Action potential recorded optically B: Method to determine APD90. 
Act=Activation time, Rep=90% repolarisation time. The difference (Rep-Act)= APD90 
 
Figure 4.3 Optical data.  
(a) Example of activation map showing 3x3 sites (9 pixels) chosen for APD analysis. (b) 
Mean optical action potential (OAP) from 9 sites paced at 500ms. 
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Results 
Figure 4.4 illustrates a typical full protocol time course obtained from one 
experiment. Characteristic changes in APD90 at different times reflect the 
different parts of the protocol. Under control conditions, APD90 was stable; 
immediately after the drug was added, APD90 rose to a new steady state and the 
protocols were repeated. On washout of the drug, APD90 returned to baseline. 
Effect of different concentrations of E-4031 on APD90 
The results summarized in Table 4.1 show that E-4031 (0.01M) significantly 
prolonged APD90 (P<0.01) by 21.0 ± 2.5ms (n=4); at 0.03M (n=6), by 42.7 ± 
6.7ms (P<0.01); and at 0.3 (n=3), by 48.6 ± 5.8ms (P<0.05). Even though 3M 
E-4031 prolonged the APD90 by 32.0 ± 11.7ms, the change in APD pre and post 
drug was not statistically significant. The effect of 0.003M E-4031 was 
undetectable. Figure 4.5 shows the variation in action potential (AP) shape at 
different E-4031 concentrations. 0.03M and 0.3 E-4031 concentrations 
produced the largest effect on APD. The effect of E-4031 on APD90 was fully 
reversible, although the early phase of repolarisation did not return to control 
values (Figure 4.5). The mean APD90 prolongation for each drug concentration 
obtained in Table 4.1 was used to plot the dose-response (Figure 4.6). Based on 
this curve, the EC50 for E-4031 in this study was 0.01 ± 0.003M.  
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Figure 4.4 Full protocol time course at 0.3M E-4031 concentration. 
The dotted lines and the numbering in between the lines indicate different interventions. The experimental protocol began with abrupt rate changes, 
followed by different pacing cycle length and continuous pacing at 500ms. The whole sets of protocol were done for the control (protocols 1-4) and in the 
presence of the drug (protocols 5-7). Protocol 8 was the washout of the drug.
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Table 4.1 Effect of different E-4031 concentrations on rabbit ventricular APD. 
 
 
 
Figure 4.5 Effect of E-4031 on action potential.  
Variations in action potential shapes at maximum effect during control (black line), during the drug (red line) and after drug washout (blue line). 
Comparison of APs at three different E-4031 concentrations (0.01, 0.03 and 0.3 M).
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Figure 4.6 Dose-response curve for 4 different concentrations of E-4031.  
AP traces show example of control APD (black) and prolongation of APD (red) after the 
heart being perfused with corresponding drug concentration. 
Logistic curve of APD change =   MaxChange / [(1 + (X/EC50)
Slope
]. 
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APD adaptation during rate changes 
Abrupt sustained rate changes from long cycle length to shorter cycle length and 
back to long cycle length (500ms300ms500ms) showed clear memory effects 
in terms of APD. Figure 4.7 shows an example of the time course of APD 
shortening and lengthening after sequential changes in step decrease and step 
increase in cycle length. During rate changes, APD did not adjust immediately to 
the new cycle length but required some time to reach a new steady state. The 
first action potential after changing the cycle length from 500ms to 300ms 
showed abrupt shortening followed by a much slower time course until steady-
state was reached. When the cycle length was changed back abruptly, APD was 
incompletely restored and gradually returned to the control value over a period 
of ~60s. Figure 4.7b shows an example of APD alternans that was sometimes 
observed at higher drug concentrations and at the faster pacing rate. 
Figure 4.8b shows that abrupt rate changes exhibited a shorter mean time 
constant in the presence of 0.03M E-4031. For example, rate changes from 
short cycle length to longer cycle length exhibit a significantly shorter time 
constant (30.1 ± 5.0s during control, 11.9 ± 1.4s during E-4031).  
Chapter 4  102 
 
Figure 4.7 APD adaptation during rate changes.  
Time course of APD adaptation after sequential increases and decreases in pacing cycle 
length. Both changes from long to shorter cycle length (500ms300ms) and from shorter 
back to long cycle length (300ms500ms) were followed by an initial rapid phase and a 
subsequent slow phase of action potential shortening and lengthening, respectively. (a) 
Comparison between control and 0.03M E-4031. The inserts in the black boxes show 
illustration of the exponential fits used for analysis. (b) Comparison between control and 
0.3 E-4031. In presence of 0.3M E-4031, abrupt decrease in cycle length produced 
alternation between shorter and longer APD (alternans).  
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Figure 4.8 Mean time constant during abrupt rate changes at 0.03M E-4031  
(a) From long to short cycle length (500ms300ms) (b) From short to long cycle length 
(300ms500ms). 
Rate-dependent property of E-4031 
The hearts were also subjected to a range of pacing cycle lengths from 1000ms 
down to 200ms to study the rate-dependent property of the drug. Figure 4.9 
illustrates the frequency dependent effect of E4031. The drug exhibits greater 
effect at longer cycle length compared to shorter cycle length. At slower than 
physiological rates (approximately 300ms), the effect of the drug was larger 
than that seen at higher than physiological rates. For example, at 200ms cycle 
length there was no significant change in APD90 at 0.3 E-4031 (7.8 ± 11.7ms, 
n=3). At normal heart rate (300ms cycle length), 0.03M E-4031 significantly 
prolonged the APD90 by 8.5 ± 1.7ms (P<0.01) whereas at lower stimulation 
frequency (1Hz) the effect was considerably larger with the APD prolongation of 
73.7 ± 13.7ms (P<0.05).  
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Figure 4.9 Reverse rate-dependent effect of E-4031.  
Cycle-length related changes in rabbit ventricular action potential duration by different 
concentrations of E-4031. 
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T-wave alternans (TWA), early afterdepolarisations (EADs) and 
ventricular tachycardia (VT) 
In these experiments, incidence of TWA, EADs and VT at different cycle lengths 
were recorded after exposure to the four different E-4031 concentrations. The 
observations are summarized in Table 4.2. During control (pre-drug phase), 
episodes of alternans were observed at 200ms cycle length in 6 out of 15 hearts; 
in contrast, no  EADs or instances of VT were observed. Some (~50%) of the 
hearts which exhibit APD alternans at 200ms cycle length pre-drug also showed 
alternans after E-4031 perfusion. Incidences of EADs were observed at all drug 
concentrations at various cycle lengths ranging from 1000ms down to 500ms. 
Some hearts also developed VT at slower cycle lengths. In most but not all 
hearts, VT was preceded by EADs, but not all hearts with EADs developed VT. All 
episodes of VT were non-sustained and reverted back to sinus rhythm within 
seconds; none of them progressed into ventricular fibrillation. Examples of AP 
recordings with corresponding ECG signals showing the incidence of APD 
alternans, EADs, and VT after exposure to different drug concentrations are 
displayed in Figure 4.10 (0.01M E-4031) and Figure 4.11 (0.3M E-4031). 
  
Chapter 4  106 
Table 4.2 T-wave alternans, EADs, and VT.  
Incidence of alternans, early afterdepolarisations (EADs), and ventricular tachycardia (VT) at different cycle lengths in hearts perfused with 4 different E-
4031 concentrations. “Control” was the initial pre-drug phase of each experiment before the hearts being perfused with the drug. Star with the same colour 
indicates the same heart. 
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Figure 4.10 EADs and VT in the presence of 0.01M E-4031.   
Example of EADs (indicated by the blue box) and VT (indicated by the red box) occurred at 
Vpaced 800ms and 700ms cycle lengths in heart perfused with 0.01M E-4031 
concentration. Top panel shows the AP with corresponding ECG in the lower panel. 
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Figure 4.11 EADs and alternans in the presence of 0.03M E-4031.   
Example of EADs (indicated by the blue box) occurred at Vpaced 600ms cycle length and T-
wave alternans (indicated by the orange box) occurred at Vpaced 200ms cycle length in 
heart perfused with 0.03M E-4031 concentration. The arrows are pointing the alternating 
pattern of the T-wave. Top panel shows the AP with corresponding ECG in the lower panel. 
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Discussion 
Role of IKr in repolarisation, rate dependence of APD and 
adaptation 
The repolarisation phase of the cardiac action potential involves many 
interacting ionic conductances, including the inactivation of the L-type Ca 
current and the activation of the delayed rectifier currents (IK). In ventricular 
muscle, IK has two components: the rapidly inactivating IKr and the slower 
component IKs. IKr is generated by the hERG channel (Kv11.1). The role of this 
channel in repolarisation is complex. The channel is rapidly activated in the 
plateau phase (Phase 2) and subsequently inactivates, but its influence on APD 
arises mainly from the recovery from inactivation (re-activation) that occurs 
during Phase 3 and results in a secondary rise in current which provides the 
steep return of the membrane voltage to the resting potential (Gintant, 2000). 
Hereditary defects in this channel typically give rise to abnormally long APs, 
predisposition to early afterdepolarisations, and to Torsade de Pointes. 
Recovery from inactivation of IKr at negative membrane potentials occurs over 
hundreds of milliseconds, so at high heart rates, when the diastolic interval is 
reduced, IKr has insufficient time to recover fully and is therefore less available 
for repolarisation. Under these circumstances, other ionic currents become 
dominant: for example, INCX (sodium-calcium exchanger current) and, in some 
species, ICl(Ca)  (calcium-activated chloride current). In larger mammals, 
including rabbits, dogs and humans, APD decreases at higher stimulation rates 
during continuous pacing. At cycle lengths >1 second, rabbit ventricular APs have 
been reported to show a decrease in APD below the peak achieved at ~1s. This 
biphasic relationship is not present in human and guinea-pig. In the experiments 
described in this chapter, the range of cycle lengths used was restricted to <1 
second and only monophasic restitution curves were seen. 
In vivo and in vitro studies have shown that APD adaptation to abrupt changes in 
rate show two phases. A rapid phase, last only 1 or 2 beats, is followed by a 
slow, exponential phase with a time constant of tens of seconds. This behaviour, 
sometimes also known as ‘cardiac memory’, is not properly understood but is 
thought to have its basis in a number of time-dependent processes including: 1) 
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recovery from inactivation of IKr and IKs, 2) changes in SR Ca
2+ content and 
subsequent changes in Ca2+ transient amplitude, and 3) the L-type Ca2+ current 
ICa,L. The consequences in terms of heart function are linked to the inotropic 
response to altered heart rate, in that rapid changes cause slower changes in 
inotropic state similar to that of AP adaptation. Altered cardiac memory is 
thought to occur during ischaemia and other pathological situations, and may 
have consequences for arrhythmogenic status (Patberg et al., 2005). 
E-4031 dose-dependence on isolated channel and whole heart 
In this chapter, E-4031, a Class III anti-arrhythmic agent that selectively inhibits 
IKr, prolonged the APD in a dose dependent fashion. The concentration 
dependence of the action of E-4031 on IKr has been studied in a number of 
preparations. Commonly the behaviour of the isolated channel is studied in 
expression systems (oocytes or mammalian cell lines) and under these 
circumstances the EC50 for E-4031’s blocking action ranges from ~10nM to 1M 
(Anderson et al., 2006; Herzberg et al., 1998). More consistent results were 
obtained in intact myocardium where EC50 values in terms of ventricular APD 
prolongation were approximately 10nM in guinea-pig (Wettwer et al., 1991) and 
dog (Holahan et al., 1992; Wallace et al., 1991). These values are close to the 
EC50 value observed in the current study (10.5nM) which appears to be the first 
report of the dose-dependence of E-4031 in rabbit ventricle. As seen in other 
studies at high concentrations of E-4031, APD values reach a peak value and then 
decline. The reason for this is unknown but could represent effects of the drug 
on other ion channels other than IKr.  
As reported in other species, the effect of E-4031 is considerably smaller at 
shorter cycle length. At values approximating physiological heart rates of the 
rabbit (cycle length = 300ms) the maximal effect of E-4031 prolongs APD to 
~115% of control level, while at a cycle length of 1s, APD is prolonged by 215%. 
This reverse rate dependence of the effect of hERG channel blockers has been 
reported in a number of studies and represents the reduced role of IKr in AP 
repolarisation at short diastolic intervals due to the incomplete recovery from 
inactivation. 
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E-4031 on adaptation 
As shown in Figure 4.8, the time constant for the slow phase of recovery of APD 
following a step change in cycle length was 20-30s. Using a maximal dose of 
E-4031 to effectively block IKr, caused an approximate halving of the time 
constant for adaptation. These data suggest that recovery of IKr during the 
diastolic period is the major rate-determining process governing the APD 
following abrupt changes in cycle length. In the absence of IKr, the rate of 
recovery is determined by other processes such as the equilibration of SR Ca2+ 
content or the rate of recovery of ICa,L. The physiological significance of this 
result is that at normal heart rates for rabbits (cycle length <300ms), IKr is 
unlikely to play a major role in cardiac memory or adaptation. In this respect, 
rabbit may differ from mammals with lower heart rates, e.g. canine or human, 
where IKr may have a significant role in repolarisation. 
E-4031 and alternans (role of IKr) 
In this study, alternans was routinely observed at short cycle lengths in the 
presence and absence of E-4031 (Table 4.2). The role of IKr in alternans has been 
previously studied (Hua and Gilmour, Jr., 2004). This study suggested that IKr 
stabilized APD and reduced the incidence and amplitude of alternans in canine 
myocardium. Partial inhibition of IKr increased the relative amplitude of 
alternans, such that short APDs were caused by a larger IKr component than the 
corresponding long APD. The current study appears to contradict this last point; 
alternans was only observed at short cycle lengths when the contribution of IKr to 
repolarisation was small. Furthermore, suppression of IKr reduced the incidence 
of alternans but did not abolish it. These results suggest that, in agreement with 
the published study, IKr may stabilize APD and may thus prevent alternans since 
alternating APDs were not observed at longer cycle lengths where IKr is active in 
the rabbit. In further agreement with Hua & Gilmour, Jr. (2004), the small 
amount of IKr present at short cycle lengths facilitated alternans, which was less 
likely after E-4031 treatment despite the minimal role of IKr in repolarisation at 
these rates and the small change in APD as a consequence of E-4031. 
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Early afterdepolarisations (EADs) 
As reported in this chapter, IKr block is associated with prolongation of APD and 
development of EADs. A common consequence of higher doses of E-4031 is the 
development of tachycardia in the form of Torsade de Pointes (TdP) in larger 
mammals (Nalos et al., 2012). In the present study, VT was observed, but TdP 
did not occur in any rabbits studied despite use of high concentrations of E-4031. 
However, EADs were common at the long cycle lengths (sub-physiological rates), 
while at physiological rates, EADs were never observed. The EADs reported in 
this study appeared in the later stages of repolarisation with a coupling interval 
>100ms. These late EADs are relatively rarely reported in the literature. In single 
cell preparations, EADs occur in the plateau phase of the AP in guinea pig, rabbit 
and dog (Nalos et al., 2012). The late coupling of the EADs observed in the 
current study may be due to the propagation of arrhythmic events originating 
below the epicardial surface. Propagation of a non-sinus depolarisation may 
generate EAD-like deflections in the epicardial optical signal. For example, hERG 
channel block may lead to EADs in the Purkinje fibre system on the endocardial 
surface (Carlsson et al., 1997) which provides triggered events which can 
propagate to the rest of the myocardium. 
Conclusion 
E-4031 significantly and reversibly prolonged APD90 at different drug 
concentrations with the largest effect observed at 0.03M. Abrupt rate changes 
from long to short cycle length and back (500ms300ms500ms) evinced clear 
memory effects in terms of APD. The time constant for recovery after a rate 
change was shorter after E-4031 block, suggesting that IKr recovery is the 
dominant factor at low heart rates in the rabbit ventricle. This study also 
demonstrated that the reverse rate-dependent effect of E-4031 in which the 
effect of the drug was diminished at shorter cycle lengths. Tachycardia-induced 
alternans behaviour was less common but not abolished in the presence of E-
4031, suggesting that IKr was not a prerequisite for alternating APD. VT was 
present at high concentrations of E-4031, but TdP (a form of VF) did not occur in 
the rabbit ventricle on IKr block, unlike that seen in canine and human studies 
(Fujiki et al., 1994; Nalos et al., 2012).
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Chapter 5: Single view optical mapping - Acute 
regional ischaemia in isolated rabbit hearts  
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Aim 
The main aim of these experiments was to get a better understanding of the 
mechanistic link between acute regional ischaemia and the incidence of 
ventricular arrhythmia in rabbit.  
Introduction 
According to cardiovascular disease statistics from British Heart Foundation 
(2013a), coronary heart disease (CHD) is the UK's biggest killer, in which around 
one in six men and more than one in ten women die from the disease amounting 
to  around 74,000 deaths in the UK each year with an average of 200 people 
each day. People with CHD are having a high risk of myocardial infarction as a 
result of atherosclerosis (2013b). Clinical evidence suggests that post-infarction 
patients are at risk of sudden cardiac death secondary to arrhythmia (De Groot 
and Coronel, 2004; Luqman et al., 2007; Marcus et al., 1988; Prystowsky, 2004). 
Approximately 50% of deaths from cardiac causes are arrhythmic and occur 
within 1 hour of the onset of symptoms. Pathological examination reveals that in 
the majority of cases show signs of acute myocardial infarction. However, the 
mechanistic link between ischaemia and lethal arrhythmia is poorly understood. 
Acute myocardial ischaemia results from interruption of blood supply to part of 
the heart (Figure 5.1) commonly due to occlusion of one or more coronary 
arteries. The research described in this chapter is designed to examine the 
electrophysiological events during acute regional ischaemia and subsequent 
ventricular arrhythmias by using a model of coronary artery occlusion in the 
isolated rabbit heart.  
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Figure 5.1 Acute regional ischaemia.  
Diagram showing region of myocardial infarction secondary to acute coronary artery 
occlusion. 
Methods 
Preparation of the rabbit hearts for coronary artery occlusion 
A total of 21 animals were used in this set of experiments. In this study, New 
Zealand White rabbits (2.5-3.5kg) were used. After the rabbit was sacrificed 
with overdose injection of anaesthesia, the heart was removed and perfused in 
Langendorff mode. The left posterior division of the coronary artery was 
occluded with a suture using a short piece of polyethylene tubing to form a 
snare. The ligature was then connected to a calibrated spring device to ensure 
standardised occlusion forces. Details on the method to produce acute coronary 
artery occlusion were explained in detail in Chapter 2. Two additional measures 
were taken to reduce motion artefact: (i) mechanically constraining the heart 
within a perspex chamber and (ii) pharmacologically reducing contraction by 
adding Blebbistatin (10M) into the Tyrode’s solution. The perfusing solution and 
the solution surrounding the hearts inside the chamber was maintained at 37oC. 
A constant perfusion rate of 30ml/min was used throughout the experiments. 
Perfusion pressure was continuously monitored via a transducer connected to the 
aortic cannula. 
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Experimental protocols 
The experimental protocol is illustrated in Figure 5.2. All optical signal 
recordings in this study were recorded at the intrinsic heart rate, i.e. hearts 
were not paced externally. 
 
Figure 5.2 Experimental protocol for control experiments. 
 
Dye loading 
At the beginning of the experiment, the heart was loaded with 100L bolus of 
RH237 administered by slow injection into the coronary circulation over 1 
minute through an injection port in a bubble trap in line with the aortic cannula. 
During the experiment, bolus injections of RH237 were repeated twice; before 
the occlusion period and before the reperfusion period.   
Pre-occlusion 
Approximately 10-15 minutes after dye injection when the optical signals were 
stabilized, serial recordings of optical signals were performed at 1 minute 
intervals for 30 minutes. For the purpose of analyzing the data, the analysis was 
performed using the data recorded at Pre-occlusion 10min (time point at 10 
minutes after beginning of the pre-occlusion period) and at Pre-occlusion 30min 
(time point at 30 minutes after beginning of the pre-occlusion period).  
Coronary artery occlusion 
After 30 minutes of pre-occlusion period, the coronary artery was occluded by 
tightening the snare to produce regional ischaemia (see Chapter 2). Serial 
recordings were made at 1 minute intervals for 30 minutes. During this protocol, 
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some hearts developed VF and some hearts did not. If the heart went into VF, 
the snare was released to reperfuse the heart and allow the rhythm to revert 
back to sinus rhythm. However, if the heart was still in VF after releasing the 
snare, a small bolus (0.2ml) of potassium chloride (KCl) (1M concentration) was 
injected into the heart through the injection port to provide a phase of uniform 
transient depolarisation, sinus rhythm returned after the potassium returned to 
normal levels.   
Reperfusion 
For the hearts that did not develop VF, the snare was released after 30 minutes 
of occlusion to reperfuse the heart. Serial recording at 1 minute intervals was 
done for 40 minutes.  
Optical data analysis 
The optical signals obtained from this study were analysed using the programme 
OPTIQ (see Chapter 2). The results presented in this chapter (except for Figure 
5.6 and 5.7) were analysed from the whole mapping field of 252 sites (excluding 
the 4 corner sites) as displayed in Figure 5.3a. Figure 5.3b shows average AP 
traces from 252 pixels from Figure 5.3a. The parameters that were analysed 
include the action potential duration at 50% repolarisation (APD50), the range of 
APD50, the activation time (TActM) and the range of TActM. The value for each 
parameter was expressed as mean ± SEM. As for Figure 5.6 and 5.7, the results 
were representing the data from 3 x 3 pixel selections (9 sites) from 3 different 
zones. 
 
Figure 5.3 Optical data analysis in OPTIQ software.  
a) Example of activation map from the apex of the left ventricle showing 252 pixels used for 
analyzing purposes. The pixels at each corner were excluded. b) Mean optical action 
potentials (OAPs) from 252 sites at intrinsic heart rate. 
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Results 
Incidence 
From the response to the protocol, the hearts could be placed into one of two 
groups, those that developed arrhythmia during acute regional ischaemia 
following the coronary artery occlusion and those that did not (up to the time 
limit of 30 minutes). The bar graph in Figure 5.4a displays the comparison 
between the incidence of hearts that went into VF and the hearts that did not 
develop VF. From 21 experiments performed with this protocol, almost 50% of 
the hearts developed VF during coronary artery occlusion within 30 minutes and 
the rest did not. Some of the hearts developed VF as early as within the first 5 
minutes of occlusion and some hearts developed VF later during the occlusion. 
Most of the arrhythmic events (40%) occur between 15 to 20 minutes of occlusion 
(Figure 5.4b).  
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Figure 5.4 Incidence of VF during acute coronary artery occlusion. 
a) Incidence of hearts that developed VF and did not develop VF during acute ischaemia (VF 
= 47.6% and no-VF = 52.4%). b) Incidence of VF relative to the time during occlusion. More 
hearts developed VF between 15 to 20 minutes of occlusion. 
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Premature ventricular contractions (PVCs) and T-wave alternans 
(TWA) 
Two phenomena that have been clinically associated with arrhythmia are PVCs 
(Boineau and Cox, 1973) and TWA (Pastore et al., 1999; Rosenbaum et al., 
1994).  During the optical signal recordings in our experiments, the instances of 
PVCs and TWA were noted. The incidence of PVCs and TWA before and during 
occlusion was analysed to see whether there was any correlation between these 
phenomena and the incidence of arrhythmia as demonstrated in Figure 5.5. The 
occurrence of PVCs was noted before and during occlusion whereas TWA were 
only present during the occlusion. Both no-VF and VF groups had roughly the 
same incidence of PVCs and TWA.     
 
Figure 5.5 PVCs and TWA. 
Incidence of PVCs and TWA before and during occlusion in no-VF and VF groups. There 
were no instances of TWA before occlusion in both groups. 
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Effect of coronary artery occlusion 
Figure 5.6 shows an example of the optical mapping data obtained during the 
experiments showing the effect of coronary artery occlusion. In this example, 
the OAPs were sampled from 3 x 3 pixel selections from normal (A), border (B) 
and ischaemic (C) zones. The pixel selections were indicated by the small white 
boxes. These pixel selections were chosen based on the degree of shortening of 
the APD during coronary artery occlusion. The normal zone was chosen on the 
basis of the region that having the longest APD during occlusion. For the infarct 
zone, it was selected from the region where there were maximal shortening in 
APD and the border zone was the region where there was an intermediate 
change of the APD.  
In Figure 5.6, the above panels show the ECG signals and the lower panels show 
the APD50 colour maps together with the representative AP from different zones 
before, during and after occlusion. The blue colour indicates the APD50 of about 
140-160ms. During occlusion, the area in zone C became ischaemic and the 
APD50 shortened which generated a gradient of APD which is shown in the colour 
map in the middle. The ECG recorded during occlusion demonstrates S-T 
segment depression which is a classic clinical signs of acute ischaemia. On 
reversal when the snare was released to reperfuse the heart, the APD returned 
to normal and the ECG returned towards normal even though there were some 
slight S-T changes.
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Figure 5.6 Effect of coronary artery occlusion.  
Example of optical mapping data before, during and after occlusion. Above panels show ECG signals, lower panels show the APD50 colour maps together 
with the representative AP from different zones. The OAPs from each zone were sampled from 3 x 3 pixel selections as indicated by the small white boxes.
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Figure 5.7 demonstrates an example of full protocol time course in our 
experiments. During the pre-occlusion period, the APD50 stabilised to a steady-
state value. During occlusion, the APD50 especially in Zone C showed dramatic 
shortening. Reperfusion restored the APD50 to normal, but the value appeared to 
continue to gradually increase for the duration of the reperfusion period. Some 
hearts developed VF during the occlusion, in this case ~20 minutes after 
occlusion. For the purpose of this study, only arrhythmic events – either 
sustained or non-sustained VF – that occurred within 30 minutes duration of 
occlusion were included in the VF group. Any episode of arrhythmia that took 
place pre-occlusion or during reperfusion was not included in the VF group. 
 
Figure 5.7 Full protocol time course. 
Example of full protocol time course showing changes of APD50 obtained from three 
different zones during acute coronary artery occlusion experiment. The value is expressed 
as the mean APD50 and the error bars indicate the standard error of the mean (SEM) from 3 x 
3 pixel selections from each zone as indicated by the white boxes on the colour map. Zone 
A= Normal zone, Zone B= Border zone, Zone C= Ischaemic zone. 
  
Chapter 5  124 
For the purpose of comparing the results effectively, the electrophysiological 
parameters were analysed at the same time points throughout the experiments 
for both no-VF and VF groups. The standard time points used in this study were 
10 minutes into the pre-occlusion phase (Pre-occlusion 10min), after 30 minutes 
of control period, i.e. immediately prior to occlusion (Pre-occlusion 30min), 5 
and 10 minutes after occlusion (Occlusion 5min and Occlusion 10min). 
APD50 (no-VF vs. VF groups) 
One of the electrophysiological parameters analysed in this study was the APD50. 
The plotted graph of APD50 at Pre-occlusion 30min for each individual 
experiments (n=21) interestingly revealed that the hearts which developed VF 
had significantly shorter APD with the mean APD50 of 141.5 ± 3.5ms whereas the 
hearts that did not develop VF have a longer APD50 with the mean of 168.8 ± 
5.5ms as demonstrated in Figure 5.8. The APD50 difference between the two 
groups was greatly significant (P<0.001).  
 
Figure 5.8 APD50 (no-VF vs. VF groups)    
APD50 (mean ± SEM) for each individual experiment at Pre-occlusion 30min (n=21). The 
hearts that developed VF had a significantly shorter APD50 (P<0.001) as compared to the no-
VF hearts.  
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Box plots diagram in Figure 5.9 further demonstrates the difference in the APD50 
between both groups. The APD50 was significantly prolonged at Pre-occlusion 
30min as compared to the APD50 at Pre-occlusion 10min in both groups. The 
result also shows that the APD50 at 10 and 30 minutes of the pre-occlusion period 
in VF group were significantly shorter as compared to the no-VF group at the 
corresponding time point. The mean values for the APD50 at Pre-occlusion 10min 
and Pre-occlusion 30min in both no-VF and VF groups were listed in Table 5.1.  
 
Figure 5.9 APD50 at pre-occlusion period.  
Box plots of the mean APD50 between no-VF and VF groups at 10 and 30 minutes pre-
occlusion. The upper and lower limits of the box represent the 75
th
 and 25
th
 percentile, 
respectively. The upper and lower limits of the error bars represent the maximum and 
minimum, respectively and the line in the middle represents the median. APD50 was 
significantly longer at Pre-occlusion 30min as compared to APD50 at Pre-occlusion 10min in 
both groups. Both APD50 at 10 and 30 minutes in the VF group were significantly shorter 
than the APD50 at corresponding time frame in the no-VF group. (*P<0.05, **P<0.01, 
***P<0.001) 
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 Table 5.1 APD50 at Pre-occlusion 10min and Pre-occlusion 30min.  
Comparison between no-VF and VF groups. 
 
The APD50 at Pre-occlusion 30min, Occlusion 5min and Occlusion 10min were 
analysed and plotted in box plots diagram as in Figure 5.10. Comparison of the 
APD50 was made between the two groups. The result reveals that in both no-VF 
and VF groups, the APD50 were significantly shorter during occlusion as compared 
to the pre-occlusion period. Further analyses show that the APD50 at Pre-
occlusion 30min and during Occlusion 5min in the VF group were significantly 
shorter than the APD50 at corresponding time points in the no-VF group. The 
mean APD50 values at each time point in both groups were listed in Table 5.2. 
 
Figure 5.10 APD50 before and during occlusion. 
Box plots of the mean APD50 at Pre-occlusion 30min, Occlusion 5min and Occlusion 10min 
for no-VF and VF groups. The hearts in VF group have significantly shorter APD50 at pre-
occlusion and during Occlusion 5min as compared to the no-VF group at the same time 
point. (*P<0.05, **P<0.01, ***P<0.001)  
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Table 5.2 APD50 before and during occlusion. 
APD50 at Pre-occlusion 30min, Occlusion 5min and Occlusion 10min in no-VF (n=11) and VF 
(n=10) groups.  
 
Apart from the APD50, the range of APD50 (difference between the longest APD 
and the shortest APD from 252 sites) was also analysed to look at the 
heterogeneity of the hearts. The results for the range of APD50 in both groups 
were plotted in box plots diagram in Figure 5.11. The range of APD50 was larger 
during occlusion as compared to the range of APD50 at Pre-occlusion 30min in 
each no-VF and VF groups. At Pre-occlusion 30min, there was no significant 
difference between the two groups. However, during Occlusion 5min, the hearts 
that developed VF had a greater range of APD50 as compared to the hearts that 
did not develop VF. This result indicates that in the hearts that went into VF, 
there was greater heterogeneity in terms of APD50 which might predispose the 
hearts to VF. 
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Figure 5.11 Range of APD50 before and during occlusion. 
Box plots of the range of APD50 at Pre-occlusion 30min and during Occlusion 5min and 
Occlusion 10min. In each no-VF and VF groups, the range of APD50 was significantly larger 
during occlusion as compared to the Pre-occlusion 30min. However, when the range of 
APD50 was compared between the two groups, only the range of APD50 during Occlusion 
5min was significantly different (*p<0.05) in which the VF group had a greater range of 
APD50. (*P<0.05, **P<0.01, ***P<0.001)  
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Activation time (no-VF vs. VF groups) 
Analysis of the activation time in both no-VF and VF groups revealed no 
significant difference between the two groups either pre-occlusion or during 
occlusion as shown in Figure 5.12a. As the range of activation time during 
occlusion became significantly longer compared to the Pre-occlusion 30min in 
the no-VF group, the box plots diagram in Figure 5.12b show no significant 
difference in the range of activation time between the two groups. 
 
Figure 5.12 Activation time before and during occlusion.  
a) Box plots of the activation time at Pre-occlusion 30min and during Occlusion 5min and 
Occlusion 10min in both groups. b) Box plots graph of the range of activation time at similar 
time points in no-VF and VF groups. There was no significant different in the activation time 
as well as the range of activation time between both groups either pre-occlusion or during 
occlusion. 
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APD50 vs. heart rate 
From the results shown so far, the only significantly different parameter prior to 
occlusion that correlated with the presence of arrhythmias is the APD50. Based 
on this finding, the relation between the APD50 and the heart rate was studied. 
Figure 5.13 demonstrates the mean APD50 at Pre-occlusion 30min from each 
experiment plotted against the sinus cycle length. The result reveals that the 
hearts in VF group had significantly shorter APD50 (P<0.001) and shorter cycle 
length (mean cycle length 0.359 ± 0.007ms) whereas the hearts in no-VF group 
had longer APD50 and longer cycle length (mean cycle length 0.391 ± 0.012ms). 
Therefore the sinus cycle length was significantly different between the two 
groups (P<0.05) even though there was also considerable overlap between the 
two groups.   
 
Figure 5.13 APD50 vs. heart rate. 
APD50 (mean ± SEM) plotted against the sinus cycle length (mean ± SEM) for all hearts in 
both no-VF and VF groups. Hearts in VF group had significantly shorter APD50 and shorter 
cycle length. 
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ECG parameters 
In addition to the electrophysiological parameters, the ECG parameters were 
also analysed to see whether there was any correlation between the 
electrophysiological parameters and the ECG parameters in both groups of 
hearts. The values for the ECG parameters were taken from the average of 5 
consecutive ECG complexes. Based on the relation between APD50 and the heart 
rate seen in Figure 5.13, the relationship between the QT and RR interval at Pre-
occlusion 30min was studied. The graph of the QT interval against the RR 
interval was plotted in Figure 5.14 (top panel). The result reveals a similar 
pattern as seen in the previous figure in which the hearts that went into VF had 
shorter QT and shorter RR intervals compared to the hearts that did not develop 
VF. The mean QT interval for VF group was 0.204 ± 0.004ms whereas the mean 
QT interval for no-VF group was 0.230 ± 0.006ms. The means were significantly 
different (P<0.01). The graph of corrected QT interval (QTc) against the RR 
interval was plotted as well (Figure 5.14 bottom panel). In our experiments, the 
mean heart rate (HR) for the VF group was 168 ± 3bpm and the mean HR for the 
no-VF group was 155 ± 5bpm. The mean ± SEM for the ECG parameters in both 
no-VF and VF group were listed in Table 5.3. It shows that the mean RR and QT 
interval was significantly shorter in VF hearts as compared to the hearts that did 
not develop VF. In addition, even after correcting the QT interval for the heart 
rate, the difference between the two groups still existed.  
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Figure 5.14 ECG parameters at Pre-occlusion 30min.  
Top: Graph of QT interval against the RR interval in both no-VF and VF groups. Bottom: The 
graph of QTc against RR interval was plotted as well. Error bar on both X and Y axis 
represents the SEM from 5 consecutive ECG complexes.  
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Table 5.3 ECG parameters at Pre-occlusion 30min. 
Comparison of the ECG parameters (mean ± SEM) at Pre-occlusion 30min between the no-
VF and VF hearts. The hearts that developed VF during occlusion had intrinsically faster 
heart rate at Pre-occlusion 30min as compared to the hearts that did not develop VF. The 
RR, QT and QTc intervals in the VF group was significantly shorter than the no-VF group. 
 
In this study, the Fredericia’s formula was used to calculate the corrected QT 
interval. 
  Fredericia’s formula: QTc = QT / RR 
1/3 
An alternative formula for the calculation of the QTc is Bazett’s formula. In 
Bazett’s formula, the QT interval is divided by the square root of RR interval 
instead of the cube root. Although Bazett’s formula is the most commonly used 
formula for the corrected QT calculation, it has a tendency to over-correct at 
heart rates > 100bpm and under-correct at heart rates < 60bpm. In this study, 
the hearts that developed VF had intrinsically faster heart rates as compared to 
the hearts that did not develop VF and the mean heart rates for both groups 
were > 100bpm. Therefore, the Fredericia’s formula is more appropriate and 
was chosen to calculate the QTc values. 
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Is the behaviour of the epicardial sites homogeneous in terms of 
APD50 (no-VF vs. VF groups) 
The histogram in Figure 5.15 indicates the change in APD50 in terms of the 
number of sites getting shorter or longer at certain periods of time during the 
protocol in both groups of hearts (no-VF and VF). Each colour represents a 
different heart; colour in the same group represents the same heart. 
Behaviour pre-occlusion 
Figure 5.15a shows the number of sites that got longer or shorter between the 
10 and 30 minutes pre-occlusion phases. In the VF group, the average number of 
sites that showed an increase in APD50 from the Pre-occlusion 10min phase to the 
Pre-occlusion 30min phase was 198 and on average 54 sites became shorter. On 
the other hand, at very few sites did the APD50 decrease in the no-VF group, 
instead at most of the sites (247) the APD50 became longer. The number of sites 
with longer and shorter APD50 was significantly different between the two groups 
(Figure 5.15a).  
Behaviour on occlusion 
Figure 5.15b demonstrates the change in APD50 between Pre-occlusion 30min and 
the Occlusion 5min. It reveals that the APD50 at some sites got longer and some 
sites got shorter in both groups but most of the sites got shorter. In the VF 
group, on average there were 101 sites where the APD50 got longer and 151 sites 
where APD50 shortened. On the contrary, in the no-VF group, the APD50 got 
longer only in 56 sites and the APD50 shortened in 196 sites. However, the 
differences between the two groups were not significant. Between Pre-occlusion 
30min and Occlusion 10min, more sites got shorter in both no-VF and VF groups 
as represented in Figure 5.15c but the difference between the two groups was 
not significant. This was probably because, as the duration of the coronary 
artery occlusion increased, more epicardial sites exhibited APD50 shortening.  
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Figure 5.15 Behaviour of APD50 on epicardial surface pre-occlusion and during occlusion. 
Histograms showing the number of sites in which the APD50 got longer or shorter at certain 
period of time in both no-VF and VF groups. a) APD50 changes between Pre-occlusion 10min 
and Pre-occlusion 30min. b) APD50 changes between Pre-occlusion 30min and Occlusion 
5min. c) APD50 changes between Pre-occlusion 30min and Occlusion 10min.  
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Further analysis on the absolute shortening of APD50 during occlusion relative to 
the pre-occlusion period (Figure 5.16) also did not reveal any significant finding. 
Although the mean APD50 was shorter in the VF group, the average absolute 
shortening of APD50 was not significantly different from the no-VF group with 
longer mean APD50.  
 
Figure 5.16 Absolute shortening of APD50. 
Average absolute shortening of APD50 at Occlusion 5min (top panel) and Occlusion 10min 
(bottom panel) relative to the APD50 at Pre-occlusion 30min for each individual experiment 
in both groups. 
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Discussion  
The purpose of this chapter was to examine LV epicardial electrophysiology 
before and during local occlusion of the coronary artery in an effort to find the 
underlying causes of ischemia-induced arrhythmias. In approximately 50% of 
experimental preparations VF occurred within 30 minutes of occlusion of the 
coronary artery. The area of LV epicardium imaged in these experiments 
included regions served by the coronary artery and sub-regions within the 
imaged field showed changes in action potential characteristics that are 
consistent with underlying ischaemia. Correlating electrophysiological changes 
to the presence of VF suggested that electrophysiological characteristics prior to 
occlusion were a significant determinant of tendency to VF during ischaemia. 
Shorter APD prior to occlusion predicts tendency to VF 
The mean APD50 prior to occlusion both at the Pre-occlusion 30min and Pre-
occlusion 10min time points were good predictors of VF: on average the hearts 
that developed VF had an APD50 value approximately 15-20ms less than those 
that remained in sinus rhythm during coronary artery occlusion. The difference 
in APD could be due to differences in sinus rates of individual hearts, i.e. shorter 
APD could be a consequence of a higher intrinsic rate, but this is not the 
explanation for this data because choosing a subgroup with comparable range of 
heart rates still exhibited shorter APDs in the VF group.  
An alternative explanation is that within the population of animals used in this 
study, there was a range of variation in the ventricular action potential duration 
from one individual heart to the next. This spread in electrophysiological 
characteristic is due to a range of ion channel expression levels across a 
population. This type of variation has been studied in computational models and 
the extent of changes in ion channel activity that would cause a range of AP 
repolarisation characteristics was quantified (Romero et al., 2009).  
In both groups, there was a trend to shortening of APD50 between 30 minutes and 
10 minutes prior to occlusion, and in the VF group a greater number of sites 
significantly shortened during this period. This could be explained by supposing 
the existence of a slowly developing ischaemic region before the occlusion of 
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the coronary artery. However, this is unlikely because: (i) APD shortening due to 
slowly developing ischaemic changes during the experiment may be expected to 
be paralleled by slowly increasing perfusion pressure. The perfusion pressure at 
the pre occlusion 30 minutes phase was not significantly different in the two 
groups (for the VF hearts 46.8 ± 3.1mmHg and the no-VF hearts 52.8 ± 
2.7mmHg). (ii) There were no obvious ST segment changes observed on the ECG 
during the pre-occlusion phase which would be indicative of the development of 
an ischaemic region. 
Extrinsic pacing was not used in these experiments in order to replicate as 
closely as possible the in vivo circumstances, and it could be argued that a 
regular pacing stimulus would mask any changes in heart rate and rhythm during 
ischaemia and arrhythmia. On the other hand, one disadvantage of not pacing 
the heart is that there are two sources of variation in APD, one due to intrinsic 
rate and the other arising from other processes. However, based on previous 
works done in the lab, the variation in intrinsic rate within any one heart was 
minimal. In this chapter, it emerged that the intrinsic rate of the heart appeared 
to be different in the two groups. Further experiments revealed that the 
intrinsic rate was not a critical variable: experiments in Chapter 6 (isoprenaline 
experiments) and Chapter 8 (panoramic view optical mapping experiments) in 
which the heart was controlled at certain rate demonstrated that there were the 
same splits between no-VF and VF incidence. 
Decreased APD equates to shorter QT interval 
Parallel ECG measurements showed a decreased QT interval in the VF group 
which remained after QT correction. The vulnerability of arrhythmias associated 
with a decreased QT interval is a known syndrome in humans as short QT 
syndrome (SQTS). Studies have described that abnormal QT intervals are 
associated with increased risk of ventricular arrhythmia (Modell and Lehmann, 
2006; Sanguinetti and Mitcheson, 2005). Over the last 15 years, distinct genetic 
syndromes involving abnormally abbreviated QT interval (and hence accelerated 
ventricular repolarisation) have been identified (Bjerregaard et al., 2006; Gussak 
et al., 2000; McPate et al., 2006). Patients with the genetic short QT syndrome 
(SQTS) typically exhibit: abbreviated QT intervals (<320ms) (Bjerregaard et al., 
2006); poor rate-adaptation of the QT interval; tall, upright T waves; shortened 
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atrial and ventricular effective refractory periods; and an increased risk of 
ventricular and atrial arrhythmias and of sudden death in the absence of 
structural heart disease (Giustetto et al., 2006; Gollob et al., 2011; Gussak et 
al., 2000; Gussak et al., 2002; Schimpf et al., 2005). Recent analysis of 61 SQTS 
cases reported arrhythmia-linked index events in ~57% of the cases (Gollob et 
al., 2011); an analysis of a long-term follow-up of a paediatric cohort with the 
SQTS reported ventricular fibrillation in ~28% of patients (Villafane et al., 2013). 
The SQTS is genetically heterogeneous. Since 2004, defects in three cardiac 
potassium (K+) channel genes have been found in SQTS patients (Giustetto et al., 
2011; Maury et al., 2008; Schimpf et al., 2005): (i) KCNH2 ('HERG', responsible 
for the -subunit of the IKr channel) for SQT1 (Brugada et al., 2004; Hong et al., 
2005a; Sun et al., 2011); (ii) KCNQ1 (KvLQT1, responsible for the -subunit of 
the IKs channel) for SQT2 (Bellocq et al., 2004; Hong et al., 2005b); and (iii) 
KCNJ2, responsible for the Kir2.1 inwardly rectifier K+ channel) for SQT3 
(Hattori et al., 2012; Priori et al., 2005). In addition, loss-of-function cardiac 
calcium channel mutations (CACNA1C (SQT4), CACNB2 (SQT5) and CACNA2D1 
(SQT6)) have also been identified in association with QT shortening, S-T segment 
elevation and arrhythmia risk (Antzelevitch et al., 2007; Templin et al., 2011). 
However, no one has found a SQTS variant linked to altered mutation of the KATP 
channel. 
A clinical study in patients with a first ST-elevation myocardial infarction (STEMI) 
revealed that family history of sudden death and higher cumulative ST deviation 
from ECG analysis are strong predictors for primary VF (Dekker et al., 2006). 
Based on this finding, the existence of familial sudden death might suggest that 
there is a possibility of genetic abnormality related to KATP channel mutation and 
short QT syndrome. Although these phenomena are rare, this suggests that, 
within the population of people with myocardial infarction, there could be an 
inherited predisposition to precipitating or maintaining VF following myocardial 
infarction.  
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VF is associated with decreased APD and increased variability of 
APD. 
The data from this study also showed that hearts that exhibited VF shortly after 
occlusion had a significantly decreased APD50 at the Occlusion 5min time point 
along with a higher variability of APD50 values.  These changes are consistent 
with previous literature suggesting that: (i) decreased APD will predispose the 
myocardium to re-entrant arrhythmias, (ii) increased variability of APD is a pro-
arrhythmic change (Extramiana and Antzelevitch, 2004). The combined effect of 
these changes would make the myocardium more capable of initiating and 
maintaining re-entrant arrhythmias. These changes may be the result of a more 
severe ischaemic challenge since there is considerable variability in the size and 
extent of the ischaemic region caused by the occlusion of the coronary artery. 
However, the group of hearts prone to VF also displayed shorter APD50 in the 
pre-occlusion phase. This suggests that these hearts may have exhibited a 
shorter APD50 during occlusion because of pre-existing tendency to shorter APD 
values. 
Is there a correlation with area of myocardium that undergoes 
ischaemic changes in APD? 
To see if the size of the infarct during occlusion was correlated with the 
incidence of arrhythmia, the changes of APD50 during occlusion were compared 
with those during the pre-occlusion period. Quantifying the number of sites 
where the APD50 decreased during occlusion revealed that there was no 
significant difference in the number of sites i.e. the area affected by occlusion 
between no-VF and VF groups. This can only be an estimate since only part of 
the myocardium affected by occlusion was imaged in these experiments and 
areas outside the field of view may represent the majority of the myocardium 
involved. 
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Conclusion 
The electrophysiology of hearts before the occlusion appears to predispose the 
heart to VF during the occlusion. The APD50 prior to the occlusion was 
significantly shorter in the hearts that developed VF. This difference in APD50 
was also reflected in the ECG parameters in which the QT interval is also shorter 
in the hearts that developed VF. The VF group also had a significantly faster HR, 
but the data does not support this as the primary cause. The group of hearts that 
developed VF also displayed shorter and more variable APD50 values during 
occlusion, changes that are known to predispose to arrhythmias, but the 
mechanistic link to the electrophysiology prior to occlusion is unclear. One 
explanation is the inherently shorter QT interval in the VF group of hearts which 
may predispose this group to arrhythmias, to test this hypothesis the APD50 was 
manipulated experimentally in an effort to change the relative population of 
hearts prone to VF (see Chapter 6).  
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Chapter 6: Single view optical mapping during 
acute regional ischaemia after pharmacological 
manipulation of action potential duration 
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This chapter continues the studies from the previous chapter (Chapter 5) in an 
effort to understand the mechanistic link between acute regional ischaemia and 
ventricular arrhythmia. Results from the previous chapter have shown that pre-
occlusion APD seems to be a key variable that might predispose the hearts to VF 
during occlusion. In this chapter, we varied the APD by the chronic application of 
E-4031 and transient application of isoprenaline to test whether modifying the 
APD either by prolonging or simulation of sympathetic activity would alter the 
tendency of the hearts towards showing VF. E-4031 was chosen because the drug 
is selective for the hERG channel and previous work (Chapter 4) quantified the 
extent of the effect and allowed selection of a drug concentration to be used in 
these experiments. Prolongation of APD by E-4031 should shift the gross 
electrophysiology of the hearts to the “no-VF” population and reduce the 
incidence of VF if APD alone is the main determinant. 
A transient exposure to isoprenaline was used to address one main hypothesis, 
i.e. that sympathetic activity of the animal prior to sacrifice may be a factor in 
determining predisposition to VF. If sympathetic activation was high prior to 
sacrifice and removal of the heart, this may have a long term effect on the heart 
that persists into the experimental phase. For this reason, a group of hearts 
were exposed to isoprenaline for a period of 15 minutes then perfusion was 
returned to the normal solution. This was done to simulate sympathetic 
activation prior to sacrifice. If this was a significant factor, then this manoeuvre 
should shift the predisposition to VF. Ng et al. (2007) have reported that 
sympathetic stimulation in the isolated rabbit heart decreased ERP and VF 
threshold. Another study by Brunner et al. (2008) has reported that exposure to 
isoproterenol triggered EADs that degenerates into polymorphic ventricular 
tachycardia (pVT) and VF in long QT syndrome (LQTS) rabbits.  
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Part 1: E-4031 experiments 
Experimental protocol 
The experimental protocol is illustrated in Figure 6.1. All optical signal 
recordings in this study were obtained at the intrinsic heart rate. The protocol 
was identical to the experimental protocol used in previous chapter, except that 
the pre-occlusion period was divided into two phases: during the first 10 minutes 
of the pre-occlusion period, the heart was perfused with Tyrode’s solution 
without the drug, and during the subsequent 20 minutes, the heart was perfused 
with 0.03M E-4031 added into the Tyrode’s solution. A total of 14 animals were 
used in this set of experiments. 
 
Figure 6.1 Experimental protocol for E-4031 experiments. 
 
Dye loading 
Initially, the heart was loaded with 100L bolus of RH237 administered by slow 
injection into the coronary circulation over duration of 1 minute through an 
injection port in a bubble trap in line with the aortic cannula. During the 
experiment, bolus injection of RH237 was repeated twice; before the occlusion 
period and before the reperfusion period.   
Pre-occlusion 
Approximately 10-15 minutes after dye injection when the optical signals were 
already stabilized, serial recordings of optical signals were performed at 1 
minute intervals for 30 minutes. The data obtained during the pre-occlusion 
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period were analysed at two different time points and presented in the result 
section as Pre-occlusion 10min (without the drug) and Pre-occlusion 30min (after 
20 minutes perfused with E-4031). 
Coronary artery occlusion 
After 30 minutes of pre-occlusion period, the coronary artery was occluded by 
tightening the snare to produce regional ischaemia (see Chapter 2). Serial 
recordings were made at 1 minute intervals for 30 minutes. During this protocol, 
some hearts developed VF and some hearts did not. If the heart went into VF, 
the snare was released to reperfuse the heart and the rhythm would revert back 
to sinus rhythm. However, if the heart was still in VF after releasing the snare, a 
small bolus (<0.2ml) of KCL (1M concentration) was injected into the heart 
through the injection port.   
Reperfusion 
For the hearts that did not develop VF, the snare was released after 30 minutes 
of occlusion to reperfuse the heart. Serial recording at 1 minute intervals was 
done for 40 minutes.  
E-4031 drug 
As described in Chapter 4, E-4031 is a selective inhibitor of delayed rectifier K+ 
current (IKr). In this study, only one concentration of E-4031 (0.03M) was used 
to study the electrophysiological property of heart during acute regional 
ischaemia in the presence of E-4031. This drug concentration was chosen 
because it was the lowest concentration of the drug that produced a 
prolongation of APD comparable to the difference observed between the no-VF 
and VF group (prior to occlusion). The drug was dissolved in DMSO into a stock 
solution (2mM) and stored at -20oC.  
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Results 
Incidence 
From total number of 14 hearts that were exposed to E-4031, 8 hearts developed 
VF during coronary artery occlusion and the rest did not develop VF (Figure 6.2).  
 
Figure 6.2 Incidence of VF during coronary artery occlusion.  
Incidence of hearts that developed VF and did not develop VF during acute regional 
ischaemia in experiments with 0.03M E-4031 (no-VF = 42.9% and VF = 57.1%) 
Effect of coronary artery occlusion 
Figure 6.3 demonstrates an example of full protocol time course during 
experiments with E-4031. During the pre-occlusion period, the APD50 from all 
three zones gradually prolonged as the heart went from phase 1 (without drug) 
to phase 2 (with 0.03M E-4031). During occlusion, the APD50 especially in Zone 
C which was the ischaemic zone showed dramatic shortening. The reperfusion 
brought back the APD50 to the pre-occlusion level. Some hearts developed VF 
during the occlusion as shown in the Figure 6.3. As mentioned in the previous 
chapter, only arrhythmic events either sustained or non-sustained VF that 
occurred within 30 minutes duration of occlusion were included in the VF group. 
Any episode of arrhythmia that took place pre-occlusion or during reperfusion 
was not included in the VF group. 
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Figure 6.3 Example of full protocol time course during E-4031 experiment.  
APD50 plotted in the graph were the mean APD ± SEM from 3 x 3 pixel selections (indicated 
by the white boxes) from 3 different zones. Zone A = Normal zone, Zone B = Border zone, 
Zone C = Ischaemic zone 
APD50 (no-VF vs. VF groups) 
In the study described in the previous chapter (control experiments), it was 
shown that those hearts with intrinsically longer APD prior to the occlusion did 
not develop VF. In order to study the basis of that and to correlate with the 
incidence of arrhythmia, the APD was artificially prolonged with the drug E-4031 
(concentration 0.03µM) before the period of ischaemic induction by coronary 
artery occlusion. The graphs shown in Figure 6.4 demonstrate the APD50 from 
both no-VF and VF groups at Pre-occlusion 10min (Figure 6.4a) and at Pre-
occlusion 30min (Figure 6.4b). The APD50 was significantly prolonged at Pre-
occlusion 30min as compared to the Pre-occlusion 10min (Figure 6.5) in both 
groups. The mean APD50 at Pre-occlusion 10min in VF hearts was 144.7 ± 5.5ms 
and in no-VF hearts was 147.4 ± 7.3ms. After exposure to the drug, the mean 
APD50 at Pre-occlusion 30min was 168.0 ± 9.5ms and 176.4 ± 7.4ms in VF and no-
VF hearts, respectively (Table 6.1). These changes in APD were accompanied by 
a significant decrease in spontaneous heart rate: in VF group; mean RR pre drug 
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0.362 ± 0.011s, mean RR post drug 0.391 ± 0.011s and in no-VF group; mean RR 
pre drug 0.367 ± 0.018s, mean RR post drug 0.396 ± 0.018s. However, there was 
no significant different in the APD50 between the two groups at both pre-
occlusions 10 and 30 minutes.   
 
Figure 6.4 APD50 prior to coronary artery occlusion. 
Graph showing the APD50 (mean ± SEM) at a) Pre-occlusion 10min (without drug), and b) 
Pre-occlusion 30min (after exposure to 0.03 E-4031) prior to ischaemia between the 
hearts that developed VF and the hearts that did not develop VF. 
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Figure 6.5 Effect of E-4031 on APD50. 
Exposure to 0.03M E-4031 significantly prolonged the APD50 in both no-VF and VF groups. 
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Table 6.1 APD50 (no-VF vs. VF groups). 
Mean APD50 at Pre-occlusion 10min and Pre-occlusion 30min (after 20 minutes perfusion 
with 0.03M E-4031) in both no-VF and VF groups. 
 
APD50 changes (no-VF vs. VF groups) 
Further analysis to look at the change in APD50 before and during occlusion was 
performed. The histogram in Figure 6.6 indicates the change in APD50 in terms of 
the number of sites getting shorter or longer APD50 at certain periods of time 
during the experiments in both groups of animal. The colours represent different 
hearts. Figure 6.6a shows the APD50 changes between 10 and 30 minutes of the 
pre-occlusion phase. As the hearts was perfused with E-4031, more sites got 
longer APD50 in both groups of hearts. However, at Pre-occlusion 30min the VF 
group had more sites with shorter APD50 (33 sites) whereas only at 9 sites did the 
APD shorten in the no-VF group but the different between the two groups was 
not significant. During Occlusion 5min, some sites showed APD50 increases and 
some decreases relative to the APD50 at Pre-occlusion 30min in both groups of 
animal as shown in Figure 6.6b, but there was no significant difference between 
groups. Between Pre-occlusion 30min and Occlusion 10min as the heart became 
more ischaemic, the APD50 for most of the sites got shorter. Only small number 
of sites got longer in both groups as shown in Figure 6.6c. 
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Figure 6.6 Changes in APD50 before and during occlusion.  
Histograms showing the number of sites in which the APD50 got longer or shorter at certain 
period of time in both no-VF and VF groups. a) APD50 changes between Pre-occlusion 10min 
and Pre-occlusion 30min (with E-4031) b) APD50 changes between Pre-occlusion 30min (with 
E-4031) and Occlusion 5min c) APD50 changes between Pre-occlusion 30min (with E-4031) 
and Occlusion 10min. 
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T-wave alternans and EADs 
In control experiments (Chapter 5), instances of PVCs and T-wave alternans were 
observed during the pre-occlusion period as well as during the occlusion. In this 
study with E-4031, abnormality in the heart rhythm in the form of T-wave 
alternans and EADs were observed as well. Examples of EADs and T-wave 
alternans in heart are shown in Figure 6.7 (VF heart) and Figure 6.8 (no-VF 
heart). The observations are summarized in Table 6.2; in the presence of E-
-4031, T-wave alternans and EADs were more common in the hearts that 
developed VF. 
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Figure 6.7 EADs and TWA in heart that developed VF. 
AP signals with parallel ECG recordings in E-4031 experiments (VF heart). Example of EADs 
(indicated by the blue boxes) and T-wave alternans (indicated by the arrow in the orange 
box) observed during acute coronary artery occlusion before the heart went into VF (shows 
in the red box). 
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Figure 6.8 EADs and TWA in heart that did not go into VF. 
AP signals with parallel ECG recordings in E-4031 experiments (no-VF heart). Example of 
heart that had episodes of EADs (indicated by the blue boxes) and T-wave alternans 
(indicated by the arrow in the orange box) during acute coronary artery occlusion but this 
heart did not go into VF. 
Table 6.2 Incidence of EADs and TWA. 
No of hearts having T-wave alternans and EADs during 30 minutes of acute regional 
ischaemia in no-VF and VF groups. 
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Part 2: Isoprenaline experiments 
We considered that some hearts tend to be more prone to develop arrhythmia 
due to some status of the hearts before we isolated the hearts from the rabbits. 
In order to simulate the sympathetic drive due to stress in the rabbits, we 
exposed the hearts to a high level of isoprenaline for 15 minutes before starting 
the standard coronary artery occlusion protocol. A total of 7 animals were used 
in this set of experiments.  
Experimental protocol 
The experimental protocol for the isoprenaline experiments is illustrated in 
Figure 6.9. 
 
Figure 6.9 Experimental protocol for experiments with 0.3M isoprenaline. 
 
AV node ablation 
In this study, the AV node ablation was performed to ensure that the heart could 
be paced slower than the intrinsic cycle length. Details on the procedure to 
perform AV node ablation was explained in Chapter 4. 
Pacing protocol 
The control experiments described in previous chapter and the E-4031 
experiments explained in Part 1 of this chapter were performed at intrinsic 
heart rates. However, in the series of experiments involving isoprenaline the 
heart was subjected to right ventricular pacing at a pacing rate of 380ms cycle 
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length during occlusion and reperfusion. During the pre-occlusion period as the 
isoprenaline was washed in and washed off, the heart was unpaced to see the 
effect of isoprenaline on APD and heart rate.  
Dye loading 
The protocol for dye loading was similar as previous experiments with E-4031. 
The bolus of RH237 was repeated two times throughout the experiment. 
Approximately 10 – 15 minutes after the dye loading, the heart was temporarily 
paced at 380ms cycle length in order to obtain a baseline recording. 
Pre-occlusion 
In this study, the pre-occlusion period was divided into two phases. The first 
phase was when the 0.3M isoprenaline was perfused for 15 minutes. Serial 
optical signal recordings were performed at 1 minute intervals. In the second 
phase, the isoprenaline was washed off from the hearts. The duration for the 
second phase varied between the hearts. Some hearts took longer to wash off 
the drug but the majority of the hearts took approximately 15 minutes to 
remove the effect of isoprenaline. During the second phase, serial optical signal 
recordings were also performed at 1 minute intervals. The heart was unpaced in 
both phases. Just prior to the coronary artery occlusion, the heart was paced at 
380ms cycle length and another signal recording at RV paced was obtained prior 
to occlusion.  
Coronary artery occlusion 
The coronary artery was occluded to produce acute regional ischaemia. Serial 
recordings were made at 1 minute intervals for 30 minutes. The optical signal 
recordings were obtained at RV paced 380ms cycle length.  
Reperfusion 
For the hearts that did not develop VF, the snare was released after 30 minutes 
of occlusion to reperfuse the heart. Serial recording at 1 minute intervals was 
done for 40 minutes. This protocol was conducted at pacing rate as well.  
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Isoprenaline drug 
Isoprenaline [1-(3′,4′-Dihydroxyphenyl)-2-isopropylaminoethanol] (Figure 6.10) is 
a catecholamine compound and non-selective β-adrenoceptor agonist that is 
commonly used in cardiovascular research. The drug was dissolved in water 
(H2O) into a stock solution (0.1M), freshly prepared before each experiment. A 
high dose of isoprenaline (0.3M concentration) was used to study the 
predisposition of heart towards VF during acute regional ischaemia in the 
presence of sympathetic stimulation before the episode of ischaemia. 
 
Figure 6.10 Chemical structure of isoprenaline 
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Results 
Incidence 
In this study, 2 hearts went into VF during occlusion after brief exposure to 
0.3M isoprenaline and 5 hearts did not (Figure 6.11). From the 5 hearts in the 
no-VF group, 3 hearts developed VF during reperfusion. However, according to 
our criteria, only hearts that developed VF during coronary artery occlusion will 
be included in the VF group. Any heart which developed arrhythmic event during 
reperfusion will be included in the no-VF group. 
 
Figure 6.11 Incidence of no-VF and VF during isoprenaline experiments. 
 
APD50 
Figure 6.12 displays an example of full protocol time course during the 
isoprenaline experiment. The mapping field was divided into 3 zones, the normal 
zone, border zone and ischaemic zone. During the first 15 minutes of pre-
occlusion period, the heart was perfused with 0.3M isoprenaline. During this 
period of time, the APD50 gradually shortened in all 3 zones. After 15 minutes, 
the isoprenaline was washed off and the APD50 in the 3 regions steadily 
prolonged. Occlusion of the coronary artery to produce regional ischaemia 
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dramatically shortened the APD50. The greatest shortening of the APD50 was 
mainly seen in zone C. During the reperfusion period, the APD50 from the 3 zones 
returned back to almost similar levels.  
 
Figure 6.12 Full protocol time course for isoprenaline experiment. 
Example of full protocol time course for the isoprenaline experiment showing the APD50 
changes throughout the experiment. The data were presented as mean ± SEM from 3 x 3 
pixel selections (indicated by the white boxes on the colour map) from three different zones. 
The mean APD50 (at RV paced 380ms cycle length) before and after the heart 
was perfused with isoprenaline were plotted in Figure 6.13. The APD50 in some 
hearts were prolonged and some hearts were shortened but the mean APD50 was 
somewhat shortened after isoprenaline in hearts that developed VF and did not 
develop VF but the difference was not significantly different. Comparison 
between the mean APD50 before and after isoprenaline in both groups is 
displayed in Table 6.3. 
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Figure 6.13 APD50 before and after exposure to isoprenaline. 
APD50 (mean ± SEM) before isoprenaline and after isoprenaline washout in no-VF and VF 
hearts during pre-occlusion. The recording was obtained when the hearts were paced at 
380ms cycle length. There was no significant difference between the two groups. 
Table 6.3 APD50 before and after exposure to isoprenaline. 
APD50 before and after isoprenaline recorded at RV-paced 380ms cycle length in both no-VF 
and VF groups. Exposure to isoprenaline had shortened the APD50 in both groups but the 
difference was not significant. 
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Discussion 
The experiments described in the previous chapter (5), suggest that the 
electrophysiological status of the myocardium was significantly different in a 
group of hearts that rendered them more prone to VF after occlusion of the 
coronary artery. In the experiments described in this chapter we attempted to 
alter the status of the myocardium to either suppress or accentuate the 
tendency to VF using E-4031 and transient exposure to isoprenaline. 
Effects of E-4031 
In the control situation, the APD of epicardial surface prior to the ligation were 
significantly smaller in the hearts that developed VF. Using E-4031 to prolong the 
APD (and reduce the heart rate) to the extent that the epicardial APD values are 
now as long as those in the no-VF group, there was no change in the tendency of 
hearts to develop VF. The incidence of hearts that developed VF in control 
experiments and in E-4031 experiments was comparable to that after treatment 
with E-4031 (Figure 6.14). 
 
Figure 6.14 Incidence of no-VF and VF in control and E-4031 experiments. 
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Comparison of the mean APD50 between control and E-4031 experiments 
revealed that the mean APD50 at Pre-occlusion 30min in no-VF and VF groups 
from the set of E-4031 experiments were significantly longer as compared to the 
APD50 from the VF group in control experiments (Figure 6.15). Statistical analysis 
using a Split-Plot ANOVA test revealed that the APD50 were significantly different 
within the groups and between the groups in both sets of experiments.  
 
Figure 6.15 APD50 in control experiments and E-4031 experiments. 
Box plots of mean APD50 at Pre-occlusion 10min and Pre-occlusion 30min. It displays the 
comparison between the mean APD50 from no-VF and VF groups in control and E-4031 
experiments. 
In addition to the APD50, we also looked at the change of APD50 at certain period 
of time during the protocol. Table 6.4 lists the average number of sites where 
the APD50 got shorter or longer during the pre-occlusion period. It shows that in 
both control and E-4031 experiments, more sites got shorter in the VF group 
even before the occlusion as compared to the no-VF group. 
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Table 6.4 Behaviour of APD50 prior to coronary artery occlusion. 
Average number of sites that got longer or shorter APD50 between 10 and 30 minutes pre-
occlusion. Comparison between no-VF and VF hearts in control and E-4031 experiments.  
 
Effects of transient isoprenaline treatment 
The second set of experiments described in this chapter was designed to address 
the concern that the sympathetic activity of the animal prior to sacrifice may 
have a bearing on the incidence of VF after occlusion of a coronary artery. As 
described earlier, there is considerable evidence that increased sympathetic 
activity increases predisposition to VF in humans. The reasons for this are 
unclear and therefore the extent to which sympathetic effects may still remain 
after sacrifice of the animal is uncertain. In an effort to test this hypothesis, all 
hearts within one experimental group were exposed to isoprenaline to mimic 
sympathetic activation. An unanticipated effect of this procedure is that APD50 
values after washout of isoprenaline (prior to occlusion) were significantly 
shorter (P<0.001) than the no-VF hearts at Pre-occlusion 30min in control 
experiments (mean APD50 of 131.5 ± 3.3ms in the hearts from isoprenaline 
experiments and 168.8 ± 5.5ms in the no-VF group from control experiments). 
However, despite the shorter APD, there was a significant group of hearts that 
did not develop VF (Figure 6.16). Ventricular APD shortening during β-adrenergic 
stimulation has been previously reported (Ng et al., 2007) and is thought to be 
the result of changes in several ionic conductances including ICl, IKs and IKr 
(Harvey et al., 1990; Thomas et al., 2006; Volders et al., 2003). The reason for 
the sustained shortening after wash-off of the agonist as observed in the current 
study is not clear and suggests that some of the electrophysiological changes 
may require a considerable time to recover. 
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Figure 6.16 APD50 in control experiments vs. isoprenaline experiments.  
Hearts exposed to 0.3M isoprenaline prior to occlusion (both no-VF and VF groups) 
revealed a significantly shorter APD50 than the no-VF hearts from control experiments at 
Pre-occlusion 30min. 
Based on the findings of this section of experiments, several conclusions can be 
drawn: 
(1) Prior sympathetic activity in the intact animal prior to sacrifice is unlikely 
to be the cause of the predisposition to VF in a subgroup of hearts. 
(2) Shortened APD (cause uncertain) did not predispose the hearts to VF. 
(3) Standardisation of the pacing cycle length to a set value does not alter 
significantly the fraction of hearts that develop VF after occlusion of the 
coronary artery. 
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Conclusion 
Artificially prolonging the APD (and reducing HR) by inhibited hERG (with 0.03M 
E-4031) prior to ischaemia did not significantly change the incidence of 
arrhythmia post occlusion. Brief and transient exposure to a high dose of 
isoprenaline (concentration 0.3M) before the coronary artery occlusion 
shortened the average APD prior to occlusion but did not increase the likelihood 
of VF. Therefore, intrinsically shorter epicardial APD is associated with, but is 
not the cause of, the predisposition to arrhythmias post-occlusion. Alternative 
cellular mechanisms that link APD to predisposition to arrhythmias should be 
considered as an explanation.
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Chapter 7: ECG simulation 
  
Chapter 7  167 
Aim 
The aim of this study is to look at the relationship between the site and size of 
the ischaemic region that might contribute to the variation seen in the ECG 
patterns during acute coronary artery occlusion experiments by simulating the 
ECG using a simulation programme. 
Introduction 
ECG during coronary artery occlusion 
ECG changes during acute myocardial ischaemia following coronary artery 
occlusion have been discussed in Chapter 1. Severe myocardial ischaemia results 
in several ECG changes within minutes. These ECG changes disappear when the 
myocardium is reperfused.   
Modelling of ECG  
In this study, ECG recordings made in parallel with the optical measurement 
suggest distinct pattern of changes of ECG in hearts that went into VF and those 
that did not and these suggest that there may be distinct changes that 
precipitate VF. In order to understand this better, an attempt was made to 
simulate the ECG findings. There are marked changes in the ECG profiles during 
occlusion of the coronary artery clinically and they are characterized by ST 
segment changes (see Chapter 1). In parallel with the optical measurement, 
ECGs were recorded and appeared to have distinct changes depending on 
whether the heart went into VF or non VF. These are presented in this chapter 
along with computational model to try and help understand the causes of these 
changes. 
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Methods 
Experimental ECG measurement 
Method of ECG signal recordings during coronary artery occlusion experiments 
was described in Chapter 2. 
ECGSim software 
ECGSim, the software used in this study is free software and can be downloaded 
at www.ecgsim.org. It is an interactive simulation programme developed by two 
researchers at the Radbound University Medical Center, Netherland (Oostendorp 
and van, 2004). This software allows the user to study the relationship between 
the electrical activity of the heart and the resulting 12-lead ECG signals. There 
are two basic heart models with different orientation, normal male and normal 
young male. In this simulation study, the normal male heart model was chosen 
because the orientation of this model seemed to produce an ECG pattern that 
was closer to that generated experimentally. By using the software, the AP in 
certain regions of the heart can be shortened to mimic the ischaemic AP. The 
position of the shortened AP can be changed to different areas of the heart to 
study the effect of such changes on the ECG. 
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Figure 7.1 Example of ECGSim display.  
a) the heart pane with the normal male heart model. The colour represents the depolarisation pattern on the heart surface, b) the thorax pane showing the 
thorax geometry and position of the ECG leads (grey patches), c) the transmembrane potential (TMP) pane displaying the transmembrane potential at the 
selected node indicated by the arrow in panel a), and d) the leads pane displaying the standard 12-lead ECG. 
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Figure 7.1 demonstrates the display of the ECGSim software. It consists of: 
a) the heart pane which is used to display the geometry of the heart (left 
and right ventricles) as well as a wide range of functions on its surface 
such as changing the parameters of the local transmembrane potential 
(TMP) in the area of the node indicated by the white circles in the figure 
as well as changing the location and radius of the node, 
b) the thorax pane which is used to display the geometry of the thorax and 
the position of the nine electrodes (shown as grey patches) of the 
standard 12-lead system, 
c) the TMP pane which displays the transmembrane potential at the selected 
node on the heart surface (shown by the black arrow in panel a). The 
white trace indicates the initial parameter values, whereas the red trace 
relates to the user adapted parameters. The shape of the TMP can be 
adjusted to either shorten or lengthen the action potential. 
d) the leads pane which allows the display of the signals from the standard 
12-lead system. The white trace indicates the initial signals while the red 
trace display the resulting signals after changing the parameters on the 
TMP pane.  
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Results 
Experimental ECG 
During the coronary artery occlusion experiments, simultaneous ECG signal 
recordings were obtained together with the optical signal recordings. From the 
ECG signals, some variations in the ECG before and during occlusion were 
observed.  
Figure 7.2 shows examples of ECG signals from three different sets of coronary 
artery occlusion experiments at Pre-occlusion 30min and during Occlusion 5min 
and Occlusion 10min in hearts that developed VF during occlusion. In example 1 
from a control experiment, the T wave had a negative polarity. At Occlusion 
5min, there was ST segment depression and at Occlusion 10min, there were 
instances of TWA observed. During occlusion, the T wave retained a negative 
polarity. Example 2 shows ECG signals from a coronary artery occlusion 
experiment with E-4031. Under these conditions, the T wave had a positive 
polarity. During Occlusion 5min and Occlusion 10min, there was ST depression 
but this time the T wave changed its polarity. ECG signals obtained during an 
experiment using the isoprenaline intervention described in chapter 6 is shown 
in example 3. The ST segment was higher than the isoelectric point at Pre-
occlusion 30min with an inverted T wave. At Occlusion 5min, the ST depression 
became prominent, this heart developed VF at 6 minutes occlusion.  
Examples of ECG signals obtained from the hearts that did not develop VF from 
three sets of experiments are demonstrated in Figure 7.3. From the examples 
given, all hearts show positive polarity of the T wave at Pre-occlusion 30min. 
Later during the occlusion, the T wave changed its polarity in all three examples 
along with ST segment depression. 
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Figure 7.2 ECG from VF heart. 
Examples of ECG from the hearts that developed VF in three different sets of experiment showing variation in the repolarisation pattern as indicated by the 
ST changes at Pre-occlusion 30min, Occlusion 5min and Occlusion 10min. 
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Figure 7.3 ECG from no-VF heart. 
Examples of ECG from the hearts that did not develop VF in three different sets of experiment showing variation in the repolarisation pattern as indicated 
by the ST changes at Pre-occlusion 30min, Occlusion 5min and Occlusion 10min. 
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Simulation of ECG 
When implementing the model, two different sites were chosen to mimic an 
ischaemic event via local shortening the AP. The sites were the anterior region 
of the heart (site 1) and the postero-lateral side of the LV (site 2). Site 1 was 
representative of the mapping region from the experimental work whereas site 2 
was the site which was not mapped during the optical mapping experiments but 
the region was supplied by the coronary artery occluded during the experiments. 
The degree or size of the infarct was varied from mild which only localised to 
the centre to moderate which involved slightly bigger area and severe infarct 
which involved most LV regions.   
Anterior infarction (Site 1) 
Figure 7.4 shows a simulation of normal AP at the anterior inferior region of the 
LV. The corresponding ECG signal in lead II shows normal QRS and T wave with 
positive polarity of the T wave. There was no ST elevation or ST depression 
observed. 
In Figure 7.5, the heart was simulated to have mild, moderate and severe 
infarction with the centre area marked with the black arrow. During mild 
infarction, there was slight ST segment depression but the T wave was still in 
the same polarity. As the size of the infarct was increased to simulate moderate 
infarction, ST depression and the T wave changes were observed. With a severe 
infarction that involved almost all regions of the LV, the ST depression became 
more prominent and this time the T wave also changed its polarity.
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Figure 7.4 Simulation of normal AP at site 1 (indicated by black arrow).  
The heart pane on the left figure illustrates the heart model with the black arrow pointing towards the centre of site 1. ECG signal at lead II (in the black 
square) shows flat ST segment with positive polarity of the T wave.
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Figure 7.5 Simulation of varying severity of infarction. 
Simulation of mild, moderate and severe infarction at site 1 produced by shortening the AP 
in this region. ECG signals in lead II shows slight depression of the ST segment in mild 
infarct but there is no change in the T wave polarity. As the size of the infarct became larger, 
the ST depression became more prominent and T wave also change its polarity.   
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Postero-lateral infarction (Site 2) 
In this model, the heart was simulated to have an ischaemic condition at the 
postero-lateral aspect of the LV (site 2). The AP and ECG signals before the 
episode of infarction are displayed in Figure 7.6. Under normal conditions, the T 
wave observed in lead II had a positive polarity with no ST segment changes.  
The model was then adjusted to produce varying degree of infarction; mild, 
moderate and severe infarction by increasing the size of the infarct as shown in 
Figure 7.7. During mild infarction, there was no obvious change on the T wave 
and the ST segment. In moderate infarction, there was slight ST segment 
elevation. Severe infarction involving most regions of the LV resulted in a very 
prominent ST segment elevation in lead II. In all three varying degrees of 
infarction at site 2, the T wave maintained its positive polarity.
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Figure 7.6 Simulation at site 2. 
The heart pane on the left figure illustrates the heart model with the black arrow pointing towards the centre of site 2 at the postero-lateral region of the LV. 
The ECG signals (left lower figure) in lead II (in the black square) shows normal QRS and T wave with positive polarity. The ST segment is flat. 
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Figure 7.7 Simulation of varying severity of infarction. 
Simulation of mild, moderate and severe infarct at site 2 showing variation in ECG signals in 
lead II. As the size of the infarct became larger, the ST segment elevation became more 
prominent but the T wave was maintained in the positive polarity. 
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Discussion 
The three sets of coronary artery occlusion experiments (control, E-4031 and 
isoprenaline experiments) revealed an incidental observation in terms of the 
variation in the repolarisation pattern on the ECG pattern and its relation to the 
incidence of VF. During the experiments, ST segment depression or elevation as 
well as changes of T wave polarity were observed. Invariably when the T wave 
changed polarity from positive polarity at pre occlusion to negative polarity 
during occlusion, the hearts did not develop VF and when the T wave did not 
change the polarity, the hearts went into VF. Therefore, the experimental 
situation was simulated with a computer programme to study factors that might 
contribute to the variation in the repolarisation pattern of the ECG. Two main 
factors studied in this simulation were the site and the size of the ischaemic 
regions. In this study, the normal male heart model was chosen because the 
orientation of heart appeared to generate an ECG pattern similar to that 
obtained experimentally. Lead II in the simulation programme was examined 
because this was representative of the lead used during the experimental works.   
In the heart model ischaemia was simulated by shortening the AP shape at two 
different sites of the LV. The first site was at the anterior region of the LV with 
the centre at the apex (site 1). During mild ischaemia at site 1, there were few 
changes in the ST segment or T wave on lead II. As the area of the infarct 
increased representing the transition from moderate to severe infarction, there 
was ST depression which depressed the T wave and produced a T wave signal of 
negative polarity. Next, the heart was simulated to have an ischaemic condition 
at site 2 which was the postero-lateral site of the LV. Mild ischaemia did not 
show much change in lead II. Moderate to severe infarction caused ST segment 
elevation. As the size of the infarct got bigger, the ST elevation became more 
prominent. 
Relating this information back to the experimental measurements is difficult 
because the size and position of the ischaemic area was not assessed. However, 
inversion of T-wave, a phenomenon which correlated to the absence of VF, was 
modelled by larger, more extensive ischaemia areas. This suggests that smaller 
infarct areas may be associated with a higher incidence of VF, a conclusion that 
will have to be tested experimentally. 
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From a clinical perspective, one of the big thrombolysis trials (Newby et al., 
1998) reported that patients with anterior STEMI rather than lateral STEMI or 
inferior STEMI were more likely to have VF. 
Conclusion 
The site and size of the infarct appear to be able to explain the ECG variation 
observed in isolated heart experiments. As the size of the infarct at the anterior 
region became larger, there was ST depression as well as changes in the T wave 
polarity observed in lead II. On the other hand, the infarct occurring at the 
postero-lateral region of the LV will cause ST segment elevation and no change 
in the T wave polarity monitored in lead II.
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Chapter 8: Acute coronary artery occlusion – 
panoramic view optical mapping study 
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Aim: 
This chapter reports a study of the repolarisation pattern on the majority of the 
epicardial surface of the heart and attempts to correlate these findings with the 
incidence of VF post coronary artery occlusion. 
Introduction 
Cardiac optical mapping is a powerful tool to study the initiation, maintenance 
and termination of arrhythmias (Efimov et al., 2004). Typical 2D cardiac optical 
mapping has been limited to recording from only a single field of view of the 
optical sensor but in cardiac arrhythmias, especially of the re-entrant type, the 
pattern of arrhythmia can be unstable with rotors/wavelets moving around the 
heart. Thus conventional single-camera mapping is limited in terms of obtaining 
comprehensive information during the event of arrhythmia (Qu et al., 2007). In 
recent years, there have been developments in panoramic 3D imaging of the 
heart allowing multiple field of views to be mapped and imaged from the entire 
epicardial heart surface using more than one camera (Lou et al., 2008; Qu et 
al., 2007; Ripplinger et al., 2009).  
Previous optical measurements in this laboratory were limited to recording from 
the anterior aspect of the left ventricle (LV) (see Chapter 5). These showed that 
during the pre-occlusion phase the epicardial APs were shorter in the subgroup 
that developed VF post-occlusion. However, the extent to which this observation 
applied to sites in regions outside the field of view was unknown. Also, the 
region directly affected by ischaemia on occlusion clearly involved sites outside 
the mapped area. To extend the coverage to include these regions, a panoramic 
optical mapping technique was developed to look at the electrophysiological 
properties across the majority of the ventricular surface.  
Previously reported panoramic systems (Bourgeois et al., 2012; Qu et al., 2007) 
have used three cameras to provide 360 degree coverage to track complex 
patterns of activation and repolarisation. The essential point to realize here is 
that, to study steady-state phenomena that are not changing on a beat-to-beat 
basis, the requirement for multiple cameras is removed. Therefore, we devised 
a methodology that facilitated multiple sequential recordings from three 
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equivalent aspects of the heart surface. This necessitated constructing a 
perfusion apparatus that could be easily and rapidly rotated to each of three 
angles. Details of this apparatus are given below. 
Methods 
Preparation of the rabbit hearts 
A total of 17 animals were used in this panoramic-view optical mapping 
experiments. Hearts from adult New Zealand White rabbits (2.5-3.5kg) used in 
this study were prepared as previously described. As before, the 
electromechanical uncoupler Blebbistatin (10μM) was used to reduce motion 
artefact. Once the heart was stabilised and aligned within the chamber, a bolus 
of voltage-sensitive dye di-4-ANEPPS (100μl of 1 mg/ml) was loaded into the 
heart.  
Panoramic view optical mapping 
A panoramic optical mapping system was recently developed in our lab by 
Francis Burton and Godfrey Smith (University of Glasgow). In this system, the 
heart inside a specialised rotating chamber was rotated through fixed angles and 
data acquired sequentially from each viewpoint using a single CCD camera. A 
schematic diagram of the panoramic view optical mapping setup is illustrated in 
Figure 8.1. The heart inside the chamber was illuminated by an annular array of 
cyan LEDs (OptoLED, Cairn Research Ltd.) at 480nm wavelength. The excitation 
light from each LED was passed through interference filters. The emitted 
fluorescence light was then collected through a photographic lens and passed 
through a LP filter (665nm wavelength) and focused onto a CCD camera (80x80 
pixels, 1000 fps) which is part of a RedShirt Cardioplex system (RedShirt Imaging, 
Decatur, GA). Another higher resolution Dalsa camera (Coreco Imaging, Canada) 
with 256 x 256 spatial resolutions was used to acquire white light images of the 
preparation. During the experiment, the heart was rotated to record the 
epicardial membrane potentials from the whole ventricular surface of the heart. 
The mapping field was divided into 3 different views, namely the RV/LV view 
which comprised mainly the LV and part of the RV, the LV view which consisted 
of the postero-lateral part of the LV and the RV view which had only RV. 
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Example of images of the heart surface captured by the Dalsa camera from the 
three different views is displayed in Figure 8.2.   
 
Figure 8.1 Schematic diagram of panoramic optical mapping setup. 
 
 
Figure 8.2 Images from three different heart surfaces. 
Example of images obtained by the Dalsa camera from three different mapping views.  
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Rotating chamber 
 
Figure 8.3 Rotating chamber. 
Images of the components of specialised rotating chamber used together with the 
panoramic optical mapping system, showing a) the whole set-up, b) the main rotating 
chamber, and c) the gearbox container.  
Figure 8.3a shows the different components of the rotating chamber used in the 
panoramic optical mapping system. It comprises the basic chamber (Figure 8.3b) 
with a screw and spindle that is attached to a hypoid gearbox (Reliance Precision 
Ltd.) via a coupling. The gearbox is attached to a stepping motor which is run by 
a driver circuit that can be run either manually or can be run from a computer. 
In this study, the speed and direction of rotation were controlled via a custom-
made programme written by Francis Burton (University of Glasgow). Initially, 
after the heart was mounted on the aortic cannula and placed inside the 
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chamber, it was manually positioned so that the RV/LV view was facing the 
camera. The centre midline point was then determined and the heart was 
rotated ±120 degrees from that centre point to move the heart to another view. 
Rotation to a new position takes less than 1s.  
Coronary artery occlusion using vertical ligation system 
In this study, a vertical ligation system was used to produce acute coronary 
artery occlusion instead of the horizontal ligation system used for the single view 
optical mapping experiments (see Chapter 2).  This vertical ligation system was 
specifically designed to be used with this panoramic view optical mapping set-
up. The ligature from the snare was passed through a small hole on top of the 
chamber and tied to a vertical spring device attached to the chamber (Figure 
8.4). During the experiments, the spring was tightened for 30 minutes to occlude 
the vessel and produce a local ischaemia. Because the ligation site, suture 
thread and cannula tubing was identical to that used previously, it was assumed 
that the effect of ligation in this system would be comparable. After 30 minutes 
of occlusion, the snare was released to reperfuse the hearts.  
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Figure 8.4 Vertical ligation set-up. 
a) Arrangement of vertical ligation set-up used in panoramic view optical mapping 
experiments to produce acute local ischaemia. b) Close-up view of the ligation system from 
front (left) and side (right) view.  
Experimental protocol 
The experimental protocol for this study is illustrated in Figure 8.5. The 
experiment was divided into three periods; pre-occlusion, during occlusion and 
reperfusion similar to the time periods in previous single view studies. However, 
instead of using the intrinsic heart rate, the heart was paced at the right atrium 
at 350ms cycle length. Each recorded time point consisted of three consecutive 
recordings, one at each view (RV/LV, LV and RV). During the occlusion, if the 
heart went into VF, the snare was released to reperfuse the heart. If this failed 
to revert the heart back to sinus rhythm, a bolus of 1M KCl (0.2ml) was injected 
into the heart through the injection port (see Chapter 2).       
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Figure 8.5 Experimental protocol. 
 
Electrocardiogram (ECG) 
During the experiments, simultaneous ECG recordings (see Chapter 2) with a 
configuration approximating to lead I in a 12-lead ECG were made (Figure 8.6) 
and could be viewed in real time during the course of the experiment.  
 
Figure 8.6 Example of ECG recording with corresponding APs. 
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Optical data analysis 
Optiq 
The optical signals obtained from this study were visualized and analysed using 
Optiq. Different settings were appropriate for these data sets because the 
signal-to-noise characteristic of the RedShirt camera and optics differs from the 
single-view system based on the Hamamatsu camera. Prior to analysis of the 
optical signals, spatial (Gaussian) and temporal (Medians + Boxcar) filtering was 
applied. Unlike the single-view system, all the camera views included pixels 
outside the profile of the heart. These background pixels were excluded on the 
assumption that no signal would be present. In practice, however, many pixels 
showed a very weak (noisy) signal presumed to be due to reflections from the 
sides of the chamber. Therefore, a signal-to-noise ratio (SNR) threshold criterion 
was used to exclude any pixels which did not correspond to the epicardial 
surface of the heart. Based on preliminary measurements, a threshold SNR < 20 
was found to provide a faithful representation of the heart profile. This pixel 
selection was then trimmed further to exclude signals from myocardium lying at 
a steep angle with respect to the camera plane such that overlapping marginal 
regions were divided between the three views. A boundary angle of ±60o from 
the central line of the heart was imposed on the initial pixels selection, 
excluding any pixels which lay beyond this boundary (Figure 8.7). A typical 
experimental example of the exclusion criteria is demonstrated in Figure 8.8, 
showing the original pixel selection in Figure 8.8a and the applied exclusion 
criteria in Figure 8.8b. 
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Figure 8.7 Idealised model of the surface of the heart based on a semi-prolate ellipsoid.  
The angles indicated by the colour bars on the right represent the angle at each point with 
respect to the difference between the surface normal and perpendicular to the central line. 
(Produced by Mr Andrew Allen, University of Glasgow) 
 
 
Figure 8.8 Application of exclusion criteria.  
Illustration of a typical selection of the heart, showing the a) original pixel selection, and b) 
selection after applying the exclusion criteria. 
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GGobi 
Some of the optical data obtained in this study was analysed with GGobi, an 
interactive and dynamic graphic package that can be used for automatic 
brushing to change the colour, glyph type and size of points. Here GGobi was 
used to correlate the APD and the activation time on the heart surface. Optical 
data recorded from the experiments was imported into the software. Automatic 
brushing was applied to the data and the results are presented in the Result 
section. Example of automatic brushing by GGobi is displayed in Figure 8.9. 
 
Figure 8.9 GGobi software display.  
Example of automatic brushing for a) ECG showing each component of the ECG is marked 
with different colour, and b) APD50 showing the distribution of AP duration across the heart 
surface.  
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Results 
Incidence 
Overall, 5 out of 17 hearts developed VF during acute ischaemia in this study 
(Figure 8.10). For the purpose of this analysis, only hearts that developed VF 
within 30 minutes of the start of occlusion were included in the VF group. Any 
episode of arrhythmia that occurred during the reperfusion period was included 
in the no-VF group.   
 
Figure 8.10 Incidence of VF in panoramic view experiments. 
Incidence of hearts that developed VF (29.4%) and did not develop VF (70.6%) in panoramic 
view optical mapping experiments. 
Electrophysiological parameters 
The electrophysiological parameters analysed were APD at 50% repolarisation 
(APD50) and activation time (TActM). Figure 8.11 shows examples of contour 
maps of APD50 and TActM prior to occlusion, 10 minutes after occlusion 
(Occlusion 10min) and during reperfusion. Prior to occlusion, APD50 ranged from 
100 – 140ms. During occlusion, there was shortening of APD50, particularly in a 
region of the LV. During reperfusion, APD50 returned to the pre-occlusion level 
over most of the heart surface but APD50 at some sites on the LV still remained 
shorter than control values. Activation time was measured relative to the RA 
pacing stimulus. From the example shown in the bottom panel of Figure 8.11, 
the activation time at pre-occlusion ranged from 90 – 110ms. At Occlusion 10 
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min, there was delayed activation time in the region of shortened APD. 
However, the activation time was restored during reperfusion.  
 
Figure 8.11 APD50 and TActM. 
Contour maps showing changes in APD50 and TActM before, during and after occlusion 
from 3 different views of the heart; RV/LV, LV and RV. 
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APD50 
In the single-view optical mapping experiments, hearts with intrinsically longer 
APD prior to ischaemia tended not to develop VF and vice versa. In this 
experiment, there was no significant difference in combined (LV+RV) epicardial 
APD50 prior to occlusion between the hearts that went into VF and those that did 
not (Figure 8.12). However, APD50 in the LV was significantly shorter than the RV 
in hearts that developed VF. In the LV alone, APD50 was not significantly shorter 
in the group that developed VF, with the current sample size. Therefore, the LV 
was further analysed to look for any difference of APD50 between the apical and 
basal regions (Figure 8.13). Interestingly, the APD50 in the apex of VF hearts was 
significantly shorter as compared to the apex of no-VF hearts. This region 
corresponds approximately to the single-camera view recorded in previous 
experiments.  
The range (max-min) of APD50 at the same time point was also analysed and the 
result shown in Figure 8.14. It shows that the range of APD50 in the LV of hearts 
that developed VF was significantly greater compared to the no-VF hearts 
consistent with the expectation that greater heterogeneity in the hearts that 
developed VF would predispose the heart to develop VF during ischaemic insults. 
Most of the heterogeneity is due to the presence of shorter APD50 in the apical 
region relative to the basal region in VF hearts. 
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Figure 8.12 APD50 from three different surfaces of the heart. 
Box plots diagram comparing the APD50 at pre-occlusion in three different views of the 
heart. It demonstrates significant APD differences between RV/LV and LV in both no-VF and 
VF groups, as well as between RV/LV and RV views in no-VF hearts which do not exist in VF 
hearts. (*P<0.05, ***P<0.001) 
 
Figure 8.13 Apex-base difference in APD. 
Apical to basal APD50 differences during pre-occlusion period in hearts that developed VF 
and did not develop VF showing the APD50 in apical region of LV was significantly shorter in 
hearts that went into VF. (*P<0.05) 
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Figure 8.14 Range of APD50 from three different heart surfaces. 
Box plots diagram comparing the range of APD50 at pre-occlusion period in hearts that did 
and did not develop VF. Hearts that developed VF had a significantly greater range of APD50 
in the LV. (*P < 0.05) 
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Figure 8.15 APD50 prior to coronary artery occlusion. 
Bar graph of percentage of sites prior to ischaemia with APD50 <100ms in all three views: 
RV/LV, LV and RV. The LV in hearts that developed VF has significantly more sites of 
shorter APD. (**P<0.01) 
The number of sites with APD50 < 100ms at the pre-occlusion time point was also 
analysed (Figure 8.15). VF hearts tended to have more sites with shorter APD 
(APD50 <100ms) but only in the LV region was this difference significant.  
In order to visualize the APD pattern across the whole epicardial surface of both 
groups of hearts, the APD distribution before and during occlusion was binned 
into 20ms ranges using GGobi and plotted (Figure 8.16). At the pre-occlusion 
time point, APD50 in VF hearts appeared to have greater heterogeneity (range of 
colours) compared to the no-VF heart, particularly on the LV. In general, both 
groups had APD50 ranged between 100 – 160ms in all three views. However, the 
VF heart had more sites with shorter APD50 less than 100ms as compared to the 
no-VF heart, and most of the shorter sites were located in the LV region. An 
unexpected observation in terms of the APD distribution in VF hearts was that, 
after 10 minutes of coronary artery occlusion, most of the APD50 in the LV region 
shortened with the APD50 ranged between 40 – 100ms, but at the same time 
there was prolongation of the APD (APD50>160ms) on most sites in the RV/LV 
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view. Interestingly, this phenomenon was not seen in the no-VF hearts even 
though the APD50 in the LV region also shortened in this group.  
 
Figure 8.16 Distribution of APD across the heart surface. 
Example of APD50 distribution in no-VF and VF hearts at pre-occlusion and during 
Occlusion 10min. 
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Figure 8.16 tends to give the impression that in VF hearts there is a global APD 
shortening in response to regional ischaemia, in contrast to regional shortening 
seen in the no-VF hearts. However, scatter plot analysis of the APD50 during 
Occlusion 10min from 3 random samples of hearts in each no-VF (Figure 8.17a) 
and VF groups (Figure 8.17b) failed to show any difference in APD50 distribution 
pattern during acute regional ischaemia between the two groups. 
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Figure 8.17 APD50 distribution during Occlusion 10min (no-VF vs. VF hearts). 
Scatter plot analysis showing the distribution of APD50 during acute regional ischaemia 
from 3 different hearts in each a) no-VF group, and b) VF group. In Figure b (iii) some of the 
pixels were excluded due to SNR < 20 (threshold for the exclusion criteria). 
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TActM 
Another significant finding was that the hearts that developed VF had 
significantly delayed activation times compared to the no-VF hearts, 
predominantly in the LV view (Figure 8.18). Both apical and basal regions of the 
VF hearts had significantly longer activation times compared to the 
corresponding regions of the no-VF hearts (Figure 8.19). 
 
Figure 8.18 Activation time pre-occlusion. 
Box plots diagram showing significantly longer activation times in hearts that developed 
VF, mainly in the LV. (*P<0.05, ***P<0.001) 
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Figure 8.19 Apex-base difference in activation time. 
Apex to base comparison of TActM in LV. Both apical and basal regions in VF hearts have 
significantly longer activation as compared to no-VF hearts. (*P<0.05, ***P<0.001) 
QRS timing in relation to epicardial activation  
One advantage of panoramic optical mapping is that it allows us to correlate 
total epicardial ventricular activation sequence with the recorded ECG. An 
example of the correlation between the activation time and the QRS complex is 
given in Figure 8.20. In this example, we compared the activation sequence in 
no-VF and VF hearts at both Pre-occlusion 10min and at Occlusion 10min. The 
QRS complex was arbitrarily split into 5 phases as follows: 1) phase 1 was from 
the beginning of the Q to the midpoint between Q and R waves, 2) phase 2 was 
from the end of phase 1 to the peak of R wave, 3) phase 3 began from the peak 
of R wave until midpoint between R and S waves, 4) phase 4 was from the end of 
phase 3 to the beginning of S wave, and 5) phase 5 was from the beginning of 
the S wave to the end of the S wave. In general, the activation time in VF heart 
prior to ischaemia ranged from 109 – 153ms whereas the activation time in no-VF 
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heart ranged from 67 – 125ms at Pre-occlusion 10min. At Occlusion 10min, the 
RV/LV regions tended to have earlier activation as compared to the ischaemic LV 
region in both groups of heart. The ischaemic sites on the LV region were 
activated the latest compared to other non ischaemic sites.   
 
Figure 8.20 QRS timing in relation to epicardial activation. 
Example of correlation between the timing of activation matched with the QRS complex on 
the ECG in both no-VF and VF hearts during Occlusion 10min. The timing was split into 5 
phases with blue indicating phase 1, green indicating phase 2, purple indicating phase 3, 
orange indicating phase 4 and yellow indicating the latest activation time, phase 5. 
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ECG  
A notable observation from the previous single-view study was the alteration of 
the ECG shape before and during occlusion, in particular T wave polarity. In 
these experiments, variation in ECG in both groups of hearts was also observed. 
Figure 8.21 shows examples of ECG at three different time points before and 
during occlusion in both groups. At Pre-occlusion 10min, the T waves in all VF 
hearts had a positive polarity whereas the T waves in no-VF hearts had a 
negative polarity. At Occlusion 10min, there was broadening of the QRS complex 
and elevation of the ST segment observed in both groups of heart. However, I 
was unable to quantitatively analyze these ECG changes because it was difficult 
to determine the cursor placement for the ECG analysis. This limitation in 
analyzing the ECG has been discussed in previous chapter on ECG (see Chapter 
7). As the duration of the ischaemic episodes prolonged further, the ST segment 
elevation became more prominent in both groups. It was difficult to distinguish 
changes in T wave polarity in both groups since the change in ST segment level 
affected the negative- and positive-going T waves differently. Therefore, it was 
not possible to determine whether the underlying electrical events responsible 
for the measured ECGs were the same in the two experiments.  
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Figure 8.21 ECG from panoramic view optical mapping experiments. 
Example of ECG from VF and no-VF hearts at pre-occlusion, Occlusion 10min and 
Occlusion 20min. In the VF heart, the T wave at pre-occlusion period had positive polarity. 
During Occlusion 10min, there was widening of the QRS complexes and slight elevation of 
the T wave. As the heart became more ischaemic, the ST elevation became more prominent 
at Occlusion 20min. On the other hand, the T wave in no-VF heart had negative polarity 
during pre-occlusion period. During occlusion, there was elevation of the ST segment 
together with broadening of the QRS complex. At Occlusion 20min, the ST elevation became 
more pronounced and it also dragged the T wave to a positive polarity. 
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Discussion 
In summary, initial studies with single view optical mapping approach suggested 
that a shorter LV APD prior to local ischaemia predisposed the heart to VF. 
Current studies with the panoramic 3D view optical mapping technique 
confirmed this correlation and indicate that the shorter APD was confined to the 
apical half of the LV, and did not include basal LV or RV electrophysiology. 
Panoramic imaging also revealed a delayed activation time predominantly in the 
basal aspects of the LV. Both of these events, shorter APD in the apex and longer 
activation time in the base were features of hearts that developed VF on 
coronary artery ligation. 
A number of previous papers have described differences in AP duration from 
different areas on the myocardium; in particular, cells from the apex of hearts 
are known to have shorter AP than cells isolated from the base (Bryant et al., 
1997; de Bakker and Opthof, 2002). This difference has been attributed to 
differences in expression of Ito or to IK (Brahmajothi et al., 1997; Bryant et al., 
1999; Cheng et al., 1999; Szentadrassy et al., 2005). Across both groups, this 
apex-base difference was observed. However, it is not clear why the apical 
region of hearts prone to VF possessed an APD that was shorter than the no-VF 
hearts, and therefore had an apical-basal APD gradient that was significant 
greater. These heart-to-heart differences in ventricular electrophysiology may 
arise from the natural variation in ion channel expression in these animals. In 
the single view experiments described previously, the area of myocardium 
imaged overlapped considerably with the LV apical region which demonstrated 
the AP shortening described here. 
Although the ECG morphology changes observed using the two systems were 
similar in some respects, there were also clear differences that cannot be 
attributed to experimental conditions or optical configuration. Electrode 
positioning relative to the heart was similar in terms of distance and angle 
around the long axis, but the shape and “field of view” of the electrodes 
differed between the two setups. In the single camera system, the ECG 
electrodes were effectively two discs (diameter ~5mm); in the panoramic 
system, they were two metal pillars (~4mm diameter, 50mm long) which also 
served as structural elements for the chamber. This discrepancy limited 
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comparison between the two sets of ECG recordings, and in future experiments 
it would be beneficial to attempt to insulate the pillars in such a way as to 
approximate the “standard” electrode configuration of the single camera 
system.  
Even though the incidence of VF in panoramic view optical mapping experiments 
is less than in earlier experiments with single view optical mapping, a Fisher’s 
exact probability test performed on the data revealed that they were not 
statistically significant. Results were expressed as the mean +/- SEM, with 
P<0.05 considered significant. 
Correlation of optical signals with phases of the ECG 
Systematic analysis of the phase of the ECG relative to the optical mapping data 
was not performed. But what was clear from the initial measurements was that 
activation time followed the expected epicardial pattern, and earlier events 
were detected in the RV because of the thinner free wall compared to the LV. 
This difference in dimension means that activation will start at a similar time on 
the endocardium of both ventricles, and activation will appear on the epicardial 
surface of the thinner ventricle sooner. 
Regarding the repolarisation event, there were no prominent differences in 
APD50 under normal circumstances (Figure 8.16) across both ventricles. The un-
physiologically short APD50 (<50ms) values obtained may be due to analysis of 
inappropriate signals from tissue either damaged if at an acute angle to the 
Illumination and camera. 
Is the shorter APD in the LV apex an artefact of the experimental 
procedure? 
One possibility is that the shorter APDs in the LV are due to the snare application 
at the beginning of the experiment procedure. During the snare application, 
damage to the coronary vessel may compromise some of the blood flow and 
cause the partial ischaemia before the actual occlusion procedure. However, 
similar analysis done using the data obtained from different study performed by 
another PhD student in the lab using a procedure that did not involve snare 
application revealed that there was still significant number of shorter sites on 
Chapter 8  209 
the epicardial surface of the heart prior to occlusion. Furthermore, TActM times 
longer than 100ms were common. On the basis that the electrical activation and 
repolarisation times across the LV were no different from a “normal” heart, the 
concept that these differences were attributable to damage associated with the 
ligation procedure was not thought to be valid. 
Physiological basis for shorter APD in LV apex 
As mentioned earlier in this chapter and in Chapter 6, the electrophysiological 
bases for differences in APD between apical and basal regions have been studied 
previously. One possibility is the differential expression of ion channels 
(particularly IKs and IKr) across apical and basal regions (Brahmajothi et al., 1997; 
Bryant et al., 1999; Cheng et al., 1999; Szentadrassy et al., 2005). Further work 
is required to determine the underlying cause of the electrophysiological 
differences and why a shorter APD value in the apical region predisposes the 
heart to VF as discussed in Chapter 6.
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Chapter 9: In vivo coronary artery ligation in rabbit 
– ECG measurements 
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Aim 
The purpose of these experiments was to attempt a limited study to look at the 
tendency of the heart to develop ventricular fibrillation (VF) during in vivo 
procedure of acute coronary artery ligation and to analyse the ECG data 
recorded during ligation of left anterior descending artery in the rabbit. 
Introduction 
Acute MI is frequently used in animal models of myocardial ischaemia for both 
physiological and pharmacological studies (De Groot & Coronel, 2004; Man and 
Bril, 1991). In the rabbit, Bril et al. (1991) reported a cumulative incidence of VF 
after 20 minutes of coronary artery ligation in 27% of normal rabbit heart. 
Previous experiments on Langendorff-perfused rabbit hearts have indicated that, 
on ligation of the left anterior descending artery, approximately 50% of the 
preparations developed VF within 30 minutes. The data also showed that 
predisposition to VF in this phase was related to shortened QT interval and 
corresponding APD in the pre-occlusion phase. One concern about the in vitro 
data is that the artificial circumstances of the preparation may affect the 
physiology of the heart to the extent that the incidence of VF does not represent 
the situation in vivo. The in vitro preparation has several factors that could 
affect the physiological response to ischaemia: (1) Langendorff perfusion 
(retrograde) of the aorta using a crystalloid medium may not be an adequate 
model for a blood-perfused working heart, (2) the absence of autonomic 
innervations may alter the predisposition to arrhythmia, (3) the use of 
mechanical uncouplers may alter the arrhythmia substrate via removal of 
mechano-electrical feedback (Coronel, 2002) and/or side-effects on ion channels 
and calcium handling. Given these concerns, it seemed appropriate to attempt 
to reproduce the coronary artery occlusion procedure in vivo. 
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Methods 
Left coronary artery ligation 
In vivo surgical procedures were performed in collaboration with Mr Michael 
Dunne in accordance with the UK Animals (Scientific Procedures) Act 1986 and 
complying with the Guide for the Care and Use of Laboratory Animals published 
by the US National Institutes of Health (NIH Publication No. 85-23, revised 1996). 
A total of 12 animals were used in this in vivo study. Adult male New Zealand 
White rabbits were given premedication with 0.3ml/kg Hypnorm (fentanyl 
citrate 0.315mg/ml + fluanisone 10mg/ml) administered intramuscularly. 
Anaesthesia was induced with intravenous injection of 0.15 – 0.3 mg/kg 
midazolam (Hypnovel, Roche) given via a cannula in the marginal ear vein. The 
rabbit was then intubated and ventilated with a small animal positive pressure 
ventilator set to a frequency of 38 per minute and at 50ml stroke volume. The 
rabbit anaesthesia was maintained on 1% halothane with a 1:1 mixture of oxygen 
and nitrous oxide. A left thoracotomy through the 4th intercostal space was 
performed. The proximal branch of the left coronary artery was identified and 
ligated using a 4/0 Ethibond® suture. The heart was left for 20 minutes. If the 
heart went into VF, a gentle prod was given together with a cardiac massage to 
restore sinus rhythm. If this did not work, defibrillation was attempted with a 5-
10J epicardial DC shock. Normally, an intravenous injection of quinidine 
hydrochloride solution 10mg/ml was administered before the coronary artery 
ligation as a measure to reduce the incidence of VF. However, all the ligation 
procedures for this study were done without the administration of quinidine 
because we wanted to mimic the in vitro conditions used previously. Once the 
animal was stable, the thoracotomy was closed. The rabbit was then 
intravenously infused with 20ml of isotonic saline to replace the perioperative 
fluid losses. Intramuscular injection of 0.05mg/kg Vetergesic (buprenorphine) 
was given immediately post surgery for post-operative analgesia. The animal was 
then extubated and placed in a heated recovery box. Rimadyl (4mg/kg) was 
administered subcutaneous for 2 days post-op to provide pain relief. These 
animals were used 8 weeks later in a separate study. 
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ECG monitoring and recording 
Figure 9.1 shows a sample of an ECG signal recorded throughout the ligation 
surgery to monitor for incidence of VF. The ECG data obtained in this study were 
compared with the ECG from the in vitro acute coronary artery ligation 
experiments. Needle electrodes (Grass) were placed just under the skin in a lead 
II configuration. A clearly recognizable ECG was occasionally not evident, in 
which case a lead I or III was used instead. The area used for the placement of 
ECG electrodes was shaved and cleaned using 70% ethanol with chlorhexidine 
and the electrodes were taped in place. The ECG was recorded by a Biopac 
system (Biopac Systems Inc., CA) using their Acq software. The recordings were 
started after the animal had been anaesthetised and positioned for surgery so 
that the movement of the animal was kept to a minimum. 
 
Figure 9.1 In vivo ECG data.  
Example of ECG tracings from one of the in vivo coronary artery ligation experiments. This 
ECG was taken before ligation. 
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ECG analysis 
The ECG recorded during the in vivo ligation procedure was analysed using semi-
automated software, ChartTM 5 Pro (ADInstruments Ltd, UK) (see Chapter 2). The 
software assigns the cursor to certain points on each of the ECG beat prior to 
calculating the value for the ECG parameters mentioned above. The landmarks 
for the cursors are P start, P peak, QRS start, QRS end, T peak and T end (Figure 
9.2a). However, when the quality of the ECG recordings (Figure 9.2b) was poor, 
the software was unable reliably to identify these features. As evident in Figure 
9.1, the ECG signals were noisy and the P and T waves could not be 
differentiated from the baseline. The cursors could then be manually adjusted to 
appropriate landmarks (obviously a subjective procedure). An example of 
manual analysis is given (Figure 9.3). For every recording, 5 beats were analysed 
and the mean was taken as the value for each parameters. 
Chapter 9  215 
 
Figure 9.2 ECG analysis using Chart
TM
 5 Pro software. 
Example of one beat from ECG tracing recorded during the ligation procedure. a) Completed 
set of cursor placements for calculation of ECG parameters. b) Some cursors are missing 
due to failure of the software to recognise ECG features. 
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Figure 9.3 ECG parameters.  
Top panel: Some parameter values such as PR and QT intervals were missing from initial 
analysis because the software failed to find sensible landmarks for correct placement of the 
cursors. Bottom panel: After manually adjusting the cursors, the values were recalculated 
and indicated in red font.  
 Statistical analysis 
All data obtained in this study are expressed as mean ± standard error of the 
mean (SEM). Significance testing was done using GraphPad Prism software. 
Comparison between groups of data was made with Student’s t-test (paired 
when appropriate). A two-tailed p-value of less than 0.05 was considered 
significant. Multiple comparisons were performed using one-way ANOVA followed 
by Tukey-Kramer post test to allow multiple comparisons where appropriate.  
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Results 
In this study, 12 healthy adult male New Zealand White rabbits weighing 
between 2.5 – 3.5kg were used. During the ligation surgery, 7 rabbits developed 
VF within 20 minutes of the LAD artery ligation and 5 did not. Table 9.1 displays 
an example of beat to beat variation in the ECG parameters in one experiment. 
The mean value for each parameter was calculated from 5 consecutive beats. 
 
Figure 9.4 Incidence of no-VF and VF in in vivo study.  
Bar graph displaying the percentage of hearts that developed and not developed VF during 
the in vivo procedure of coronary artery ligation. No-VF (n=5) and VF (n=7). 
The heart rate in rabbits in the VF group before the coronary artery ligation 
varied from 142 to 257bpm with a mean of 203 ± 14bpm. In no-VF group, the 
heart rate ranged from 194 to 252bpm with a mean of 215 ± 10bpm. This 
difference in heart rates was not significant. The mean durations of RR, PR, QRS 
and QT intervals before the LAD artery ligation are presented in Table 9.2. It 
compares the results from the hearts that went into VF within 30 minutes of the 
coronary artery ligation and the hearts that did not develop VF. As shown in the 
table, although there appeared to be a trend towards the VF group having a 
shorter QT there was no statistically or physiologically significant difference 
between the two groups (P=0.643).  
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Table 9.1 Beat to beat variation in ECG parameters. 
Example of individual value for different ECG parameters from 5 consecutive beats in one 
experiment. 
 
Table 9.2 ECG parameters (no-VF vs. VF groups). 
Comparison of duration of different pre-ligation ECG parameters in rabbits between the 
hearts that developed VF and the hearts that did not develop VF (Mean ± SEM). 
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The relation between the rate and repolarisation, represented by RR and QT 
interval respectively, was examined. Figure 9.5 shows values of uncorrected QT 
plotted against the RR interval for both groups. Because there was no obvious 
relationship, the use of a correction factor was considered unnecessary.   
 
Figure 9.5 Graph showing the relation between RR interval and QT interval.  
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Discussion 
Experimentally in vivo or in vitro, the coronary artery can be ligated to simulate 
an occlusion creating an ischaemic field. In this in vivo experiment, the 
incidence of VF was 58%. This was a higher proportion than a previous report 
(Bril et al., 1991) using a similar procedure in vivo. One obvious factor that can 
account for this difference is the position of the ligature on the left descending 
artery and hence the size of the consequent ischaemic area. Of relevance here is 
that approximate 50% incidence in vivo is similar to that seen in the in vitro 
experiments, suggesting that the data gained in vitro does not misrepresent the 
vulnerability of the myocardium to arrhythmias in vivo. However, analysis of the 
ECG data did not reveal a correlation between incidence of VF and QT interval 
as was observed in vitro. The reasons for this are unclear, but one significant 
factor was the inter-subject variability of heart rate and ECG parameters. The 
variability of the latter is likely to be at least partly due to the lower signal-to-
noise of the ECG recordings. Future studies should involve improvement of this 
aspect of the measurements. Another reason is likely due to the small number of 
sample size for this study. To determine the sample size required to get a 
significant difference in the QT interval between the two groups, it can be 
calculated based on the formula:  
     
In this formula, the sample size (n) is calculated based on Zα/2, the 95% 
confidence coefficient which is equal to 1.96, sigma (σ) which is the standard 
deviation, and E which is the margin of error. The values for σ and E for this 
calculation were obtained from the QT interval data in the in vitro experiments 
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(see Chapter 5). From the calculation, it shows that the sample size need to be 
increased to at least n = 24 in order to detect a significant difference between 
the two groups when the underlying population difference approximates to the 
difference observed in vitro (12ms). This would suggest that a considerably 
higher number of procedures would be required. The group is currently acquiring 
this extra data to ensure sufficient resolution.
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Chapter 10: Discussion 
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General discussion 
Optical mapping studies have previously used single wavelength measurements 
to monitor cardiac electrophysiology. In the initial part of these studies, I 
attempted to upgrade this approach by investigating the use of dual-wavelength 
ratiometric measurement techniques applied to electrical mapping of isolated 
rabbit hearts. In theory, this approach offers important advantages over the 
single wavelength technique: (i) measurement of action potential amplitude in 
absolute units of mV and (ii) elimination (or at least reduction) of artefacts that 
arise from movement of the myocardium. However, despite optimising the 
wavelengths for ratiometric measurements and demonstrating the potential for 
measuring AP amplitude, several sources of artefact remained that could not be 
easily addressed without improvements in illumination techniques and camera 
alignment.  Therefore the experimental sections of the thesis used conventional 
single wavelength approach. 
The main finding in this study is that predisposition to VF during acute regional 
ischaemia following coronary artery occlusion was a function of the 
electrophysiology of the ventricle prior to occlusion. Approximately 50% of 
hearts with shorter than average QT intervals arising from shorter LV action 
potential duration values, particularly in the apical region of the LV free wall, 
were more prone to VF. Artificially prolonging ventricular action potential 
duration with a hERG channel blocker (E-4031) did not protect these hearts from 
VF post-occlusion. Potential confounding factors such as prior increased 
sympathetic activity did not alter the relative tendency to VF post occlusion. 
The conclusion from these studies was that the predisposition to VF post-
occlusion was not a direct consequence of shorter than averaged QT interval but 
the strong association suggests that other underlying differences in 
electrophysiology are important determinants of predisposition to VF. Attempts 
to verify these observations in vivo failed because of the high variability of QT 
interval but a similar (approximately 50:50) ratio of VF/no-VF population was 
present. 
As part of the preliminary studies, I investigated the effect of hERG channel 
inhibition on rabbit ventricular myocardium. Despite the well known role of this 
channel (IKr) in the repolarisation phase of the action potential, few studies on 
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rabbit myocardium exist. The drug produced a clear dose-dependent increase in 
action potential duration similar to a number of other species, at slower than 
physiological rates. Early after-depolarisations were present, again as seen in 
other species including man. There were also examples of spontaneous 
ventricular tachycardia at the higher E4031 concentrations, but no examples of 
spontaneous VF (in the form of Torsade de Pointes) which is a common 
occurrence in man and some larger experimental animals. This work suggested 
that, in rabbit, IKr is present in myocardium, but contributes only to a small 
extent to the action potential duration at normal physiological heart rates in 
rabbit. This difference and the monomorphic tachycardia observed after 
profound IKr block suggests that rabbit ventricular myocardium may not be ideal 
for screening for potentially lethal drugs that act via IKr block since these 
responses differ significantly from human myocardium. 
Clinical studies on victims of sudden cardiac death following acute coronary 
events and survivors of such events have shown that patients with a higher 
prevalence of electrocardiographic early repolarisation are more susceptible to 
sudden cardiac death during acute myocardial ischaemia (Tikkanen et al., 2012). 
In another study (Haissaguerre et al., 2009), early repolarisation has been 
associated with a variant of the mutation of the KATP channel subunit. One of the 
predictors of VF in patients having myocardial infarction is an early 
repolarisation pattern and this early repolarisation has been linked to mutation 
in KATP channel. These clinical findings are interesting in relation to my current 
work.  
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Future work  
1) Examine the molecular basis for the distribution of QT interval in the 
rabbit. This would address the hypothesis that the shorter action potential 
duration in the apical region of the LV is due to a change in ion channel 
expression that may underlie the predisposition to VF. For example, if the 
shorter QT is due to expression of IKATP channels with a lower than normal 
sensitivity to ATP, this may explain the linkage between pre-occlusion 
electrophysiology and predisposition to VF. 
2) Increase the size of the in vivo study to at least n=24 to determine 
whether occlusion of the coronary artery results in a similar 50:50 
distribution between no-VF and VF groups. 
3) In a wider context and beyond the realm of experimental study, 
information on how early repolarisation relates to VF incidence would be 
gained by clinical/epidemiological studies examining the link between 
early repolarisation and KATP channelopathy.
226 
 
 
References 
 
Cardiovascular disease statistics. British Heart Foundation . 4-12-2013a.  
Ref Type: Online Source 
Coronary heart disease. British Heart Foundation . 4-12-2013b.  
Ref Type: Online Source 
Agarwal, A., Jing, L., & Patwardhan, A. 2012. Effect of rapid delayed rectifier 
current on hysteresis in restitution of action potential duration in swine. 
Conf.Proc.IEEE Eng Med Biol.Soc., 2012, 673-676. 
Akar, F.G., Roth, B.J., & Rosenbaum, D.S. 2001. Optical measurement of cell-to-
cell coupling in intact heart using subthreshold electrical stimulation. Am.J 
Physiol Heart Circ.Physiol, 281, (2) H533-H542. 
Allingham, J.S., Smith, R., & Rayment, I. 2005. The structural basis of 
blebbistatin inhibition and specificity for myosin II. Nat Struct.Mol.Biol., 12, (4) 
378-379. 
Anderson, C.L., Delisle, B.P., Anson, B.D., Kilby, J.A., Will, M.L., Tester, D.J., 
Gong, Q., Zhou, Z., Ackerman, M.J., & January, C.T. 2006. Most LQT2 mutations 
reduce Kv11.1 (hERG) current by a class 2 (trafficking-deficient) mechanism. 
Circulation, 113, (3) 365-373. 
Antzelevitch, C., Pollevick, G.D., Cordeiro, J.M., Casis, O., Sanguinetti, M.C., 
Aizawa, Y., Guerchicoff, A., Pfeiffer, R., Oliva, A., Wollnik, B., Gelber, P., 
Bonaros, E.P., Jr., Burashnikov, E., Wu, Y., Sargent, J.D., Schickel, S., 
Oberheiden, R., Bhatia, A., Hsu, L.F., Haissaguerre, M., Schimpf, R., Borggrefe, 
M., & Wolpert, C. 2007. Loss-of-function mutations in the cardiac calcium 
channel underlie a new clinical entity characterized by ST-segment elevation, 
short QT intervals, and sudden cardiac death. Circulation, 115, (4) 442-449. 
Armoundas, A.A., Nanke, T., & Cohen, R.J. 2000. Images in cardiovascular 
medicine. T-wave alternans preceding torsade de pointes ventricular 
tachycardia. Circulation, 101, (21) 2550. 
Ataklte, F., Erqou, S., Laukkanen, J., & Kaptoge, S. 2013. Meta-analysis of 
ventricular premature complexes and their relation to cardiac mortality in 
general populations. Am.J Cardiol., 112, (8) 1263-1270. 
Avitall, B. 1979. Computer simulation of ventricular tachyarrhythmias during 
coronary artery ligation and release. J Electrocardiol., 12, (1) 17-22. 
Bayes de Luna, L.A., Coumel, P., & Leclercq, J.F. 1989. Ambulatory sudden 
cardiac death: mechanisms of production of fatal arrhythmia on the basis of data 
from 157 cases. Am.Heart J, 117, (1) 151-159. 
Beach, J.M., McGahren, E.D., Xia, J., & Duling, B.R. 1996. Ratiometric 
measurement of endothelial depolarization in arterioles with a potential-
sensitive dye. Am.J Physiol, 270, (6 Pt 2) H2216-H2227. 
227 
Behrens, S., Li, C., & Franz, M.R. 1997. Effects of myocardial ischemia on 
ventricular fibrillation inducibility and defibrillation efficacy. J 
Am.Coll.Cardiol., 29, (4) 817-824. 
Bellocq, C., van Ginneken, A.C., Bezzina, C.R., Alders, M., Escande, D., 
Mannens, M.M., Baro, I., & Wilde, A.A. 2004. Mutation in the KCNQ1 gene 
leading to the short QT-interval syndrome. Circulation, 109, (20) 2394-2397. 
Bernier, M., Curtis, M.J., & Hearse, D.J. 1989. Ischemia-induced and 
reperfusion-induced arrhythmias: importance of heart rate. Am.J Physiol, 256, 
(1 Pt 2) H21-H31. 
Bigger, J.T., Jr., Dresdale, F.J., Heissenbuttel, R.H., Weld, F.M., & Wit, A.L. 
1977. Ventricular arrhythmias in ischemic heart disease: mechanism, 
prevalence, significance, and management. Prog.Cardiovasc Dis., 19, (4) 255-
300. 
Bijl, M. & Verheugt, F.W. 1992. Extreme QT prolongation solely due to reversible 
myocardial ischemia in single-vessel coronary disease. Am.Heart J, 123, (2) 524-
526. 
Billman, G.E. 1994. Role of ATP sensitive potassium channel in extracellular 
potassium accumulation and cardiac arrhythmias during myocardial ischaemia. 
Cardiovasc Res, 28, (6) 762-769. 
Bjerregaard, P., Jahangir, A., & Gussak, I. 2006. Targeted therapy for short QT 
syndrome. Expert.Opin.Ther.Targets., 10, (3) 393-400. 
Boineau, J.P. & Cox, J.L. 1973. Slow ventricular activation in acute myocardial 
infarction. A source of re-entrant premature ventricular contractions. 
Circulation, 48, (4) 702-713. 
Botting, J.H., Curtis, M.J., & Walker, M.J. 1985. Arrhythmias associated with 
myocardial ischaemia and infarction. Mol.Aspects Med, 8, (4) 307-422. 
Bourgeois, E.B., Reeves, H.D., Walcott, G.P., & Rogers, J.M. 2012. Panoramic 
optical mapping shows wavebreak at a consistent anatomical site at the onset of 
ventricular fibrillation. Cardiovasc Res, 93, (2) 272-279. 
Brack, K.E., Coote, J.H., & Ng, G.A. 2010. Vagus nerve stimulation inhibits the 
increase in Ca2+ transient and left ventricular force caused by sympathetic 
nerve stimulation but has no direct effects alone--epicardial Ca2+ fluorescence 
studies using fura-2 AM in the isolated innervated beating rabbit heart. 
Exp.Physiol, 95, (1) 80-92. 
Brahmajothi, M.V., Morales, M.J., Reimer, K.A., & Strauss, H.C. 1997. Regional 
localization of ERG, the channel protein responsible for the rapid component of 
the delayed rectifier, K+ current in the ferret heart. Circ.Res, 81, (1) 128-135. 
Bricknell, O.L. & Opie, L.H. 1978. Effects of substrates on tissue metabolic 
changes in the isolated rat heart during underperfusion and on release of lactate 
dehydrogenase and arrhythmias during reperfusion. Circ.Res, 43, (1) 102-115. 
228 
Bril, A., Forest, M.C., & Gout, B. 1991. Ischemia and reperfusion-induced 
arrhythmias in rabbits with chronic heart failure. Am.J Physiol, 261, (2 Pt 2) 
H301-H307. 
Brown, B.G., Lin, J.T., Kelsey, S., Passamani, E.R., Levy, R.I., Dodge, H.T., & 
Detre, K.M. 1989. Progression of coronary atherosclerosis in patients with 
probable familial hypercholesterolemia. Quantitative arteriographic assessment 
of patients in NHLBI type II study. Arteriosclerosis, 9, (1 Suppl) I81-I90. 
Brugada, R., Hong, K., Dumaine, R., Cordeiro, J., Gaita, F., Borggrefe, M., 
Menendez, T.M., Brugada, J., Pollevick, G.D., Wolpert, C., Burashnikov, E., 
Matsuo, K., Wu, Y.S., Guerchicoff, A., Bianchi, F., Giustetto, C., Schimpf, R., 
Brugada, P., & Antzelevitch, C. 2004. Sudden death associated with short-QT 
syndrome linked to mutations in HERG. Circulation, 109, (1) 30-35. 
Brunner, M., Peng, X., Liu, G.X., Ren, X.Q., Ziv, O., Choi, B.R., Mathur, R., 
Hajjiri, M., Odening, K.E., Steinberg, E., Folco, E.J., Pringa, E., Centracchio, J., 
Macharzina, R.R., Donahay, T., Schofield, L., Rana, N., Kirk, M., Mitchell, G.F., 
Poppas, A., Zehender, M., & Koren, G. 2008. Mechanisms of cardiac arrhythmias 
and sudden death in transgenic rabbits with long QT syndrome. J Clin Invest, 
118, (6) 2246-2259. 
Bryant, S.M., Shipsey, S.J., & Hart, G. 1997. Regional differences in electrical 
and mechanical properties of myocytes from guinea-pig hearts with mild left 
ventricular hypertrophy. Cardiovasc Res, 35, (2) 315-323. 
Bryant, S.M., Shipsey, S.J., & Hart, G. 1999. Normal regional distribution of 
membrane current density in rat left ventricle is altered in catecholamine-
induced hypertrophy. Cardiovasc Res, 42, (2) 391-401. 
Bullen, A., Patel, S.S., & Saggau, P. 1997. High-speed, random-access 
fluorescence microscopy: I. High-resolution optical recording with voltage-
sensitive dyes and ion indicators. Biophys.J, 73, (1) 477-491. 
Burton, F.L. & Cobbe, S.M. 2001. Dispersion of ventricular repolarization and 
refractory period. Cardiovasc Res, 50, (1) 10-23. 
Cantillon, D.J. 2013. Evaluation and management of premature ventricular 
complexes. Cleve.Clin J Med, 80, (6) 377-387. 
Carlsson, L., Amos, G.J., Andersson, B., Drews, L., Duker, G., & Wadstedt, G. 
1997. Electrophysiological characterization of the prokinetic agents cisapride 
and mosapride in vivo and in vitro: implications for proarrhythmic potential? J 
Pharmacol.Exp.Ther., 282, (1) 220-227. 
Carmeliet, E. 1985. Electrophysiologic and voltage clamp analysis of the effects 
of sotalol on isolated cardiac muscle and Purkinje fibers. J Pharmacol.Exp.Ther., 
232, (3) 817-825. 
Carmeliet, E. 1999. Cardiac ionic currents and acute ischemia: from channels to 
arrhythmias. Physiol Rev., 79, (3) 917-1017. 
229 
Carmeliet, E. & Vereecke, J. 2002, "Ionic Currents and Action Potentials," In 
Cardiac Cellular Electrophysiology, Dordrecht: Kluwer Academic Publishers, pp. 
95-177. 
Cheng, J., Kamiya, K., Liu, W., Tsuji, Y., Toyama, J., & Kodama, I. 1999. 
Heterogeneous distribution of the two components of delayed rectifier K+ 
current: a potential mechanism of the proarrhythmic effects of 
methanesulfonanilideclass III agents. Cardiovasc Res, 43, (1) 135-147. 
Chou, C.C., Zhou, S., Hayashi, H., Nihei, M., Liu, Y.B., Wen, M.S., Yeh, S.J., 
Fishbein, M.C., Weiss, J.N., Lin, S.F., Wu, D., & Chen, P.S. 2007. Remodelling of 
action potential and intracellular calcium cycling dynamics during subacute 
myocardial infarction promotes ventricular arrhythmias in Langendorff-perfused 
rabbit hearts. J Physiol, 580, (Pt.3) 895-906. 
Coromilas, J., Costeas, C., Deruyter, B., Dillon, S.M., Peters, N.S., & Wit, A.L. 
2002. Effects of pinacidil on electrophysiological properties of epicardial border 
zone of healing canine infarcts: possible effects of K(ATP) channel activation. 
Circulation, 105, (19) 2309-2317. 
Coronel, R. 2002. Repolarization abnormalities in heart failure. Cardiovasc Res, 
54, (1) 11-12. 
Curtis, M.J. 1998. Characterisation, utilisation and clinical relevance of isolated 
perfused heart models of ischaemia-induced ventricular fibrillation. Cardiovasc 
Res, 39, (1) 194-215. 
Curtis, M.J. & Hearse, D.J. 1989. Ischaemia-induced and reperfusion-induced 
arrhythmias differ in their sensitivity to potassium: implications for mechanisms 
of initiation and maintenance of ventricular fibrillation. J Mol.Cell Cardiol., 21, 
(1) 21-40. 
Czarnecka, M., Lewartowski, B., & Prokopczuk, A. 1973. Intracellular recording 
from the in situ working dog heart in physiological conditions and during acute 
ischemia and fibrillation. Acta Physiol Pol., 24, (2) 331-337. 
D'Alonzo, A.J., Darbenzio, R.B., Hess, T.A., Sewter, J.C., Sleph, P.G., & Grover, 
G.J. 1994. Effect of potassium on the action of the KATP modulators 
cromakalim, pinacidil, or glibenclamide on arrhythmias in isolated perfused rat 
heart subjected to regional ischaemia. Cardiovasc Res, 28, (6) 881-887. 
de Bakker, J.M. & Opthof, T. 2002. Is the apico-basal gradient larger than the 
transmural gradient? J Cardiovasc Pharmacol., 39, (3) 328-331. 
De Groot, J.R. & Coronel, R. 2004. Acute ischemia-induced gap junctional 
uncoupling and arrhythmogenesis. Cardiovasc Res, 62, (2) 323-334. 
De, A.L. & Corlan, A.D. 2007. Clinical use of body surface potential mapping in 
cardiac arrhythmias. Anadolu.Kardiyol.Derg., 7 Suppl 1, 8-10. 
Dekker, L.R., Bezzina, C.R., Henriques, J.P., Tanck, M.W., Koch, K.T., Alings, 
M.W., Arnold, A.E., de Boer, M.J., Gorgels, A.P., Michels, H.R., Verkerk, A., 
Verheugt, F.W., Zijlstra, F., & Wilde, A.A. 2006. Familial sudden death is an 
230 
important risk factor for primary ventricular fibrillation: a case-control study in 
acute myocardial infarction patients. Circulation, 114, (11) 1140-1145. 
Dixit, S. & Callans, D.J. 2002. Mapping for ventricular tachycardia. Card 
Electrophysiol.Rev., 6, (4) 436-441. 
Doroghazi, R.M. & Childers, R. 1978. Time-related changes in the Q-T interval in 
acute myocardial infarction: possible relation to local hypocalcemia. Am.J 
Cardiol., 41, (4) 684-688. 
Downar, E., Janse, M.J., & Durrer, D. 1977. The effect of acute coronary artery 
occlusion on subepicardial transmembrane potentials in the intact porcine heart. 
Circulation, 56, (2) 217-224. 
Drouin, E., Charpentier, F., Gauthier, C., Laurent, K., & Le, M.H. 1995. 
Electrophysiologic characteristics of cells spanning the left ventricular wall of 
human heart: evidence for presence of M cells. J Am.Coll.Cardiol., 26, (1) 185-
192. 
Durrer, D., van Dam, R.T., Freud, G.E., Janse, M.J., Meijler, F.L., & Arzbaecher, 
R.C. 1970. Total excitation of the isolated human heart. Circulation, 41, (6) 899-
912. 
Efimov, I.R., Nikolski, V.P., & Salama, G. 2004. Optical imaging of the heart. 
Circ.Res, 95, (1) 21-33. 
Eldar, M., Sievner, Z., Goldbourt, U., Reicher-Reiss, H., Kaplinsky, E., & Behar, 
S. 1992. Primary ventricular tachycardia in acute myocardial infarction: clinical 
characteristics and mortality. The SPRINT Study Group. Ann.Intern.Med, 117, (1) 
31-36. 
Elharrar, V. & Surawicz, B. 1983. Cycle length effect on restitution of action 
potential duration in dog cardiac fibers. Am.J Physiol, 244, (6) H782-H792. 
Elliott, A.C., Smith, G.L., Eisner, D.A., & Allen, D.G. 1992. Metabolic changes 
during ischaemia and their role in contractile failure in isolated ferret hearts. J 
Physiol, 454, 467-490. 
Engblom, H., Hedstrom, E., Heiberg, E., Wagner, G.S., Pahlm, O., & Arheden, H. 
2005. Size and transmural extent of first-time reperfused myocardial infarction 
assessed by cardiac magnetic resonance can be estimated by 12-lead 
electrocardiogram. Am.Heart J, 150, (5) 920. 
Engels, W., Reiters, P.H., Daemen, M.J., Smits, J.F., & van der Vusse, G.J. 
1995. Transmural changes in mast cell density in rat heart after infarct induction 
in vivo. J Pathol., 177, (4) 423-429. 
Estes, E.H., Jr., Entman, M.L., Dixon, H.B., & Hackel, D.B. 1966. The vascular 
supply of the left ventricular wall. Anatomic observations, plus a hypothesis 
regarding acute events in coronary artery disease. Am.Heart J, 71, (1) 58-67. 
Ettinger, P.O., Regan, T.J., Oldewurtel, H.A., & Khan, M.I. 1973. Ventricular 
conduction delay and arrhythmias during regional hyperkalemia in the dog. 
Electrical and myocardial ion alterations. Circ.Res, 33, (5) 521-531. 
231 
Extramiana, F. & Antzelevitch, C. 2004. Amplified transmural dispersion of 
repolarization as the basis for arrhythmogenesis in a canine ventricular-wedge 
model of short-QT syndrome. Circulation, 110, (24) 3661-3666. 
Fedida, D. & Giles, W.R. 1991. Regional variations in action potentials and 
transient outward current in myocytes isolated from rabbit left ventricle. J 
Physiol, 442, 191-209. 
Fedor, J.M., McIntosh, D.M., Rembert, J.C., & Greenfield, J.C., Jr. 1978. 
Coronary and transmural myocardial blood flow responses in awake domestic 
pigs. Am.J Physiol, 235, (4) H435-H444. 
Fedorov, V.V., Lozinsky, I.T., Sosunov, E.A., Anyukhovsky, E.P., Rosen, M.R., 
Balke, C.W., & Efimov, I.R. 2007. Application of blebbistatin as an excitation-
contraction uncoupler for electrophysiologic study of rat and rabbit hearts. 
Heart Rhythm., 4, (5) 619-626. 
Feng, J., Xu, D., Wang, Z., & Nattel, S. 1998. Ultrarapid delayed rectifier 
current inactivation in human atrial myocytes: properties and consequences. 
Am.J Physiol, 275, (5 Pt 2) H1717-H1725. 
Ferrero, J.M., Jr., Saiz, J., Ferrero, J.M., & Thakor, N.V. 1996. Simulation of 
action potentials from metabolically impaired cardiac myocytes. Role of ATP-
sensitive K+ current. Circ.Res, 79, (2) 208-221. 
Fishman, G.I., Chugh, S.S., Dimarco, J.P., Albert, C.M., Anderson, M.E., Bonow, 
R.O., Buxton, A.E., Chen, P.S., Estes, M., Jouven, X., Kwong, R., Lathrop, D.A., 
Mascette, A.M., Nerbonne, J.M., O'Rourke, B., Page, R.L., Roden, D.M., 
Rosenbaum, D.S., Sotoodehnia, N., Trayanova, N.A., & Zheng, Z.J. 2010. Sudden 
cardiac death prediction and prevention: report from a National Heart, Lung, 
and Blood Institute and Heart Rhythm Society Workshop. Circulation, 122, (22) 
2335-2348. 
Fleet, W.F., Johnson, T.A., Cascio, W.E., Shen, J., Engle, C.L., Martin, D.G., & 
Gettes, L.S. 1994. Marked activation delay caused by ischemia initiated after 
regional K+ elevation in in situ pig hearts. Circulation, 90, (6) 3009-3017. 
Follmer, C.H. & Colatsky, T.J. 1990. Block of delayed rectifier potassium 
current, IK, by flecainide and E-4031 in cat ventricular myocytes. Circulation, 
82, (1) 289-293. 
Franz, M.R. 2003. The electrical restitution curve revisited: steep or flat slope--
which is better? J Cardiovasc Electrophysiol., 14, (10 Suppl) S140-S147. 
Friedman, P.A. 2002. Novel mapping techniques for cardiac electrophysiology. 
Heart, 87, (6) 575-582. 
Fujiki, A., Tani, M., Mizumaki, K., Shimono, M., & Inoue, H. 1994. 
Electrophysiologic effects of intravenous E-4031, a novel class III antiarrhythmic 
agent, in patients with supraventricular tachyarrhythmias. J Cardiovasc 
Pharmacol., 23, (3) 374-378. 
Furukawa, T., Moroe, K., Mayrovitz, H.N., Sampsell, R., Furukawa, N., & 
Myerburg, R.J. 1991. Arrhythmogenic effects of graded coronary blood flow 
232 
reductions superimposed on prior myocardial infarction in dogs. Circulation, 84, 
(1) 368-377. 
Gerlach, A.C., Stoehr, S.J., & Castle, N.A. 2010. Pharmacological removal of 
human ether-a-go-go-related gene potassium channel inactivation by 3-nitro-N-
(4-phenoxyphenyl) benzamide (ICA-105574). Molecular Pharmacology, 77, (1) 58-
68. 
Ghuran, A.V. & Camm, A.J. 2001. Ischaemic heart disease presenting as 
arrhythmias. Br.Med Bull., 59, 193-210. 
Gilmour, R.F., Jr. & Zipes, D.P. 1985. Slow inward current and cardiac 
arrhythmias. Am.J Cardiol., 55, (3) 89B-101B. 
Gintant, G.A. 2000. Characterization and functional consequences of delayed 
rectifier current transient in ventricular repolarization. Am.J Physiol Heart 
Circ.Physiol, 278, (3) H806-H817. 
Giustetto, C., Di, M.F., Wolpert, C., Borggrefe, M., Schimpf, R., Sbragia, P., 
Leone, G., Maury, P., Anttonen, O., Haissaguerre, M., & Gaita, F. 2006. Short QT 
syndrome: clinical findings and diagnostic-therapeutic implications. Eur.Heart J, 
27, (20) 2440-2447. 
Giustetto, C., Schimpf, R., Mazzanti, A., Scrocco, C., Maury, P., Anttonen, O., 
Probst, V., Blanc, J.J., Sbragia, P., Dalmasso, P., Borggrefe, M., & Gaita, F. 
2011. Long-term follow-up of patients with short QT syndrome. J 
Am.Coll.Cardiol., 58, (6) 587-595. 
Gollob, M.H., Redpath, C.J., & Roberts, J.D. 2011. The short QT syndrome: 
proposed diagnostic criteria. J Am.Coll.Cardiol., 57, (7) 802-812. 
Gussak, I., Brugada, P., Brugada, J., Antzelevitch, C., Osbakken, M., & 
Bjerregaard, P. 2002. ECG phenomenon of idiopathic and paradoxical short QT 
intervals. Card Electrophysiol.Rev., 6, (1-2) 49-53. 
Gussak, I., Brugada, P., Brugada, J., Wright, R.S., Kopecky, S.L., Chaitman, 
B.R., & Bjerregaard, P. 2000. Idiopathic short QT interval: a new clinical 
syndrome? Cardiology, 94, (2) 99-102. 
Guzman, S.V., Deleon, A.C., Jr., West, J.W., & Bellet, S. 1959. Cardiac effects 
of isoproterenol, norepinephrine and epinephrine in complete A-V heart block 
during experimental acidosis and hyperkalemia. Circ.Res, 7, (4) 666-672. 
Haissaguerre, M., Chatel, S., Sacher, F., Weerasooriya, R., Probst, V., 
Loussouarn, G., Horlitz, M., Liersch, R., Schulze-Bahr, E., Wilde, A., Kaab, S., 
Koster, J., Rudy, Y., Le, M.H., & Schott, J.J. 2009. Ventricular fibrillation with 
prominent early repolarization associated with a rare variant of KCNJ8/KATP 
channel. J Cardiovasc Electrophysiol., 20, (1) 93-98. 
Han, J. & Moe, G.K. 1964. Nonuniform recovery of excitability in ventricular 
muscle. Circ.Res, 14, 44-60. 
Harris, A.S. 1950. Delayed development of ventricular ectopic rhythms following 
experimental coronary occlusion. Circulation, 1, (6) 1318-1328. 
233 
Harris, A.S., Bisteni, A., Russell, R.A., Brigham, J.C., & Firestone, J.E. 1954. 
Excitatory factors in ventricular tachycardia resulting from myocardial ischemia; 
potassium a major excitant. Science, 119, (3085) 200-203. 
Harvey, R.D., Clark, C.D., & Hume, J.R. 1990. Chloride current in mammalian 
cardiac myocytes. Novel mechanism for autonomic regulation of action potential 
duration and resting membrane potential. J Gen.Physiol, 95, (6) 1077-1102. 
Hasenfuss, G. 1998. Animal models of human cardiovascular disease, heart 
failure and hypertrophy. Cardiovasc Res, 39, (1) 60-76. 
Hattori, T., Makiyama, T., Akao, M., Ehara, E., Ohno, S., Iguchi, M., Nishio, Y., 
Sasaki, K., Itoh, H., Yokode, M., Kita, T., Horie, M., & Kimura, T. 2012. A novel 
gain-of-function KCNJ2 mutation associated with short-QT syndrome impairs 
inward rectification of Kir2.1 currents. Cardiovasc Res, 93, (4) 666-673. 
Hayashi, H., Miyauchi, Y., Chou, C.C., Karagueuzian, H.S., Chen, P.S., & Lin, 
S.F. 2003. Effects of cytochalasin D on electrical restitution and the dynamics of 
ventricular fibrillation in isolated rabbit heart. J Cardiovasc Electrophysiol., 14, 
(10) 1077-1084. 
Hearse, D.J. 1994. Myocardial ischaemia: can we agree on a definition for the 
21st century? Cardiovasc Res, 28, (12) 1737-1744. 
Herzberg, I.M., Trudeau, M.C., & Robertson, G.A. 1998. Transfer of rapid 
inactivation and sensitivity to the class III antiarrhythmic drug E-4031 from HERG 
to M-eag channels. J Physiol, 511 ( Pt 1), 3-14. 
Hill, J.L. & Gettes, L.S. 1980. Effect of acute coronary artery occlusion on local 
myocardial extracellular K+ activity in swine. Circulation, 61, (4) 768-778. 
Hirche, H., Franz, C., Bos, L., Bissig, R., Lang, R., & Schramm, M. 1980. 
Myocardial extracellular K+ and H+ increase and noradrenaline release as 
possible cause of early arrhythmias following acute coronary artery occlusion in 
pigs. J Mol.Cell Cardiol., 12, (6) 579-593. 
Holahan, M.A., Stranieri, M.T., Stabilito, I.I., & Lynch, J.J., Jr. 1992. Effect of 
E-4031, a class III antiarrhythmic agent, on experimental infarct size in a canine 
model of myocardial ischemia-reperfusion injury. J Cardiovasc Pharmacol., 19, 
(6) 892-898. 
Holubarsch, C., Hasenfuss, G., Thierfelder, L., Pieske, B., & Just, H. 1991. The 
heart in heart failure. Ventricular and myocardial alterations. Eur.Heart J, 12 
Suppl C, 8-13. 
Hong, K., Bjerregaard, P., Gussak, I., & Brugada, R. 2005a. Short QT syndrome 
and atrial fibrillation caused by mutation in KCNH2. J Cardiovasc 
Electrophysiol., 16, (4) 394-396. 
Hong, K., Piper, D.R., Diaz-Valdecantos, A., Brugada, J., Oliva, A., Burashnikov, 
E., Santos-de-Soto, J., Grueso-Montero, J., Diaz-Enfante, E., Brugada, P., 
Sachse, F., Sanguinetti, M.C., & Brugada, R. 2005b. De novo KCNQ1 mutation 
responsible for atrial fibrillation and short QT syndrome in utero. Cardiovasc 
Res, 68, (3) 433-440. 
234 
Hua, F. & Gilmour, R.F., Jr. 2004. Contribution of IKr to rate-dependent action 
potential dynamics in canine endocardium. Circ.Res, 94, (6) 810-819. 
Huikuri, H.V., Castellanos, A., & Myerburg, R.J. 2001. Sudden death due to 
cardiac arrhythmias. N Engl J Med, 345, (20) 1473-1482. 
Ideker, R.E., Smith, W.M., & Wolf, P.D. 1989. Cardiac mapping at Duke Medical 
Center. Am.J Cardiol., 63 Suppl, 17F-30F. 
Janse, M.J., van Capelle, F.J., Morsink, H., Kleber, A.G., Wilms-Schopman, F., 
Cardinal, R., d'Alnoncourt, C.N., & Durrer, D. 1980. Flow of "injury" current and 
patterns of excitation during early ventricular arrhythmias in acute regional 
myocardial ischemia in isolated porcine and canine hearts. Evidence for two 
different arrhythmogenic mechanisms. Circ.Res, 47, (2) 151-165. 
Janse, M.J. & Wit, A.L. 1989. Electrophysiological mechanisms of ventricular 
arrhythmias resulting from myocardial ischemia and infarction. Physiol Rev., 69, 
(4) 1049-1169. 
Jonsson, M.K., Duker, G., Tropp, C., Andersson, B., Sartipy, P., Vos, M.A., & van 
Veen, T.A. 2010. Quantified proarrhythmic potential of selected human 
embryonic stem cell-derived cardiomyocytes. Stem Cell Res, 4, (3) 189-200. 
Jugdutt, B.I., Becker, L.C., & Hutchins, G.M. 1979. Early changes in collateral 
blood flow during myocardial infarction in conscious dogs. Am.J Physiol, 237, (3) 
H371-H380. 
Kagiyama, Y., Hill, J.L., & Gettes, L.S. 1982. Interaction of acidosis and 
increased extracellular potassium on action potential characteristics and 
conduction in guinea pig ventricular muscle. Circ.Res, 51, (5) 614-623. 
Kannengiesser, G.J., Lubbe, W.F., & Opie, L.H. 1975. Experimental myocardial 
infarction with left ventricular failure in the isolated perfused rat heart. Effects 
of isoproterenol and pacing. J Mol.Cell Cardiol., 7, (2) 135-151. 
Kantor, P.F., Coetzee, W.A., Carmeliet, E.E., Dennis, S.C., & Opie, L.H. 1990. 
Reduction of ischemic K+ loss and arrhythmias in rat hearts. Effect of 
glibenclamide, a sulfonylurea. Circ.Res, 66, (2) 478-485. 
Kaplinsky, E., Ogawa, S., Balke, C.W., & Dreifus, L.S. 1979a. Two periods of 
early ventricular arrhythmia in the canine acute myocardial infarction model. 
Circulation, 60, (2) 397-403. 
Kaplinsky, E., Ogawa, S., Balke, W., & Dreifus, L.S. 1979b. Role of endocardial 
activation in malignant ventricular arrhythmias associated with acute ischemia. 
J Electrocardiol., 12, (3) 299-306. 
Kardesch, M., Hogancamp, C.E., & Bing, R.J. 1958. The effect of complete 
ischemia on the intracellular electrical activity of the whole mammalian heart. 
Circ.Res, 6, (6) 715-720. 
Kishida, H., Surawicz, B., & Fu, L.T. 1979. Effects of K+ and K+-induced 
polarization on (dV/dt)max, threshold potential, and membrane input resistance 
in guinea pig and cat ventricular myocardium. Circ.Res, 44, (6) 800-814. 
235 
Klabunde, R. E. 2005, "Electrical Activity of the Heart," In Cardiovascular 
Physiology Concepts, Philadelphia: Lippincott Williams & Wilkins, pp. 9-40. 
Kleber, A.G., Janse, M.J., van Capelle, F.J., & Durrer, D. 1978. Mechanism and 
time course of S-T and T-Q segment changes during acute regional myocardial 
ischemia in the pig heart determined by extracellular and intracellular 
recordings. Circ.Res, 42, (5) 603-613. 
Kleinfeld, M.J. & Rozanski, J.J. 1977. Alternans of the ST segment in 
Prinzmetal's angina. Circulation, 55, (4) 574-577. 
Knisley, S.B., Justice, R.K., Kong, W., & Johnson, P.L. 2000. Ratiometry of 
transmembrane voltage-sensitive fluorescent dye emission in hearts. Am.J 
Physiol Heart Circ.Physiol, 279, (3) H1421-H1433. 
Kuo, C.S., Munakata, K., Reddy, C.P., & Surawicz, B. 1983. Characteristics and 
possible mechanism of ventricular arrhythmia dependent on the dispersion of 
action potential durations. Circulation, 67, (6) 1356-1367. 
Lazzara, R., El-Sherif, N., & Scherlag, B.J. 1975. Disorders of cellular 
electrophysiology produced by ischemia of the canine His bundle. Circ.Res, 36, 
(3) 444-454. 
Lederer, W.J., Nichols, C.G., & Smith, G.L. 1989. The mechanism of early 
contractile failure of isolated rat ventricular myocytes subjected to complete 
metabolic inhibition. J Physiol, 413, 329-349. 
Lee, B.H., Kim, W.H., Choi, M.J., Rho, J.R., & Kim, W.G. 2002. Chronic heart 
failure model in rabbits based on the concept of the bifurcation/trifurcation 
coronary artery branching pattern. Artificial Organs, 26, (4) 360-365. 
Lee, P., Klos, M., Bollensdorff, C., Hou, L., Ewart, P., Kamp, T.J., Zhang, J., 
Bizy, A., Guerrero-Serna, G., Kohl, P., Jalife, J., & Herron, T.J. 2012. 
Simultaneous voltage and calcium mapping of genetically purified human 
induced pluripotent stem cell-derived cardiac myocyte monolayers. Circ.Res, 
110, (12) 1556-1563. 
Lenz, T.L. & Hilleman, D.E. 2000. Dofetilide, a new class III antiarrhythmic 
agent. Pharmacotherapy, 20, (7) 776-786. 
Levick R.J 2010. An Introduction to Cardiovascular Physiology, 5 ed. Oxford 
University Press. 
Lichtman, J.W. & Conchello, J.A. 2005. Fluorescence microscopy. Nat Methods, 
2, (12) 910-919. 
Loew, L. M. 2001, "Mechanisms and Principles of Voltage-Sensitive," In Optical 
Mapping of Cardiac Excitation and Arrhythmias, D. S. Rosenbaum & J. Jalife, 
eds., Armonk, New York: Futura Publishing Company, Inc., pp. 33-46. 
Loew, L. M. 2010, "Design and Use of Organic Voltage Sensitive Dyes," In 
Membrane Potential Imaging in the Nervous System: Methods and Applications, 
M. Canepari & D. Zecevic, eds., New York, USA: Springer, pp. 13-23. 
236 
Loew, L.M., Cohen, L.B., Salzberg, B.M., Obaid, A.L., & Bezanilla, F. 1985. 
Charge-shift probes of membrane potential. Characterization of 
aminostyrylpyridinium dyes on the squid giant axon. Biophys.J, 47, (1) 71-77. 
Lord, B., Boswood, A., & Petrie, A. 2010. Electrocardiography of the normal 
domestic pet rabbit. Veterinary Record, 167, (25) 961-965. 
Lou, Q., Ripplinger, C.M., Bayly, P.V., & Efimov, I.R. 2008. Quantitative 
panoramic imaging of epicardial electrical activity. Ann.Biomed.Eng, 36, (10) 
1649-1658. 
Luqman, N., Sung, R.J., Wang, C.L., & Kuo, C.T. 2007. Myocardial ischemia and 
ventricular fibrillation: pathophysiology and clinical implications. Int.J Cardiol., 
119, (3) 283-290. 
Maciver, R.H., Stewart, R.D., Backer, C.L., Tsao, S., Harrington, D.A., & 
Mavroudis, C. 2010. An improved in vivo method for atrioventricular node 
ablation via thoracotomy. Braz.J Med Biol.Res, 43, (2) 206-210. 
Man, R.Y. & Bril, A. 1991. Effects of class I anti-arrhythmic drugs in infarcted 
tissue. Clin Invest Med, 14, (5) 466-475. 
Marcus, F.I., Cobb, L.A., Edwards, J.E., Kuller, L., Moss, A.J., Bigger, J.T., Jr., 
Fleiss, J.L., Rolnitzky, L., & Serokman, R. 1988. Mechanism of death and 
prevalence of myocardial ischemic symptoms in the terminal event after acute 
myocardial infarction. Am.J Cardiol., 61, (1) 8-15. 
Maury, P., Extramiana, F., Sbragia, P., Giustetto, C., Schimpf, R., Duparc, A., 
Wolpert, C., Denjoy, I., Delay, M., Borggrefe, M., & Gaita, F. 2008. Short QT 
syndrome. Update on a recent entity. Arch.Cardiovasc Dis., 101, (11-12) 779-
786. 
Maxwell, M.P., Hearse, D.J., & Yellon, D.M. 1987. Species variation in the 
coronary collateral circulation during regional myocardial ischaemia: a critical 
determinant of the rate of evolution and extent of myocardial infarction. 
Cardiovasc Res, 21, (10) 737-746. 
McIntosh, M.A., Cobbe, S.M., & Smith, G.L. 2000. Heterogeneous changes in 
action potential and intracellular Ca2+ in left ventricular myocyte sub-types 
from rabbits with heart failure. Cardiovasc Res, 45, (2) 397-409. 
McPate, M.J., Witchel, H.J., & Hancox, J.C. 2006. Short QT syndrome. 
Future.Cardiol., 2, (3) 293-301. 
Mines, G.R. 1913. On dynamic equilibrium in the heart. J Physiol, 46, (4-5) 349-
383. 
Miura, T., Downey, J.M., Ooiwa, H., Ogawa, S., Adachi, T., Noto, T., Shizukuda, 
Y., & Iimura, O. 1989. Progression of myocardial infarction in a collateral flow 
deficient species. Jpn.Heart J, 30, (5) 695-708. 
Modell, S.M. & Lehmann, M.H. 2006. The long QT syndrome family of cardiac ion 
channelopathies: a HuGE review. Genet.Med, 8, (3) 143-155. 
237 
Montana, V., Farkas, D.L., & Loew, L.M. 1989. Dual-wavelength ratiometric 
fluorescence measurements of membrane potential. Biochemistry, 28, (11) 
4536-4539. 
Morad, M. & Salama, G. 1979. Optical probes of membrane potential in heart 
muscle. J Physiol, 292, 267-295. 
Morgan, J.M., Cunningham, D., & Rowland, E. 1992. Electrical restitution in the 
endocardium of the intact human right ventricle. Br.Heart J, 67, (1) 42-46. 
Naik, H., Sabatine, M. S., & Lilly, L. S. 2007, "Ischemic Heart Disease," In 
Pathophysiology of Heart Disease, 4th ed. ed. L. S. Lilly, ed., Philadelphia, PA, 
USA: Lippincott Williams & Wilkins, pp. 141-167. 
Nalos, L., Varkevisser, R., Jonsson, M.K., Houtman, M.J., Beekman, J.D., van 
der Nagel, R., Thomsen, M.B., Duker, G., Sartipy, P., de Boer, T.P., Peschar, M., 
Rook, M.B., van Veen, T.A., van der Heyden, M.A., & Vos, M.A. 2012. 
Comparison of the IKr blockers moxifloxacin, dofetilide and E-4031 in five 
screening models of pro-arrhythmia reveals lack of specificity of isolated 
cardiomyocytes. Br.J Pharmacol., 165, (2) 467-478. 
Narayan, S.M. 2006. T-wave alternans and the susceptibility to ventricular 
arrhythmias. J Am.Coll.Cardiol., 47, (2) 269-281. 
Narayan, S.M., Lindsay, B.D., & Smith, J.M. 1999. Demonstration of the 
proarrhythmic preconditioning of single premature extrastimuli by use of the 
magnitude, phase, and distribution of repolarization alternans. Circulation, 100, 
(18) 1887-1893. 
Narayan, S.M. & Smith, J.M. 2000. Exploiting rate-related hysteresis in 
repolarization alternans to improve risk stratification for ventricular 
tachycardia. J Am.Coll.Cardiol., 35, (6) 1485-1492. 
Neely, J.R., Whitmer, J.T., & Rovetto, M.J. 1975. Inhibition of glycolysis in 
hearts during ischemic perfusion. Recent Adv.Stud.Cardiac.Struct.Metab, 7, 243-
248. 
Nerbonne, J.M. 2000. Molecular basis of functional voltage-gated K+ channel 
diversity in the mammalian myocardium. J Physiol, 525 Pt 2, 285-298. 
Newby, K.H., Thompson, T., Stebbins, A., Topol, E.J., Califf, R.M., & Natale, A. 
1998. Sustained ventricular arrhythmias in patients receiving thrombolytic 
therapy: incidence and outcomes. The GUSTO Investigators. Circulation, 98, (23) 
2567-2573. 
Ng, G.A., Brack, K.E., Patel, V.H., & Coote, J.H. 2007. Autonomic modulation of 
electrical restitution, alternans and ventricular fibrillation initiation in the 
isolated heart. Cardiovasc Res, 73, (4) 750-760. 
Nolasco, J.B. & Dahlen, R.W. 1968. A graphic method for the study of 
alternation in cardiac action potentials. J Appl.Physiol, 25, (2) 191-196. 
Nordrehaug, J.E. 1985. Hypokalemia, arrhythmias and early prognosis in acute 
myocardial infarction. Acta Med Scand., 217, (3) 299-306. 
238 
Nordrehaug, J.E., Johannessen, K.A., & von der, L.G. 1985. Serum potassium 
concentration as a risk factor of ventricular arrhythmias early in acute 
myocardial infarction. Circulation, 71, (4) 645-649. 
Nouchi, H., Kiryu, N., Kimata, M., Tsuneoka, Y., Hamaguchi, S., Namekata, I., 
Takahara, A., Shigenobu, K., & Tanaka, H. 2011. Developmental changes in 
action potential prolongation by K+-channel blockers in chick myocardium. J 
Pharmacol.Sci., 115, (2) 235-238. 
Oinuma, H., Miyake, K., Yamanaka, M., Nomoto, K., Katoh, H., Sawada, K., 
Shino, M., & Hamano, S. 1990. 4'-[(4-Piperidyl)carbonyl]methanesulfonanilides as 
potent, selective, bioavailable class III antiarrhythmic agents. J Med Chem., 33, 
(3) 903-905. 
Oostendorp, T.F. & van, O.A. 2004. ECGSIM: an interactive tool for the study of 
the relation between the electric activity of the heart and the QRST waveforms 
at the body surface. Conf.Proc.IEEE Eng Med Biol.Soc., 5, 3559-3562. 
Opthof, T., Coronel, R., Vermeulen, J.T., Verberne, H.J., van Capelle, F.J., & 
Janse, M.J. 1993. Dispersion of refractoriness in normal and ischaemic canine 
ventricle: effects of sympathetic stimulation. Cardiovasc Res, 27, (11) 1954-
1960. 
Oster, H.S., Taccardi, B., Lux, R.L., Ershler, P.R., & Rudy, Y. 1998. 
Electrocardiographic imaging: Noninvasive characterization of intramural 
myocardial activation from inverse-reconstructed epicardial potentials and 
electrograms. Circulation, 97, (15) 1496-1507. 
Padrini, R., Bova, S., Cargnelli, G., Piovan, D., & Ferrari, M. 1992. Effects of 
pinacidil on guinea-pig isolated perfused heart with particular reference to the 
proarrhythmic effect. Br.J Pharmacol., 105, (3) 715-719. 
Pastore, J.M., Girouard, S.D., Laurita, K.R., Akar, F.G., & Rosenbaum, D.S. 
1999. Mechanism linking T-wave alternans to the genesis of cardiac fibrillation. 
Circulation, 99, (10) 1385-1394. 
Patberg, K.W., Shvilkin, A., Plotnikov, A.N., Chandra, P., Josephson, M.E., & 
Rosen, M.R. 2005. Cardiac memory: mechanisms and clinical implications. Heart 
Rhythm., 2, (12) 1376-1382. 
Perrin, M.J., Subbiah, R.N., Vandenberg, J.I., & Hill, A.P. 2008. Human ether-a-
go-go related gene (hERG) K+ channels: function and dysfunction. Progress in 
Biophysics and Molecular Biology, 98, (2-3) 137-148. 
Petchdee, S. 2009. Arrhythmia mechanisms in acute ischaemia and chronic 
infarction in rabbit heart. University of Glasgow. 
Podesser, B., Wollenek, G., Seitelberger, R., Siegel, H., Wolner, E., Firbas, W., 
& Tschabitscher, M. 1997. Epicardial branches of the coronary arteries and their 
distribution in the rabbit heart: the rabbit heart as a model of regional ischemia. 
Anatomical Record, 247, (4) 521-527. 
239 
Pogwizd, S.M. & Corr, P.B. 1987a. Electrophysiologic mechanisms underlying 
arrhythmias due to reperfusion of ischemic myocardium. Circulation, 76, (2) 
404-426. 
Pogwizd, S.M. & Corr, P.B. 1987b. Reentrant and nonreentrant mechanisms 
contribute to arrhythmogenesis during early myocardial ischemia: results using 
three-dimensional mapping. Circ.Res, 61, (3) 352-371. 
Pogwizd, S.M., Schlotthauer, K., Li, L., Yuan, W., & Bers, D.M. 2001. 
Arrhythmogenesis and contractile dysfunction in heart failure: Roles of sodium-
calcium exchange, inward rectifier potassium current, and residual beta-
adrenergic responsiveness. Circ.Res, 88, (11) 1159-1167. 
Ponte, M.L., Keller, G.A., & Di, G.G. 2010. Mechanisms of drug induced QT 
interval prolongation. Curr.Drug Saf, 5, (1) 44-53. 
Prinzmetal, M., Toyoshima, H., Ekmekci, A., Mizuno, Y., & Nagaya, T. 1961. 
Myocardial ischemia. Nature of ischemic electrocardiographic patterns in the 
mammalian ventricles as determined by intracellular electrographic and 
metabolic changes. Am.J Cardiol., 8, 493-503. 
Priori, S.G., Aliot, E., Blomstrom-Lundqvist, C., Bossaert, L., Breithardt, G., 
Brugada, P., Camm, A.J., Cappato, R., Cobbe, S.M., Di, M.C., Maron, B.J., 
McKenna, W.J., Pedersen, A.K., Ravens, U., Schwartz, P.J., Trusz-Gluza, M., 
Vardas, P., Wellens, H.J., & Zipes, D.P. 2001. Task Force on Sudden Cardiac 
Death of the European Society of Cardiology. Eur.Heart J, 22, (16) 1374-1450. 
Priori, S.G., Pandit, S.V., Rivolta, I., Berenfeld, O., Ronchetti, E., Dhamoon, A., 
Napolitano, C., Anumonwo, J., di Barletta, M.R., Gudapakkam, S., Bosi, G., 
Stramba-Badiale, M., & Jalife, J. 2005. A novel form of short QT syndrome 
(SQT3) is caused by a mutation in the KCNJ2 gene. Circ.Res, 96, (7) 800-807. 
Prystowsky, E.N. 2004. Primary prevention of sudden cardiac death: the time of 
your life. Circulation, 109, (9) 1073-1075. 
Qu, F., Ripplinger, C.M., Nikolski, V.P., Grimm, C., & Efimov, I.R. 2007. Three-
dimensional panoramic imaging of cardiac arrhythmias in rabbit heart. J 
Biomed.Opt., 12, (4) 044019. 
Qu, Z., Garfinkel, A., Chen, P.S., & Weiss, J.N. 2000. Mechanisms of discordant 
alternans and induction of reentry in simulated cardiac tissue. Circulation, 102, 
(14) 1664-1670. 
Raeder, E.A., Rosenbaum, D.S., Bhasin, R., & Cohen, R.J. 1992. Alternating 
morphology of the QRST complex preceding sudden death. N Engl J Med, 326, (4) 
271-272. 
Ridley, P.D., Yacoub, M.H., & Curtis, M.J. 1992. A modified model of global 
ischaemia: application to the study of syncytial mechanisms of 
arrhythmogenesis. Cardiovasc Res, 26, (4) 309-315. 
Ripplinger, C.M., Lou, Q., Li, W., Hadley, J., & Efimov, I.R. 2009. Panoramic 
imaging reveals basic mechanisms of induction and termination of ventricular 
240 
tachycardia in rabbit heart with chronic infarction: implications for low-voltage 
cardioversion. Heart Rhythm., 6, (1) 87-97. 
Roden, D.M., Lazzara, R., Rosen, M., Schwartz, P.J., Towbin, J., & Vincent, 
G.M. 1996. Multiple mechanisms in the long-QT syndrome. Current knowledge, 
gaps, and future directions. The SADS Foundation Task Force on LQTS. 
Circulation, 94, (8) 1996-2012. 
Romero, L., Pueyo, E., Fink, M., & Rodriguez, B. 2009. Impact of ionic current 
variability on human ventricular cellular electrophysiology. Am.J Physiol Heart 
Circ.Physiol, 297, (4) H1436-H1445. 
Rosenbaum, D. S. 2001, "Introduction: Optical Mapping of Cardiac Excitation and 
Arrhythmias: A Primer," In Optical Mapping of Cardiac Excitation and 
Arrhythmias, D. S. Rosenbaum & J. Jalife, eds., Armonk, New York: Futura 
Publishing Company, Inc, pp. 2-7. 
Rosenbaum, D.S., Jackson, L.E., Smith, J.M., Garan, H., Ruskin, J.N., & Cohen, 
R.J. 1994. Electrical alternans and vulnerability to ventricular arrhythmias. N 
Engl J Med, 330, (4) 235-241. 
Rosenbaum, D.S. & Jalife, J. 2001. Optical Mapping of Cardiac Excitation and 
Arrhythmias Armonk, New York, Futura Publishing Company, Inc. 
Russell, J.C. & Proctor, S.D. 2006. Small animal models of cardiovascular 
disease: tools for the study of the roles of metabolic syndrome, dyslipidemia, 
and atherosclerosis. Cardiovasc Pathol., 15, (6) 318-330. 
Ryan, T.J., Anderson, J.L., Antman, E.M., Braniff, B.A., Brooks, N.H., Califf, 
R.M., Hillis, L.D., Hiratzka, L.F., Rapaport, E., Riegel, B.J., Russell, R.O., Smith, 
E.E., III, & Weaver, W.D. 1996. ACC/AHA guidelines for the management of 
patients with acute myocardial infarction: executive summary. A report of the 
American College of Cardiology/American Heart Association Task Force on 
Practice Guidelines (Committee on Management of Acute Myocardial Infarction). 
Circulation, 94, (9) 2341-2350. 
Samson, W.E. & Scher, A.M. 1960. Mechanism of S-T segment alteration during 
acute myocardial injury. Circ.Res, 8, 780-787. 
Sanguinetti, M.C., Jurkiewicz, N.K., Scott, A., & Siegl, P.K. 1991. Isoproterenol 
antagonizes prolongation of refractory period by the class III antiarrhythmic 
agent E-4031 in guinea pig myocytes. Mechanism of action. Circ.Res, 68, (1) 77-
84. 
Sanguinetti, M.C. & Mitcheson, J.S. 2005. Predicting drug-hERG channel 
interactions that cause acquired long QT syndrome. Trends in Pharmacological 
Sciences, 26, (3) 119-124. 
Schaper, W. 1986. [Pathophysiology of reperfusion]. Zeitschrift fur Kardiologie, 
75 Suppl 5, 73-75. 
Schaper, W., Jageneau, A., & Xhonneux, R. 1967. The development of collateral 
circulation in the pig and dog heart. Cardiologia, 51, (6) 321-335. 
241 
Scheler, S., Motz, W., & Strauer, B.E. 1994. Mechanism of angina pectoris in 
patients with systemic hypertension and normal epicardial coronary arteries by 
arteriogram. Am.J Cardiol., 73, (7) 478-482. 
Scherlag, B.J., El-Sherif, N., Hope, R., & Lazzara, R. 1974. Characterization and 
localization of ventricular arrhythmias resulting from myocardial ischemia and 
infarction. Circ.Res, 35, (3) 372-383. 
Schimpf, R., Wolpert, C., Gaita, F., Giustetto, C., & Borggrefe, M. 2005. Short 
QT syndrome. Cardiovasc Res, 67, (3) 357-366. 
Sicouri, S. & Antzelevitch, C. 1991. A subpopulation of cells with unique 
electrophysiological properties in the deep subepicardium of the canine 
ventricle. The M cell. Circ.Res, 68, (6) 1729-1741. 
Sicouri, S., Quist, M., & Antzelevitch, C. 1996. Evidence for the presence of M 
cells in the guinea pig ventricle. J Cardiovasc Electrophysiol., 7, (6) 503-511. 
Singh, B.N. & Vaughan Williams, E.M. 1970. A third class of anti-arrhythmic 
action. Effects on atrial and ventricular intracellular potentials, and other 
pharmacological actions on cardiac muscle, of MJ 1999 and AH 3474. Br.J 
Pharmacol., 39, (4) 675-687. 
Smeets, J.L., Allessie, M.A., Lammers, W.J., Bonke, F.I., & Hollen, J. 1986. The 
wavelength of the cardiac impulse and reentrant arrhythmias in isolated rabbit 
atrium. The role of heart rate, autonomic transmitters, temperature, and 
potassium. Circ.Res, 58, (1) 96-108. 
Smith, J.M. & Cohen, R.J. 1984. Simple finite-element model accounts for wide 
range of cardiac dysrhythmias. Proc.Natl.Acad.Sci.U.S.A, 81, (1) 233-237. 
Solomon, S.D., Zelenkofske, S., McMurray, J.J., Finn, P.V., Velazquez, E., Ertl, 
G., Harsanyi, A., Rouleau, J.L., Maggioni, A., Kober, L., White, H., Van de Werf, 
F., Pieper, K., Califf, R.M., & Pfeffer, M.A. 2005. Sudden death in patients with 
myocardial infarction and left ventricular dysfunction, heart failure, or both. N 
Engl J Med, 352, (25) 2581-2588. 
Stankovicova, T., Szilard, M., De, S., I, & Sipido, K.R. 2000. M cells and 
transmural heterogeneity of action potential configuration in myocytes from the 
left ventricular wall of the pig heart. Cardiovasc Res, 45, (4) 952-960. 
Straight, A.F., Cheung, A., Limouze, J., Chen, I., Westwood, N.J., Sellers, J.R., 
& Mitchison, T.J. 2003. Dissecting temporal and spatial control of cytokinesis 
with a myosin II Inhibitor. Science, 299, (5613) 1743-1747. 
Sun, Y., Quan, X.Q., Fromme, S., Cox, R.H., Zhang, P., Zhang, L., Guo, D., Guo, 
J., Patel, C., Kowey, P.R., & Yan, G.X. 2011. A novel mutation in the KCNH2 
gene associated with short QT syndrome. J Mol.Cell Cardiol., 50, (3) 433-441. 
Sutton, P.M., Taggart, P., Opthof, T., Coronel, R., Trimlett, R., Pugsley, W., & 
Kallis, P. 2000. Repolarisation and refractoriness during early ischaemia in 
humans. Heart, 84, (4) 365-369. 
242 
Szentadrassy, N., Banyasz, T., Biro, T., Szabo, G., Toth, B.I., Magyar, J., Lazar, 
J., Varro, A., Kovacs, L., & Nanasi, P.P. 2005. Apico-basal inhomogeneity in 
distribution of ion channels in canine and human ventricular myocardium. 
Cardiovasc Res, 65, (4) 851-860. 
Templin, C., Ghadri, J.R., Rougier, J.S., Baumer, A., Kaplan, V., Albesa, M., 
Sticht, H., Rauch, A., Puleo, C., Hu, D., Barajas-Martinez, H., Antzelevitch, C., 
Luscher, T.F., Abriel, H., & Duru, F. 2011. Identification of a novel loss-of-
function calcium channel gene mutation in short QT syndrome (SQTS6). 
Eur.Heart J, 32, (9) 1077-1088. 
Thomas, D., Karle, C.A., & Kiehn, J. 2006. The cardiac hERG/IKr potassium 
channel as pharmacological target: structure, function, regulation, and clinical 
applications. Curr.Pharm.Des, 12, (18) 2271-2283. 
Thygesen, K., Alpert, J.S., Jaffe, A.S., Simoons, M.L., Chaitman, B.R., White, 
H.D., Thygesen, K., Alpert, J.S., White, H.D., Jaffe, A.S., Katus, H.A., Apple, 
F.S., Lindahl, B., Morrow, D.A., Chaitman, B.R., Clemmensen, P.M., Johanson, 
P., Hod, H., Underwood, R., Bax, J.J., Bonow, J.J., Pinto, F., Gibbons, R.J., 
Fox, K.A., Atar, D., Newby, L.K., Galvani, M., Hamm, C.W., Uretsky, B.F., Steg, 
P.G., Wijns, W., Bassand, J.P., Menasche, P., Ravkilde, J., Ohman, E.M., 
Antman, E.M., Wallentin, L.C., Armstrong, P.W., Simoons, M.L., Januzzi, J.L., 
Nieminen, M.S., Gheorghiade, M., Filippatos, G., Luepker, R.V., Fortmann, S.P., 
Rosamond, W.D., Levy, D., Wood, D., Smith, S.C., Hu, D., Lopez-Sendon, J.L., 
Robertson, R.M., Weaver, D., Tendera, M., Bove, A.A., Parkhomenko, A.N., 
Vasilieva, E.J., Mendis, S., Bax, J.J., Baumgartner, H., Ceconi, C., Dean, V., 
Deaton, C., Fagard, R., Funck-Brentano, C., Hasdai, D., Hoes, A., Kirchhof, P., 
Knuuti, J., Kolh, P., McDonagh, T., Moulin, C., Popescu, B.A., Reiner, Z., 
Sechtem, U., Sirnes, P.A., Tendera, M., Torbicki, A., Vahanian, A., Windecker, 
S., Morais, J., Aguiar, C., Almahmeed, W., Arnar, D.O., Barili, F., Bloch, K.D., 
Bolger, A.F., Botker, H.E., Bozkurt, B., Bugiardini, R., Cannon, C., de, L.J., 
Eberli, F.R., Escobar, E., Hlatky, M., James, S., Kern, K.B., Moliterno, D.J., 
Mueller, C., Neskovic, A.N., Pieske, B.M., Schulman, S.P., Storey, R.F., Taubert, 
K.A., Vranckx, P., & Wagner, D.R. 2012. Third universal definition of myocardial 
infarction. J Am.Coll.Cardiol., 60, (16) 1581-1598. 
Tikkanen, J.T., Wichmann, V., Junttila, M.J., Rainio, M., Hookana, E., Lappi, 
O.P., Kortelainen, M.L., Anttonen, O., & Huikuri, H.V. 2012. Association of early 
repolarization and sudden cardiac death during an acute coronary event. 
Circ.Arrhythm.Electrophysiol., 5, (4) 714-718. 
Uchida, T., Yashima, M., Gotoh, M., Qu, Z., Garfinkel, A., Weiss, J.N., Fishbein, 
M.C., Mandel, W.J., Chen, P.S., & Karagueuzian, H.S. 1999. Mechanism of 
acceleration of functional reentry in the ventricle: effects of ATP-sensitive 
potassium channel opener. Circulation, 99, (5) 704-712. 
Vanheel, B. & de, H.A. 1992. Influence of KATP channel modulation on net 
potassium efflux from ischaemic mammalian cardiac tissue. Cardiovasc Res, 26, 
(11) 1030-1039. 
Venkatesh, N., Lamp, S.T., & Weiss, J.N. 1991. Sulfonylureas, ATP-sensitive K+ 
channels, and cellular K+ loss during hypoxia, ischemia, and metabolic inhibition 
in mammalian ventricle. Circ.Res, 69, (3) 623-637. 
243 
Verdouw, P.D., van den Doel, M.A., de, Z.S., & Duncker, D.J. 1998. Animal 
models in the study of myocardial ischaemia and ischaemic syndromes. 
Cardiovasc Res, 39, (1) 121-135. 
Verdouw, P.D., Wolffenbuttel, B.H., & van der Giessen, W.J. 1983. Domestic 
pigs in the study of myocardial ischemia. Eur.Heart J, 4 Suppl C, 61-67. 
Verrier, R.L., Nearing, B.D., La Rovere, M.T., Pinna, G.D., Mittleman, M.A., 
Bigger, J.T., Jr., & Schwartz, P.J. 2003. Ambulatory electrocardiogram-based 
tracking of T wave alternans in postmyocardial infarction patients to assess risk 
of cardiac arrest or arrhythmic death. J Cardiovasc Electrophysiol., 14, (7) 705-
711. 
Villafane, J., Atallah, J., Gollob, M.H., Maury, P., Wolpert, C., Gebauer, R., 
Watanabe, H., Horie, M., Anttonen, O., Kannankeril, P., Faulknier, B., Bleiz, J., 
Makiyama, T., Shimizu, W., Hamilton, R.M., & Young, M.L. 2013. Long-term 
follow-up of a pediatric cohort with short QT syndrome. J Am.Coll.Cardiol., 61, 
(11) 1183-1191. 
Volders, P.G., Stengl, M., van Opstal, J.M., Gerlach, U., Spatjens, R.L., 
Beekman, J.D., Sipido, K.R., & Vos, M.A. 2003. Probing the contribution of IKs to 
canine ventricular repolarization: key role for beta-adrenergic receptor 
stimulation. Circulation, 107, (21) 2753-2760. 
Wallace, A.A., Stupienski, R.F., III, Brookes, L.M., Selnick, H.G., Claremon, D.A., 
& Lynch, J.J., Jr. 1991. Cardiac electrophysiologic and inotropic actions of new 
and potent methanesulfonanilide class III antiarrhythmic agents in anesthetized 
dogs. J Cardiovasc Pharmacol., 18, (5) 687-695. 
Wallbridge, D.R. & Cobbe, S.M. 1996. Coronary haemodynamics in left 
ventricular hypertrophy. Heart, 75, (4) 369-376. 
Waller, A.D. 1887. A Demonstration on Man of Electromotive Changes 
accompanying the Heart's Beat. J Physiol, 8, (5) 229-234. 
Wang, Z., Fermini, B., & Nattel, S. 1993. Sustained depolarization-induced 
outward current in human atrial myocytes. Evidence for a novel delayed rectifier 
K+ current similar to Kv1.5 cloned channel currents. Circ.Res, 73, (6) 1061-1076. 
Warltier, D.C., Zyvoloski, M.G., Gross, G.J., & Brooks, H.L. 1982. Subendocardial 
versus transmural myocardial infarction: relationship to the collateral circulation 
in canine and porcine hearts. Can.J Physiol Pharmacol., 60, (12) 1700-1706. 
Watanabe, T., Yamaki, M., Yamauchi, S., Minamihaba, O., Miyashita, T., Kubota, 
I., & Tomoike, H. 2002. Regional prolongation of ARI and altered restitution 
properties cause ventricular arrhythmia in heart failure. Am.J Physiol Heart 
Circ.Physiol, 282, (1) H212-H218. 
Weber, K.T., Brilla, C.G., Campbell, S.E., Guarda, E., Zhou, G., & Sriram, K. 
1993. Myocardial fibrosis: role of angiotensin II and aldosterone. Basic Res 
Cardiol., 88 Suppl 1, 107-124. 
Weiss, J. & Shine, K.I. 1982. Extracellular K+ accumulation during myocardial 
ischemia in isolated rabbit heart. Am.J Physiol, 242, (4) H619-H628. 
244 
Weiss, J.N., Garfinkel, A., Karagueuzian, H.S., Qu, Z., & Chen, P.S. 1999. Chaos 
and the transition to ventricular fibrillation: a new approach to antiarrhythmic 
drug evaluation. Circulation, 99, (21) 2819-2826. 
Weiss, J.N., Venkatesh, N., & Lamp, S.T. 1992. ATP-sensitive K+ channels and 
cellular K+ loss in hypoxic and ischaemic mammalian ventricle. J Physiol, 447, 
649-673. 
Wettwer, E., Scholtysik, G., Schaad, A., Himmel, H., & Ravens, U. 1991. Effects 
of the new class III antiarrhythmic drug E-4031 on myocardial contractility and 
electrophysiological parameters. J Cardiovasc Pharmacol., 17, (3) 480-487. 
Widimsky, P., Gregor, P., Cervenka, V., & Visek, V. 1984. Two-dimensional 
echocardiography in acute transmural and non-transmural myocardial infarction. 
Cor et Vasa, 26, (1) 12-19. 
Wolleben, C.D., Sanguinetti, M.C., & Siegl, P.K. 1989. Influence of ATP-sensitive 
potassium channel modulators on ischemia-induced fibrillation in isolated rat 
hearts. J Mol.Cell Cardiol., 21, (8) 783-788. 
Yan, G.X. & Antzelevitch, C. 1998. Cellular basis for the normal T wave and the 
electrocardiographic manifestations of the long-QT syndrome. Circulation, 98, 
(18) 1928-1936. 
Yan, G.X., Joshi, A., Guo, D., Hlaing, T., Martin, J., Xu, X., & Kowey, P.R. 2004. 
Phase 2 reentry as a trigger to initiate ventricular fibrillation during early acute 
myocardial ischemia. Circulation, 110, (9) 1036-1041. 
Zipes, D.P. & Rubart, M. 2006. Neural modulation of cardiac arrhythmias and 
sudden cardiac death. Heart Rhythm., 3, (1) 108-113. 
 
 
